Etudes thermodynamiques et structurales des interactions entre les actinides et des ligands à base de phosphonate by Ye, Gaoyang
HAL Id: tel-02169209
https://tel.archives-ouvertes.fr/tel-02169209
Submitted on 1 Jul 2019
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Thermodynamic and structural investigations on the
interactions between actinides and phosphonate-based
ligands
Gaoyang Ye
To cite this version:
Gaoyang Ye. Thermodynamic and structural investigations on the interactions between actinides
and phosphonate-based ligands. Radiochemistry. Université Paris-Saclay, 2018. English. ￿NNT :
2018SACLS286￿. ￿tel-02169209￿
 
 
 
 
 
Thermodynamic and structural 
investigations on the interactions 
between actinides and phosphonate-
based ligands 
 
 
 
Thèse de doctorat de l'Université Paris-Saclay 
Préparée à l’Université Paris-Sud 
 
 
 
École doctorale n°576 Particules Hadrons Energie et Noyau : 
Instrumentation, Image, Cosmos et Simulation (PHENIICS) 
Spécialité de doctorat: Aval du cycle nucléaire, Radioprotection et Radiochimie 
 
 
 
Thèse présentée et soutenue à Orsay, le 19 septembre, par 
 
 Gaoyang YE  
 
 
 
Composition du Jury : 
 
M. David Aitken  
Professeur, Université Paris-Sud                                                             Président 
M. Jean Aupiais 
Professeur, CEA/DAM bruyère le Chatel                                                 Rapporteur  
M. Gilles Montavon 
Professeur, SUBATECH - MINES Nantes                                               Rapporteur 
M. Loic Charbonniere 
Professeur, CNRS Strasbourg                                                                   Examinateur 
M. Christophe Den Auwer 
Professeur, Université de NICE                                                                Examinateur 
M. Wangsuo Wu 
Professeur, University of Lanzhou                                                           Examinateur 
M. Eric Simoni 
Professeur, Université Paris-Sud                                                              Directeur de thèse 
N
N
T
 :
 2
0
1
8
S
A
C
L
S
2
8
6
 
2
0
1
8
S
A
C
L
S
2
8
6
 
 
 
  
 
2 
 
 
 
Acknowledgement 
 
 
This thesis work was done at l'institut de physique nucléaire d'orsay in the group of 
Radiochemistry, Université Paris-Sud. 
This work was funded by Chinese Science council. 
I want to thank in the first place my thesis director Eric Simoni for the trust he has given me 
throughout these three years, for enlightened advice whether at the lab or for the project. Thank you 
for your patience and your availability. 
I would like to thank Gilles Montavon and Jean Aupiais who accepted to be rapporteurs of my 
work, Loic Charbonniere, Christophe Den Auwer, Wangsuo Wu and David Aitken for having 
accepted to participate in my thesis jury. 
I would also like to thank the groupe of Synthèse Pour l’Analyse (SynPA) and more particularly 
Câline Christine and Alexandre Lecointre for the advice on organic synthesize, Raphael Gillet, 
Soumaya Khalfallah and Mohamadou Sy for the French language training,  Anne Boos and Jérémy 
Brandel for your kindles help for the ligand characterization. 
I would like to thank l’équipe de Radiochimie Humaine et Environnementale (RHE). Special 
mention for Gaëlle, thank you for your support and your advice that often allowed me to avoid the 
traps of the IR,  
Many thanks for the help on EXAFS study of Jérome Roques (Groupe Radiochime), Christophe 
Den Auwer (RHE) and Pier-Lorenzo Solari as well as to the members of the MARS line. 
I also thank my ‘greater groupe radiochime family’: Florian Brulfert, Davide Rodrigues, Thi-
Kim-Khanh Le, Gabriela Duran-Klie, Quentin Le Moëne, Céline Cannes, Sylvie Delpech, Romuald 
Drot, Elisabeth Seibert, Vladimir Sladkov and Véronika Zinovyeva, as well as Mingjian He, Thanks 
to you, these three years are filled with good memories. I would also like to express my thanks to 
Nicole Barre-Boscher, who help me fixed the instrument problem. 
Finally, I thank my family and friends for supporting me during these three years. First of all, my 
sincere gratitude to my parents who encouraged and advised me throughout my studies. I also thank 
to my friends to eat and drink together sometimes to pass the hard time.  
 
 
 
 
 
 
 
3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
 
Content 
General introduction............................................................................................... 4 
Chapter 1: Bibliographic study 
1 Conception of actinides decorporation ........................................................................ 8 
2 General introduction of actinides ................................................................................ 8 
2.1 Generality ............................................................................................................. 8 
2.2 Uranium ................................................................................................................ 9 
2.2.1 Uranium in the industry and environment .................................................... 9 
2.2.2 Physic-chemical properties of uranium ...................................................... 11 
2.3 Americium/curium ............................................................................................. 12 
2.3.1 Americium/curium in the industry and environment .................................. 13 
2.3.2 Physic-chemical properties of americium and curium, europium use as the 
chemical analogue ............................................................................................................ 13 
3 Toxicology ................................................................................................................. 16 
3.1 The contamination mode .................................................................................... 16 
3.1.1 Main entry routes ........................................................................................ 17 
3.1.2 Main excretion routes ................................................................................. 18 
3.2 The factor which influences the toxicity ............................................................ 19 
3.3 The bio-distribution of actinides ........................................................................ 19 
3.3.1 Uranium ...................................................................................................... 21 
3.3.2 Americium/curium ...................................................................................... 22 
3.4 Human Health Effects ........................................................................................ 23 
3.4.1 Uranium ...................................................................................................... 23 
3.4.2 Americium/curium ...................................................................................... 24 
3.5 Conclusion .......................................................................................................... 24 
4 Chelation therapy ....................................................................................................... 24 
4.1 Actinides chelating agents under studies............................................................ 26 
4.1.1 The poly-amino-carboxylic ligands ............................................................ 27 
4.1.2 Siderophores analogues: CAM & HOPO ................................................... 28 
4.1.3 Phosphonate ligands .................................................................................... 31 
4.2 Methods for in vitro study .................................................................................. 34 
4.3 Conclusion .......................................................................................................... 34 
5 Chelation study for biology simulation with calmodulin .......................................... 35 
5.1 Description of the protein ................................................................................... 35 
5.2 Interaction between calmodulin and calcium ..................................................... 36 
 
2 
 
5.3 Interactions between calmodulin and actinides .................................................. 37 
Chapiter 2: synthesis of polyaminophosphonates ligands 
1 General strategy ......................................................................................................... 42 
2 Synthesis of precursor ............................................................................................... 42 
2.1 Synthesis of pyridinic platform .......................................................................... 43 
2.2 Synthesis of amine monophosphonate ............................................................... 43 
3 Synthesis of bisphosphonate ligand L1 ...................................................................... 44 
4 Synthesis of bisphosphonate ligand L2 ...................................................................... 44 
5 Synthesis of bisphosphonate ligand L3 ...................................................................... 45 
6 Conclusion ................................................................................................................. 47 
7 Experimental part ...................................................................................................... 48 
Chapiter 3: structural and thermodynamic study of uranyl with 
polyaminophosphonates ligands 
1 Acid-base properties of polyaminophosphonates ligands ......................................... 56 
1.1 Potentiometric study ........................................................................................... 56 
1.2 Spectrophotometric study according to the pH .................................................. 60 
1.3 Conclusion .......................................................................................................... 62 
2 Uranium/ligands interactions studied by Time-resolved laser fluorescence 
spectroscopy (TRLFS) and UV-visible spectroscopy .............................................................. 62 
2.1 Time-resolved laser fluorescence spectroscopy (TRLFS) and UV-visible 
spectroscopy ......................................................................................................................... 62 
2.2 Experimental conditions selection...................................................................... 62 
2.3 Solubility test with uranyl-ligand complex ........................................................ 63 
2.4 Stability test with uranyl-ligand complex for sample preparation ..................... 64 
2.5 Stability test of uranyl-ligand complex with TRLFS ......................................... 69 
2.6 Study of uranyl-ligand complex ......................................................................... 72 
2.7 Conclusion .......................................................................................................... 77 
3 IR characterization of two ligands with uranium in aqueous solution ...................... 77 
3.1 IR spectra of ligands ........................................................................................... 77 
3.2 IR spectra of uranyl-ligand complexation .......................................................... 80 
3.3 Conclusion .......................................................................................................... 83 
4 Structural study of uranyl-ligand complexes ............................................................. 83 
4.1 Possible structure of uranyl-ligand complexes ................................................... 83 
4.2 Possible structure optimized by DFT ................................................................. 83 
4.3 EXAFS data analysis .......................................................................................... 86 
4.4 EXAFS data analysis of the uranyl-ligand complex .......................................... 86 
4.4.1 Uranyl-ligand study at pH 3 ........................................................................ 86 
 
3 
 
4.4.2 Uranyl-ligand study at pH 7.4 ..................................................................... 88 
4.4.3 Comparison of uranyl-ligand study at two pHs .......................................... 91 
4.5 Conclusion .......................................................................................................... 91 
5 Thermodynamics study by displacement titration ..................................................... 92 
5.1 Fast screening ..................................................................................................... 92 
5.2 Determination of the ligand complexation constants ......................................... 93 
6 Selectivity study with cation ...................................................................................... 95 
7 Chelation affinity of ligand towards Calmodulin - uranyl complex .......................... 96 
8 Conclusion ................................................................................................................. 98 
Chapiter 4: thermodynamic study of uranyl with 
polyaminophosphonates ligands 
1 Thermodynamics study of europium-L3 complex ................................................... 102 
2 Europium/ligands interactions studied by Time-resolved laser fluorescence 
spectroscopy (TRLFS) and UV-visible spectroscopy ............................................................ 103 
2.1 Experimental conditions selection.................................................................... 103 
2.2 Study of europium-ligand complexes .............................................................. 104 
2.3 Conclusion ........................................................................................................ 107 
3 IR characterization of two ligands with europium in aqueous solution .................. 108 
3.1 IR spectra of europium -ligand complexation .................................................. 108 
4 Structural study of europium-ligand complexes ...................................................... 109 
4.1 Possible structure of europium-ligand complexes ........................................... 109 
4.2 Possible structure optimized by DFT ............................................................... 109 
4.3 EXAFS data analysis of the europium-ligand complex ................................... 111 
4.3.1 Eu-L3 complex study at pH 3 .................................................................... 111 
4.3.2 Eu-L4 complex at pH 7.4 ........................................................................... 112 
5 Conclusion ............................................................................................................... 112 
Chapter 5: General conclusion 
General conclusion .......................................................................................................... 116 
Perspectives ..................................................................................................................... 117 
Appendix I: materials 
 Experiment conditions ............................................................................................. 119 
 Preparation of stock solutions .................................................................................. 119 
Annexe II: Experimental methods 
1 Potentiometry ........................................................................................................... 121 
1.1 Preparation of solutions .................................................................................... 121 
1.2 Potentiometric titrations ................................................................................... 121 
 
4 
 
2 UV-visible spectrophotometry ................................................................................. 122 
2.1 Titration for free ligand L3 species ................................................................... 122 
2.2 Displacement titration of uranyl-ligand complex ............................................. 122 
2.2.1 The solutions ............................................................................................. 122 
2.2.2 Procedure for the fast screening ................................................................ 122 
2.2.3 Procedure for the titration ......................................................................... 122 
3 Time-resolved laser fluorescence spectroscopy (TRLFS) ....................................... 123 
3.1 Principle ........................................................................................................... 123 
3.2 Luminescence property of europium ................................................................ 124 
3.3 Luminescence properties of uranium ............................................................... 125 
3.4 Instrumentation ................................................................................................. 126 
3.5 Samples ............................................................................................................ 126 
4 ATR-IR Spectroscopy .............................................................................................. 126 
4.1 Principle ........................................................................................................... 126 
4.2 General ............................................................................................................. 127 
4.3 IR measurements of the uranyl-L3 complex ..................................................... 127 
4.4 IR measurements of the uranyl-L4 complex ..................................................... 127 
4.5 IR measurements of the Eu-ligand complex .................................................... 128 
5 Functional Theory of Density (DFT) ....................................................................... 128 
6 EXAFS Spectroscopy .............................................................................................. 128 
6.1 The uranyl-L3 complex sample for EXAFS measurements ............................. 128 
6.2 The uranyl-L4 complex sample for EXAFS measurements ............................. 129 
6.3 The Eu-ligand complex sample for EXAFS measurements ............................. 129 
Annexe III: Thermodynamic data .............................................................. 130 
Reference ................................................................................................................... 131 
Résumé ....................................................................................................................... 131 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 
 
 
 
 
6 
 
Table of illustrations 
Figure 1： periodic table of actinide elements17. ....................................................................... 8 
Figure 2 : illustration of nuclear fuel cycle20. ........................................................................... 10 
Figure 3 : Pourbaix diagram of uraniumin a non-complexing aqueous medium calculate by 
Hydra/Medusa Chemical Equilibrium Database and Plotting Software. [U]= 10 𝛍𝐌; T=25.0 
°C. ............................................................................................................................................. 11 
Figure 4 : Pourbaix diagram of americium a non-complexing aqueous medium. [Am]= 10E-10 
𝐌; T=25.0 °C.29 ........................................................................................................................ 14 
Figure 5 : Cohesive energy for the rare earths (full. curves) and actinides (dashed curves). The 
smooth curves denote the cohesive energy in case these elements had remained divalent in their 
metallic modification, the jagged curves the cohesive energy of their trivalent metallic state.36
 .................................................................................................................................................. 16 
Figure 6 : The main routes of intake, transfer and excretion of radionuclides in the body (ICRP 
130). .......................................................................................................................................... 17 
Figure 7 : Uranium particles during inhalation contamination (ICRP 66). .............................. 17 
Figure 8 : Systemic model of the bio-distribution of uranyl ion in human body (ICRP 72). .. 22 
Figure 9 : Systemic model of the bio-distribution of the bone-surface seekers, americium and 
curium, in human body (ICRP 72). .......................................................................................... 23 
Figure 10 : Structures, abbreviated names, and pKa values of metal-binding units of different 
chelation ligands. Carboxylic acid; phosphoate acid; catecholate (CAM); hydroxypyridinonate 
(HOPO). ................................................................................................................................... 25 
Figure 11 : Chemical structure of EDTA and DTPA. .............................................................. 27 
Figure 12 : Binding unit’s structures and abbreviated names of siderophores. catecholate 
(CAM); hydroxypyridinonate (HOPO). ................................................................................... 29 
Figure 13 : Crystal structures of uranyl 5-LIO(Me-3,2-HOPO) complex107 and Gd(III) ........ 30 
Figure 14 : chemical structures of 3,4,3-LI(1,2-HOPO), 5-LIO(Me-3,2-HOPO)  and 5-
LICAM(S). ............................................................................................................................... 30 
Figure 15 : Structure of phosphonate group and bisphosphonate group. ................................. 31 
Figure 16 : Structure of 1-hydroxyethane-1,10-diphosphonic acid (HEDP), three 
bisphosphonate sequestering ligands (2H, 3C, 7B) and polyaminophosphonates ligand (L4).75
 .................................................................................................................................................. 32 
Figure 17 : Proposed Structure of the Uranyl-HEDP Complex. .............................................. 32 
Figure 18 : Example of displacement method: Displacements (%) of the uranyl SCP complex 
are presented in a color-coded format for clarity reason. logKcond (estimates) were calculated by 
using the HYSS program supposing that the complex competitive uranyl/ligand is 1:1.123 .... 33 
Figure 19 : Structure illustration of actinides chelation agents ................................................ 35 
Figure 20 : Schematic of the calcium binding site 1 of Paramecium tetraurelia calmodulin.146
 .................................................................................................................................................. 36 
Figure 21 : Fractional species calculation for 𝐂𝐚𝐱𝟐 +(calmodulin) as a function of [Ca2+]. The 
total calmodulin concentration is 15𝛍𝐌.155 ............................................................................. 37 
Figure 22 : Theoretical models and electronic density of the U(VI) interaction sites on the 
CaMWT calculated by DFT (oxygen: red, carbon: blue, nitrogen: light green, uranium: yellow 
and neptunium: dark green).151 ................................................................................................. 38 
Figure 23 : Chemical structure of ligands L1, L2, L3and L4. .................................................... 42 
 
7 
 
Figure 24 : Chemical structure of precursors. .......................................................................... 43 
Figure 25 : 1H RMN spectrum of ligand L2 (D2O, 400 MHz, t.a.). ......................................... 46 
Figure 26 : 13P RMN spectrum of ligand L2 (D2O, 161.9 MHz, t.a.). ...................................... 47 
Figure 27 : Chemical structures of ligands L2 and L3 (fully deprotonated forms). .................. 56 
Figure 28 : Potentiometric curve of ligand L3. Solvent: H2O; I = 0.1 M (NaClO4); T = 25.0(2) °C; 
[L3]tot = 8.168E-4 M. ................................................................................................................ 56 
Figure 29 : Chemical structure of the analogue pyridine tetracarboxylate (noted LC)............. 57 
Figure 30 : Distribution curves of protonated species of ligands L2, L3 and L4. Solvent : H2O; T 
= 25,0 °C ; I = 0.1 M (NaClO4) ; [L2]tot , [L3]tot and [L4]tot = 1E-4 M. ..................................... 60 
Figure 31 : Spectrophotometric titration of L3 as a function of pH. Solvent: H2O; T = 25.0 (2) °C; 
I = 0.1M (NaClO4); l = 1 cm; [L
3] tot = 1.02E-4 M. ................................................................ 61 
Figure 32 : Electronic spectra of the protonated species of ligand L3. Solvent: H2O; T = 25.0 
(2) °C; I = 0.1M (NaClO4); l = 1 cm. ....................................................................................... 61 
Figure 33 : Species diagram of uranyl ion; [U] = 5E-5 M in 0.1M NaClO4. ........................... 63 
Figure 34 : Fluorescence study of uranyl in each ionic solution at different pH; a [U] = 5E-5 M, 
pH 3, 0.1M NaCl; b [U] = 5E-5 M, pH 7.4, 0.1M NaCl; c [U] = 5E-5 M, pH 7.4, 0.1M NaClO4.
 .................................................................................................................................................. 64 
Figure 35 : Study of uranyl-L3 complex, absorption measure (left); TRLFS measure (right); [L3] 
= 5E-5 M, [U] 0-1 eq, pH 3, 0.1M NaCl. ................................................................................. 65 
Figure 36 : Study of uranyl-L3 complex, absorption measure (left); TRLFS measure (right); [L3] 
= 5e-5 M, [U] 0-1 eq, pH 7.4, 0.1M NaClO4. .......................................................................... 65 
Figure 37 : Study of uranyl-L3 complex, absorption measure (left); TRLFS measure (right); [L3] 
= 5e-5 M, [U] 0-1 eq, pH 7.4, 0.1M NaCl. .............................................................................. 66 
Figure 38 : Steps in the photocatalyzed H-atom abstraction from hydrocarbons by the uranyl 
dication.189 ................................................................................................................................ 66 
Figure 39 : HPLC chromatograms of air-saturated solutions of 0.5 mM 𝐔𝐎𝟐𝟐 + and 5 mM 
PhCH3 in 0.01M H3PO4 after irradiation with visible light in 15 min intervals. The monitoring 
wavelength was 254 nm.193 ...................................................................................................... 67 
Figure 40 : Plot showing increase in [PhCHO] with irradiation time. Data from Figure 13.193
 .................................................................................................................................................. 67 
Figure 41 : Sunlight spectrum in space as a function of wavelength. Public Domain Image, 
image source: Christopher S. Baird, data source: American Society for Testing and Materials 
Terrestrial Reference. ............................................................................................................... 68 
Figure 42 : Solubility of oxygen in water ................................................................................ 68 
Figure 43 : Comparison of uranyl-L3 complex by two preparation method, absorption measure 
(left); TRLFS measure (right); [L3] = 5E-5 M, [U] 0.8&1 eq, pH 3, 0.1M NaCl. ................... 69 
Figure 44 : Study of uranyl-L3 complex, absorption measure (left); TRLFS measure (right); [L3] 
= 5E-5 M, [U] 0-1 eq, pH 3, 0.1M NaCl. ................................................................................. 70 
Figure 45 : Study of uranyl-L3 complex under 430nm laser excitation, absorption measure (left); 
TRLFS measure (right); [L3] = 5E-5 M, [U] 0.8 &1eq, pH 3, 0.1M NaCl. ............................. 70 
Figure 46 : Study of uranyl-L2 1:1 complex under 430nm laser excitation, absorption measure 
(left); TRLFS measure (right); [L2] = 5E-5 M, [U] = 5E-5 M, pH 7.4. ................................... 72 
Figure 47 : Study of uranyl-L3 complex, absorption measure (left); TRLFS measure (right); [L3] 
= 5E-5 M, [U] 0-1 eq, pH 3, 0.1M NaCl. ................................................................................. 73 
Figure 48 : Evolution of the absorption ratio at 262nm (left) and the emitted intensity at 522 nm 
 
8 
 
(right) as a function of uranyl/L3; [L3] = 5E-5 M, [U] 0-1 eq, pH 3, 0.1M NaCl. ................... 73 
Figure 49 : Study of uranyl-L4 complex, absorption measure (left); TRLFS measure (right); [L4] 
= 5E-5 M, [U] 0-1 eq, pH 3, 0.1M NaCl. ................................................................................. 74 
Figure 50 : Evolution of the absorption ratio at 262nm (left) and the emitted intensity at 520 nm 
(right) as a function of uranyl/L4; [L4] = 5E-5 M, [U] 0-1 eq, pH 3, 0.1M NaCl. ................... 74 
Figure 51 : Study of uranyl-L3 complex, absorption measure (left); TRLFS measure (right); [L3] 
= 5E-5 M, [U] 0-1 eq, pH 7.4, 0.1M NaClO4. .......................................................................... 75 
Figure 52 : Evolution of the absorption ratio at 263nm as a function of uranyl/L3; [L3] = 5E-5 
M, [U] 0-1 eq, pH 7.4, 0.1M NaClO4. ...................................................................................... 75 
Figure 53 : Study of uranyl-L4 complex, absorption measure (left); TRLFS measure (right); [L4] 
= 5E-5 M, [U] 0-1 eq, pH 7.4, 0.1M NaClO4. .......................................................................... 76 
Figure 54 : Evolution of the absorption ratio at 263nm as a function of uranyl/L4; [L4] = 5E-5 
M, [U] 0-1 eq, pH 7.4, 0.1M NaClO4. ...................................................................................... 76 
Figure 55 : FT-IR spectra of pH in H2O. Spectra of L
4 in red and L3 in black. Difference spectra 
L3 minus half L4 (blue). ............................................................................................................ 78 
Figure 56 : FT-IR spectra of pH 7.4 in H2O. Spectra of L
4 in red and L3 in black. Difference 
spectra L3 minus half L4 (blue). ............................................................................................... 78 
Figure 57 : FT-IR spectra of difference spectrum at pH 3(red) and 7.4(black). Difference spectra 
L3 minus half L4 at each pH. .................................................................................................... 79 
Figure 58 : FT-IR spectra of L4 in H2O. Spectra recorded at pH 7.4 (red) and pH 3 (black). 
Difference spectrum pH 7.4 minus pH 3 (blue). ...................................................................... 79 
Figure 59 : FT-IR spectra of L3 in H2O. Spectra recorded at pH 7.4 (red) and pH 3 (black). 
Difference spectrum pH 7.4 minus pH 3 (blue). ...................................................................... 80 
Figure 60 : FT-IR spectra of uranyl-L3 at pH 3 in H2O. Spectra of uranyl-L
3 in red and L3 in 
black. Difference spectrum uranyl-L3 minus L3 (blue). ........................................................... 81 
Figure 61 : FT-IR spectra of uranyl-L4 (right) at pH 3 in H2O. Spectra of uranyl-L
4 in red and 
L4 in black. Difference spectrum uranyl-L4 minus L4 (blue). .................................................. 81 
Figure 62 : FT-IR spectra of of uranyl-L3 at pH 7.4 in H2O. Spectra of uranyl-L
3 in red and L3 
in black. Difference spectrum uranyl-L3 minus L3 (blue). ....................................................... 82 
Figure 63 : FT-IR spectra of uranyl-L4 (right) at pH 7.4 in H2O. Spectra of uranyl-L
4 in red and 
L4 in black. Difference spectrum uranyl-L4 minus L4 (blue). .................................................. 82 
Figure 64 : Theoretical models optimized by DFT and electronic density of L3 & L4 interaction 
sites with uranyl at pH 3 (Oxygen: red, carbon: blue, nitrogen: light green, uranium: yellow).
 .................................................................................................................................................. 84 
Figure 65 : Theoretical models optimized by DFT and electronic density of L4 interaction sites 
with uranyl at pH 7.4 (Oxygen: red, carbon: blue, nitrogen: light green, uranium: yellow). .. 85 
Figure 66 : U LIII edge k
3–weighted EXAFS spectra (left) and the corresponding Fourier 
transforms (right) of the L3-U complex (lower traces) and L4-U (upper traces) complex formed 
at pH 3. The experimental spectra are given in dash line and the fits are given in line. .......... 88 
Figure 67 : U LIII edge k
3–weighted EXAFS spectra (left) and the corresponding Fourier 
transforms (right) of the L3-U-OH complex (lower traces) and L4-U-OH (upper traces) complex 
formed at pH 7.4. The experimental spectra are given in dash line and the fits are given in line.
 .................................................................................................................................................. 90 
Figure 68 : Theoretical models optimized by DFT and electronic density of L3 & L4 interaction 
sites with uranyl at pH 3 and 7.4 (Oxygen: red, carbon: blue, nitrogen: light green, uranium: 
yellow). ..................................................................................................................................... 91 
 
9 
 
Figure 69 : Structure of three ligands. ...................................................................................... 93 
Figure 70 : Screening results of three ligands; [ligand] = 8E-5 M, [SCP] = [U] =4E-5 M, HEPES 
buffer=12.5 mmol, [nBu4N
+Cl-] =112.5 mmol at pH 7.4. ....................................................... 93 
Figure 71 : Competition displacement titration of uranyl-SCP complex by L2; [SCP] = [UO] 
=4e-5 M, [L2] 0-8E-4 M, HEPES buffer=12.5 mmol, [Bu4N
+Cl-] =112.5 mmol. ................... 94 
Figure 72 : Competition displacement titration of uranyl-SCP complex by L3; [SCP] = [U] =4e-
5 M, [L3] 0-8E-4 M, HEPES buffer=12.5 mmol, [nBu4N+Cl-] =112.5 mmol. ....................... 94 
Figure 73 : Selectivity study of 1:1 uranyl-L3 complex by Ca2+, absorption spectrum (left); 
fluorescence spectrum (right); [L3] = [U] =5E-5 M; [Ca2+] =0-350 eq; [NaClO4]=0.1 M. ..... 95 
Figure 74 : Selectivity study of 1:1 uranyl-L3 complex by Mg2+, absorption spectrum (left); 
fluorescence spectrum (right); [L3] = [U] =5E-5 M; [Mg2+] =0-150 eq; [NaClO4]=0.1 M. .... 96 
Figure 75 : Species diagram of Ca-UO2-CaM complex from pH 5 to 8; [CaM] = [U] =5E-5 M; 
[Ca2+] =2E-4 M; [NaClO4]=0.1 M. .......................................................................................... 96 
Figure 76 : Chelation study of L3 towards Ca-UO2-CaM complex, absorption spectrum (left); 
fluorescence spectrum (right); [CaM] = [UO2
2+] =2.5E-5 M; [Ca2+] =2E-4 M; [MES]=0, 1 and 
5eq ; [NaClO4]=0.1 M ; [MES]= 5 mmol ; pH 5.5. ................................................................. 97 
Figure 77 : Devolution study of L3 towards Ca-UO2-CaM complex, 1eq L
3 (left); 5eq L3 (right). 
[CaM] = [UO2
2+] =2.5E-5 M; [Ca2+] =2E-4 M; [MES]=0, 1 and 5eq ; [NaClO4]=0.1 M ; 
[MES]= 5 mmol ; pH 5.5. ........................................................................................................ 98 
Figure 78 : Comparison of CaM spectra from two devolutions. CaM1 in black; CaM5 in red; 
UO2-CaM in blue. .................................................................................................................... 98 
Figure 79 : Chemical structures of bis-phosphonated ligand L3 & L3* and tetra-phosphonated 
ligand L4 ................................................................................................................................. 102 
Figure 80 : Species diagram of europium ion, [Eu] = 5E-5 M in 0.1M NaClO4 (left); [Eu] = [L
4] 
= 1e-4 M in 0.1M NaClO4 (right). ......................................................................................... 103 
Figure 81 : Study of europium-L4 complex, absorption measure; [Eu] = [L4] = 1E-4 M , pH 3, 
0.1M NaClO4. ......................................................................................................................... 104 
Figure 82 : Study of europium-L3 complex, absorption measure; [Eu] = [L3] = 1E-4 M , pH 3, 
0.1M NaClO4. ......................................................................................................................... 105 
Figure 83 : Study of europium-L4 complex, absorption measure; [Eu] = [L4] = 1E-4 M, pH 5, 
0.1M NaClO4. ......................................................................................................................... 105 
Figure 84 : Study of europium-L3 complex, absorption measure; [Eu] = [L3] = 1E-4 M, pH 5, 
0.1M NaClO4. ......................................................................................................................... 106 
Figure 85 : Study of europium-L4 complex, absorption measure; [Eu] = [L4] = 1E-4 M, pH 7.4, 
0.1M NaClO4. ......................................................................................................................... 107 
Figure 86 : Study of europium-L3 complex, absorption measure; [Eu] = [L3] = 1E-4 M , pH 7.4, 
0.1M NaClO4. ......................................................................................................................... 107 
Figure 87 : FT-IR spectra of europium-L4 at pH 7.4 in H2O. Spectra of europium–L
4 in red and 
L4 in black. Difference spectrum europium-L4 minus L4 (blue). ........................................... 108 
Figure 88 : FT-IR spectra of europium−L3 at pH 3 in H2O. Spectra of europium -L3 in red and 
L3 in black. Difference spectrum europium−L3 minus L3 (blue). ......................................... 109 
Figure 89 : Theoretical models optimized by DFT and electronic density of L3/Eu3+ with 6 H2O 
at pH=3 (right) and L4/Eu3+ with 1 H2O at pH=7.4 (left) (Oxygen: red, carbon: blue, nitrogen: 
light green, uranium: yellow) ................................................................................................. 110 
Figure 90 : Eu LIII edge k
3–weighted EXAFS spectra (left) and the corresponding Fourier 
transforms (right) of the L3-Eu complex at pH 3. The experimental spectra are given in line and 
 
10 
 
the fits are given in dash line. ................................................................................................. 111 
Figure 91 : Eu LIII edge k
3–weighted EXAFS spectra (left) and the corresponding Fourier 
transforms (right) of the L4-Eu complex at pH 7.4. The experimental spectra are given in line.
 ................................................................................................................................................ 112 
Figure 92 : Chemical structures of bis-phosphonated ligand L2 & L3 and tetra-phosphonated 
ligand L4 ................................................................................................................................. 116 
Figure 93: Chemical structures of bis-phosphonated pyridine ligand .................................... 118 
Figure 94 : Perrin–Jablonski diagram253 ................................................................................ 123 
Figure 95 : Energy diagram and degeneracy lift for an Ln3+ ion ........................................... 124 
Figure 96 : Partial energy diagram of Eu3+ (4f6) showing the relative magnitude of the 
interelectronic repulsion (terms), spin–orbit coupling (levels) and crystal-field effects 
(sublevels). The downward arrows indicate the excited states 5D0 and 
5D1 from which 
luminescence occurs.254 .......................................................................................................... 124 
Figure 97 : Energy levels of the aqueous Eu ion (III) and associated transitions .................. 125 
Figure 98 : Fluorescence emission of uranyl.......................................................................... 125 
Figure 99 : Energy levels for a molecule. .............................................................................. 127 
 
  
 
11 
 
List of tables 
Table 1：Main treatments used in decorporation therapies versus the type of incorporation. iv, 
Intravenous; ip, intraperitoneal; im, intramuscular16.................................................................. 8 
Table 2：Oxidation States and electronic configurations for the Actinide Elements,18 aIn bold 
font are the most stable oxidation states under aqueous conditions, and in italics are those that 
were obtained under very specific conditions. ........................................................................... 9 
Table 3：World uranium production from mining in tons U (*Data from the World Nuclear 
Association). ............................................................................................................................. 10 
Table 4：Main isotopes of uranium. Trace: natural isotope in trace amount; syn: synthetic 
isotope. ..................................................................................................................................... 11 
Table 5：Main isotopes of americium. syn: synthetic isotope. ............................................... 13 
Table 6：Main isotopes of curium. syn: synthetic isotope. ..................................................... 13 
Table 7：Ionic radii (Å) of Eu and Am in different coordination numbers (CN) and at oxidation 
states.31,32 .................................................................................................................................. 15 
Table 8：Main isotopes of europium. ...................................................................................... 16 
Table 9：Default absorption parameters for Type F, M and S materials. ............................... 19 
Table 10：Biokinetic data on actinides. Data on the distribution of Np(IV) and Np(V) in rat 
and mouse.41,42 .......................................................................................................................... 20 
Table 11：Main families of ligands tested for decontamination/decorporation of Pu ,U and 
Am.5,16 ...................................................................................................................................... 27 
Table 12：Stabilities of some metal complexes relevant to therapeutic actinide removal. a Log 
KML, measured at 0.1 to 0.3 mol/L ionic strength and 20 to 25°C, values rounded to two 
significant figures. Numerical average is shown for two suitable values. Median is shown for 
three or more suitable values; b80; c79; d78; e84; f83; g77; h85; i86; j82; k81. .................................. 28 
Table 13：pKa of the catechol and hydroxypyridinone groups.39 ........................................... 29 
Table 14：Effect of a prompt injection of bisphosphonate ligands on the biodistribution and 
excretion of 233U(VI). Ligands were injected ip (30 mmol/kg, molar ratio 100) 5 min after 
injection of 9.2 kBq of 233U(VI); animals were sacrificed 5 days later. Data are expressed as % 
of injected radioactivity, discrepancies are due to rounding. Bold means are significantly 
different than control mean.75 ................................................................................................... 33 
Table 15：Major actinide ligands (M) present in selected in vivo human biological media.135
 .................................................................................................................................................. 34 
Table 16：Summarizes the values of the protonation constants determined by potentiometry of 
ligands L2 and L3 represented in their logarithmic form (log KLHx with 1 ≤ x ≤ 7). ................ 57 
Table 17：Successive protonation constant (log KLHx) of derivatives polyaminophosphonates 
from the literature compared to data measured for L2 and L3. ................................................. 59 
Table 18：Spectral characteristics of protonated species of ligand L3. ................................... 62 
 
12 
 
Table 19：Distances calculated by DFT for the four complexes ............................................ 84 
Table 20：Distances calculated by DFT for the two complexes. ............................................ 85 
Table 21：Description of the paths used to fit the EXAFS data of the L3-U complex determined 
at pH 3. S0² = 1.19; ΔE0 = 6.50 eV. R = 0.03; χ²i ln = 115.8. .................................................... 87 
Table 22 : Description of the paths used to fit the EXAFS data of the L4-U complex determined 
at pH 3. S0² = 1.27; ΔE0 = 5.67 eV. R = 0.02; χ²i ln = 4.35. ...................................................... 87 
Table 23 : Description of the paths used to fit the EXAFS data of the L3-U-OH complex 
determined at pH 7.4. S0² = 1.20; ΔE0 = 7.20 eV. R = 0.01; χ²i ln = 5.22. ................................ 89 
Table 24 : Description of the paths used to fit the EXAFS data of the L4-U-OH complex 
determined at pH 7.4. S0² = 1.22; ΔE0 = 3.62 eV. R = 0.01; χ²i ln = 27.3. ................................ 89 
Table 25 : Displacements (%) of the uranyl-SCP complex with logKcond (estimates) at pH 7.4 
were calculated by using the HYSS program supposing that the complex competitive uranyl-
ligand is 1:1. For details on the procedure, see the appendix. .................................................. 93 
Table 26 : Thermodynamic stability constants and protonation constants for the complexes 
formed with ligands L2 and L4 and various LnIII cations along the series and corresponding 
values of pLn. [a] pLn values are defined by pLn=-log[LnIII]free at pH 7.0 for [Ln
III ]=1 𝛍𝐦 and 
[L]=10  𝛍𝐦 ;242 [2] According to reference 13. [c] Precipitationof the complexes precludes 
accurate determination. The hydrolysis con- stants of the free Ln3+ cations have been taken into 
account in the statistical processing (logKLaOH=-8.83; logKNdOH=-8.20; logKEuOH=-7.78; 
logKGdOH=-7.85; logKTbOH=-7.66; logKErOH =-7.54; log KLuOH=-7.29). ................................ 102 
Table 27 : Distances calculated by DFT for the Eu-L3 complex at pH 3 ............................... 110 
Table 28 : Distances calculated by DFT for the Eu-L4 complex at pH 7.4 ............................ 110 
Table 29 : Description of the paths used to fit the EXAFS data of the Eu-L3 complex at pH 3. 
S0² = 1; ΔE0 = 4.69 eV. R = 0.01; χ²i ln = 23.6 ........................................................................ 111 
Table 30 : Formation constant which used in this study ........................................................ 130 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
General introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
General introduction 
4 
 
 
During the military and industrial application of enriched uranium in the middle of the 20th 
century, the properties of uranium, plutonium and most of the fission product were not well 
studied. The large amount of radioactive materials which produced in this period could be 
considered equal to tons of radium1.Therefore, with the development of nuclear energy 
industry, especially industrial accidents (Mayak, Chernobyl, Fukushima), the manipulation and 
accumulation of actinides lead to consider the dispersion, fate and health effect of these 
radioactive materials2–4. Nowadays the contamination is still happened for the nuclear workers, 
scientist and soldiers.5  
After an external or internal contamination, the solubilized actinides could be distributed 
to the target organs via the bloodstream. Uranium, which is in [UO2]
2+ form and 
americium/curium, which are in Am3+ and Cm3+ form, preferentially transfer to the skeletal, 
liver and kidneys tissues and are retained at these target organs. Due to the chemo-toxicity and 
radio-toxicity of these elements, the acute effect on health could cause death and the long-term 
effect could result in cancer, anemia and necrosis6. 
In order to limit sequence damage to organs by promoting the actinides excretion, chelating 
agents was used to serve this purpose. Diethylenetriaminepentaacetic acid (DTPA) presents 
particularly affinity towards actinides(IV), and it is currently used in clinics in case of 
contamination7,8. Polyphosphonates (HEDP9) is also used in clinics for uranium(VI) 
decorporation. 3,4,3-Li(1,2-HOPO), a siderophore derivative under investigation, has shown 
strong affinities for actinides (III), (IV), (V) and (VI)10,11. With the development of actinide 
chelating agents, several properties for agents are enrolled to have strong affinity and selectivity 
towards actinides, low toxicity, high excretion rate, etc.  
The decorporation agents are toxic because of both the nature of ligand and the large 
amount injection for chelation therapy in a biological medium. Essential elements such as iron 
and calcium are also chelated just like actinides considering the concentration of essential 
elements. Therefore, good molecular designs are required for several important aspects among 
the other demands: 1) to distribute the chelating agents to the target organs; 2) to excrete the 
complex of target toxic element with chelating agents by urine or bile; 3) high selectivity and 
binding affinity with the target toxic element over the other metal ion to decrease the injection 
amount of chelating agents. The polyaminophosphonates ligands in this study are originally 
designed for  magnetic resonance imaging (MRI) contrast and Single-Photon Emission 
Computed Tomography (SPECT) study12,13. From the 99mTc ligand complex SPECT study, a 
large amount of 99mTc with four phosphonate groups ligand could be fast excrete and part of 
the complex accumulated in bone tissues after 4 h. While for 99mTc with two phosphonate 
groups ligand complex, due to the more lipophilic character, fast excretion and much less 
retention in the joints could be found. And lanthanides could forms tight binding with four 
phosphonate groups ligand with similar high stability constants like DOTP14, the phosphonated 
analogue of DOTA, than those with DOTA15. The coordination of lanthanides by the four 
phosphonate groups ligand is composed by 1 nitrogen atom from pyridine group, 2 nitrogen 
atoms from amine parts, 4 oxygen atoms from phosphonate groups and 1 oxygen atom from 
water molecular. Meanwhile two of the methylene-phosphonate groups are lie close to that 
plane of the pyridyl fragment and form 5 coordination at equatorial planar, the other two 
methylenephosphonate groups are placed above and below the mean plane of the pyridyl 
fragment.13 Due to the similarity of actinides ligand complex with 99mTc ligand complex and 
lanthanides ligand complex, we supposed the possible bio-distribution and excretion of four 
phosphonate groups ligand and two phosphonate groups ligand will show similar behaviors 
with the complex of 99mTc with ligands. According to the molecular design, high selectivity and 
binding affinity with actinides could be reached. Therefore the potential application on 
chelation therapy should be promising.  
This thesis project is a preliminary investigation on the polyaminophosphonates ligands, a 
series ligand designed for MRI contrast and SPECT agents, to chelate the actinides which are 
deposited in the target organs in order to increase their excretion.  
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This PhD work has focused on the synthesis of polyaminophosphonates ligands and on the 
structural and affinity study of the complexes form with uranium(VI) and europium(III) as 
americium/curium(III) analogue. The sphere of coordination of these cations could be observed 
by UV-visible spectroscopy, TRLFS, FT-IR and Extended X-Ray Absorption Fine Structure 
(EXAFS).The affinity study will be done with UV-visible spectroscopy, and in the case of 
europium complexes, potentiometry measurement could be done in addition. Finally, the UV-
visible spectroscopy and TRLFS will be used to test the stability of uranyl ligand complex with 
competition metal ion in biology conditions and to reveal the interaction between the ternary 
system, uranyl ion, ligand, calmodulin. 
This project was conducted as following:  
- Synthesize polyaminophosphonates ligands which capable to complex uranium (VI) and 
americium/curium(III) in a biological medium. 
- Characterize the structures of uranyl ligand complex formed by synthesized 
polyaminophosphonates ligands. Estimate affinities of these uranyl ligand complexes to 
compare with 5-LICAMS and 3,4,3-LI(1,2-HOPO), which have good potential application on 
chelation therapy. Competition mechanisms study with uranyl calmodulin complex and ligand 
and with uranyl ligand complex and competition metal ion will be done to reveal possible effect 
in biology conditions.  
- Characterize the structures of europium, as the americium/curium analogue, ligand 
complex formed by synthesized polyaminophosphonates ligands. 
This dissertation is articulated around four chapters: 
The first chapter is devoted to the description of the fate and health effect of actinides, 
uranium (VI) and americium/curium(III), in the human body. The actinide chelation agent 
current and those in development are also referenced.  
The second chapter details the synthesize of polyaminophosphonates ligands which 
designed for decorporation of actinides, uranium (VI) and americium/curium(III), that we wish 
to have a strong affinity with actinides.  
The third and fourth chapters will focus on the study of the affinity between the protein and 
the metals of interest (UV-visible spectroscopy, TRLFS and FT-IR) and on the determination 
of the coordination sphere of the uranyl ions and europium(IV) when they are complexed by 
synthesized polyaminophosphonates ligands (EXAFS and DFT calculations). Once the 
complexation proved and the sphere of coordination of the metals defined, the simulation test 
in biology conditions will be done with uranyl calmodulin complex to determine the chelation 
affinity of ligand and with uranyl ligand complex and competition metal to test the 
complexation stability.  
A conclusion of this work proposing a reflection on the applicability of this strategy based 
on polyaminophosphonates ligands will be approached to define and present the numerous 
problems that remain to be solved.  
The appendixes grouped at the end of the manuscript are related to the preparation of the 
solutions and the description of the principles of each experimental technique used. 
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Conception of actinides decorporation  
Decorporation is the method which is dedicated to remove the radioactive and toxic 
elements which has been incorporated in target organs from human body. The main treatments 
used in decorporation therapies were listed in table 1 concerninig actinide contamination. 
However, in reality, this strategy faces many obstacles: often difficult to transfer to the target 
organ, hard to withdraw radioactive and toxic elements deposited in the target organ, related to 
the complexity of a living organism. In practice, a very good in vitro ligand can be totally 
ineffective, and sometimes even harmful, in vivo evaluations.  
 
Type of incorporation Treatment 
Inhalation 
Lung washing 
Blood chelation (iv, ip, im) 
Ingestion 
Gastric dressing 
Precipitation Purge 
Wound 
Washing Surgical excision, 
dressing Blood chelation (iv, ip, im) 
Table 1：Main treatments used in decorporation therapies versus the type of 
incorporation. iv, Intravenous; ip, intraperitoneal; im, intramuscular16. 
Thus to better understand and investigate effective methods to remove actinides deposited 
in human body, three fundamental aspects related with this question need to be studied: the 
chemical and physical properties of actinides (uranium and americium/curium in this study); 
the toxicology of actinides (uranium and americium/curium in this study); countermeasures 
after contamination (chelation therapy in this study).  
For this project, we focus on synthesis chelation ligands for uranium and americium/curium 
by using europium as the chemical analogue.   
General introduction of actinides  
1.1 Generality 
The actinide elements are the 15 chemical elements with atomic numbers 89 through 103 
which are naturally occurring or artificial metallic elements (Fig. 1). The first member of 
actinide elements is actinium and the last member is lawrencium. The generation of these 
radionuclides mainly comes from accelerator driven, nucleo-synthesis, nuclear weapon 
development, decayed isotopes and civilian nuclear power plants. Owing to the radioactivity, 
actinides can be used as fuels in nuclear plants, leading to lanthanide isotopes and trans-uranium 
elements as the fission products in spent fuels. 
 
Figure 1： periodic table of actinide elements17. 
The chemical properties of actinide elements are governed by their outermost electronic 
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subshells. The actinides are the transition elements that fill the 5f subshell (Table 2). Hence 
there are some unique properties for actinide:  
• All actinide isotopes are radioactive; 
• The radii of actinides and actinide cations are very large;  
• Many of the actinide elements have a large number of oxidation states. 
eleme
nt 
Electronic configuration outside the 
[Xe] core 
low 
oxidation 
high 
oxidation 
very high 
oxidation 
  An An3+ states states states 
Ac 6d17s2 5f0 III   
Th 6d27s2 5f1 IV     
Pa 5f26d17s2 5f2 IV V  
U 5f36d17s2 5f3 III, IV V, VI   
Np 5f46d17s2 5f4 III, IV V, VI VII 
Pu 5f67s2 5f5 III, IV V, VI VII, VIII 
Am 5f77s2 5f6 III,IV V,VI VII 
Cm 5f76d17s2 5f7 III,IV     
Bk 5f97s2 5f8 III,IV   
Cf 5f107s2 5f9 III,IV     
Es 5f117s2 5f10 II,III     
Table 2：Oxidation States and electronic configurations for the Actinide Elements,18 aIn 
bold font are the most stable oxidation states under aqueous conditions, and in italics 
are those that were obtained under very specific conditions. 
For the biological point of view, actually actinides are the chemical elements which have 
no essential or beneficial for life. Due to the radioactivity (radio-toxic) and chemical behavior 
(chemo-toxic), the actinides are considered toxic. However at normal environmental levels, this 
toxicity could be managed by human body itself, by excretion and/or retention of the metal in 
a biochemically inactive form. But the nuclear weapon tests and industrial exploitation of the 
actinides with actinides, mainly uranium and plutonium, initiate societal and environmental 
questions because of the pollution and human contamination risk. Therefore the need to 
understand the behaviors of actinides with human is essential to elucidate their mechanisms of 
toxicity. Then the request for therapeutic actinide chelation agents is also urgent.  
1.2 Uranium  
Uranium is a chemical element with symbol U and atomic number 92. The Prussian chemist 
Martin Heinrich Klaproth was the first to isolate uranium from pechblende in its oxide form in 
1789. Then in 1841, Eugene-Melchior Péligot obtained the pure uranium metal by reducing 
uranium tetrachloride (UCl4) with potassium metal. In 1896 its radioactivity was found by Henri 
Becquerel and further proved by the work on the radioactivity of Pierre and Marie Curie. 
1.2.1 Uranium in the industry and environment  
Before the Second World War, interest in uranium was limited. Uranium has been used 
since ancient Rome as a pigment for faience and ceramics. It is abundant on Earth (about 3 g/t 
in granitic or sedimentary soils and 3 mg/m3 in seawater). After the discovery of the U-235 
fission by the Enrico Fermi team in December 1942, uranium has been used in military weapon 
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(uncontrolled nuclear energy) and nuclear power plant (controlled nuclear energy). The energy 
released during the complete fission of the U-235 is about 2E7 kWh/kg. Also the high-density 
and high-melting properties of this metal (U-235 depleted uranium in this case) are also used 
for tank armor, anti-tank ammunition, missiles and other projectiles. 
 
year 2010 2011 2012 2013 2014 2015 2016 
total 53,671 53,493 58,489 59,331 56,041 60,496 62,366 
% of demand* 78% 85% 86% 92% 85% 90% 98% 
Table 3：World uranium production from mining in tons U (*Data from the World 
Nuclear Association). 
Although nuclear industry suffered a crisis due to the Fukushima accident in 2011, the 
uranium industry is actually growing within recent years (Table 3). Every year, tens of 
thousands tons of uranium are chemically produced and enriched. While safety is the priority 
in the nuclear industry and can be considered excellent, several accidents have occurred in the 
past.19 In such accidents, the radiological risk may be significant due to the relatively high 
radioactive isotopes, 232U, 233U, 234U and 235U, especially during the mining and reprocessing 
processes. 
Many forms and different abundance of uranium are produced and manipulated by the 
nuclear industry along the complex and multi-stage processes of the fuel cycle (Fig. 2). These 
forms have very different physicochemical properties and therefore different dangerousness. 
An important parameter is the aqueous solubility of different forms of uranium; the biological 
transferability of species depends on this parameter. These main chemical species are: 
 
Figure 2 : illustration of nuclear fuel cycle20. 
- Soluble forms: UO2(SO4)n
(2n-2)-, UO2(CO3)n
(2n-2)- (produced during the first stage of the 
chemical treatment in mining); UO2(NO3)2; 
- Non or slightly soluble forms: UF4; UO2; UO3; U3O8 (the main form found after the 
explosion of a depleted uranium ammunition); (NH4)2U2O7 (Yellow cake); 
- "Reactive" forms: uranium metal (pyrophoric) reacts with water to give UO2 and H2; UF6 
reacts with H2O to give UO2F2 (soluble). 
Four types of uranium UOx, varying according to their isotopic compositions, are produced 
industrially: depleted uranium (-0.2% 235U) which is the secondary product of uranium 
enrichment, moderately enriched uranium (3-5% 235U) used in nuclear reactors, highly enriched 
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uranium (20 to 90% U-235) for research use and highly enriched uranium ( > 90% 235U) which 
is used in the construction of nuclear weapons. 
1.2.2 Physic-chemical properties of uranium 
Until now 24 uranium isotopes, all radioactive, have been identified. Natural uranium is 
composed of three isotopes: U-238, U-235 and U-234 (Table 4) but a total of 24 isotopes of 
uranium could be produced, from U-217 to U-242. The three natural isotopes are all radioactive. 
U-238 and U-235, the abundant isotopes, are the ascendants of the 4n+2 and 4n+3 decay 
families.  
 
Isotope Half-life (year) Abundance Decay mode 
U-238 4,47E+09 99,28% α/SF 
U-236 2,34E+07 trace α/SF 
U-235 4,04E+08 0,72% α/SF 
U-234 2,45E+05 0,01% α/SF 
U-233 1,59E+05 trace α/SF 
U-232 68,9 syn α/SF 
Table 4：Main isotopes of uranium. Trace: natural isotope in trace amount; syn: 
synthetic isotope. 
234U, 235U, 238U could decays and generate alpha-particle with a mean energies about 4.2-
4.8 MeV. Due to the relatively short half-life of 234U, the specific activity of 235U, 2.3E8 Bq/g, 
is 2880 times higher than that of 235U, 8.0E4 Bq/g and 19200 times higher than that of 238U, 
1.2E4 Bq/g. Due to the relatively long half-life for two isotopes, the power output per unit mass 
is low enough, so the heat generation after contamination could be neglected.  
The uranium atom has the following external electronic configuration: 
5s25p65d105f36s26p66d17s2. The six outermost electrons of levels 5f, 6d and 7s form the uranium 
valence electron system. Uranium, like all actinides, has several stable or unstable oxidation 
states depending on the conditions: +III (U3+), +IV (U4+), +V (UO2
+), +VI (UO2
2+) and 0 (U) in 
metallic form. 
 
Figure 3 : Pourbaix diagram of uraniumin a non-complexing aqueous medium calculate 
by Hydra/Medusa Chemical Equilibrium Database and Plotting Software. [U]= 10 𝛍𝐌; 
T=25.0 °C.  
The thermodynamic and hydrolytic properties of uranium can be represented in the form 
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of a Pourbaix diagram (Fig. 3). It shows the E/pH diagram of uranium for a total concentration 
of U (VI) equal to 10E-5 M at the temperature of 298 K in a non-complexing aqueous medium. 
This diagram shows: 1) the dominance species U (VI) (aq); 2) the instability of U(III) (aq) with 
respect to oxidation by H+ (aq); 3) the inexistence of the thermodynamic stability domain of U 
(V) (aq). 
The redox properties of uranium in an aqueous medium illustrates the thermodynamic 
instability of U3+ with respect to protons in the solution and the thermodynamic instability of 
UO2
+ with respect to U4+ and UO2
2+ disproportionation (Scheme 1). 
 
Scheme 1 : Latimer diagram of uranium in aqueous solution (potentials are expressed in 
a 1 M perchloric acid medium (in V/SHE). 
Among the four oxidation states of uranium in aqueous solution, U (IV) and in particular 
U (VI) are the most important. Indeed, it is these species that are found in the vast majority in 
the environment and in biological environments. In vivo, U (IV) is rapidly oxidized to U (VI). 
It is therefore this single degree of oxidation that focuses the interest for projects such as the in 
vivo decorporation of uranium. 
In an aqueous medium, uranyl (UO2
2+) is predominate species. Uranyl is a very stable linear 
system [O=U=O]2+. As indicated by Denning et al.,21 several symmetrical overlaps occur 
between uranium atomic orbital (OA) 6d and oxygen OA 2p to form binding OMs 3σg and 2πg. 
Plutonium, neptunium, and americium, under oxidizing conditions can also be found in their 
actinyl form (AnO2
+,2+). This trans-oxo form is specific to actinides because of the presence of 
fz3 orbitals.  
Like all other actinide cations, uranyl is a hard acid according to the Pearson classification. 
So it has strong affinity for hard bases like carboxylates or phosphonates. Because of the steric 
hindrance caused by the oxo groups, the metal/ligand orbital recovery will be in the equatorial 
plane and the electronic transfers will preferentially be ligand to the OAs d or f. The effect of a 
donor ligand on uranyl results in the weakening of the bond O=U=O, by formal reduction of 
the binding order. Thus this weakening of the bond O=U=O is observable in infrared 
spectroscopy. Indeed the antisymmetric vibrating band of the U-O bond, only IR active, will 
shift from 950 cm-1 for a hexaaquo complex22 to about 920 cm-1 in the case of coordination by 
phosphonate functions23,24.  
Due to the presence of axial “yl”-Oxygen of uranyl ion, normally five water molecules at 
equatorial plane could be found for the uranyl ion coordination for the non-complexation 
cases.25,26 But for the uranyl carbonate complexes in solution or solid, six coordination number 
was found.27 This mode of coordination is a peculiarity of the uranyl ion which can be used in 
the design of selective ligands. 
The fluorescence spectrum of the aqueous uranyl ion reflects the symmetrical vibration of 
the U-O bond. The observed emission bands correspond to the electronic transition S11→S00 
(473 nm) and S10→S0ν with n=0–4 (488, 510, 535, 560, and 587 nm).
28 The free uranyl ion 
UO2
2+ is taken as a reference in terms of spectroscopic scale since it is very likely that all the 
other species present a bathochromic shift due to complexation and a broadening due to the 
addition of new vibrational modes. 
1.3 Americium/curium  
Americium is a synthetic chemical element with symbol Am and atomic number 95. 
Chapter 1: Bibliographic study 
13 
 
Curium is also a synthetic chemical element with symbol Cm and atomic number 96. The 
discovery of americium and curium in 1944 was closely related to the Manhattan Project. These 
two elements were produced by the group of Glenn T. Seaborg at the University of California, 
Berkeley.  
1.3.1 Americium/curium in the industry and environment 
Due to the short half-life of americium and curium, any primordial americium (americium 
that was present on Earth during its formation) should have decayed by now. Existing 
americium and curium are concentrated in the areas used for the atmospheric nuclear weapons 
tests conducted between 1945 and 1980, as well as at the sites of nuclear incidents, such as the 
Chernobyl disaster. However, on a global scale these large releases resulted in very small 
concentrations of americium and curium in the environment.  
Americium and curium are produced mostly artificially in small quantities, for research 
purposes. The main source of americium and curium are from the nuclear industry. 241Am and 
243Am are the americium isotopes which could be formed by 238U (the major uranium isotope 
used in nuclear power reactor fuel) or 238,239Pu (primarily used in nuclear weapons). 242Cm and 
244Cm are the curium isotopes which could be formed by 238U (the major uranium isotope used 
in nuclear power reactor fuel) or 241Am (the fission product in nuclear power reactor fuel). By 
bombarding uranium or plutonium with neutrons in nuclear reactors, about 100 g of americium 
and 20 g of curium could be obtained in one ton of spent nuclear fuel. The oxidation states of 
these two elements are +III in the reprocessing process. 
For now, the americium and curium were mainly used for research interests. Due to the 
high radioactivity, separation of these two elements is the aim for the reprocessing process in 
order to reducing the difficulty for storage.  
1.3.2 Physic-chemical properties of americium and curium, europium use as the 
chemical analogue 
All the isotopes of these two elements are radioactive (Table 5 & 6). All of them are 
synthetic isotope. The americium atom has the following external electronic configuration: 
5f77s2, which is 5f76d17s2 for curium. The charge for the stable or unstable oxidation states 
depending on the conditions: +III (Am3+, Cm3+), +IV (Am4+, Cm4+).  
 
Isotope 
Half-
life(t1/2) 
Abun-
dance 
Decay 
mode 
Am-241 432.2 y syn α 
Am-242 141 y syn IT/α 
Am-243 7370 y syn α 
Table 5：Main isotopes of americium. syn: synthetic isotope. 
Isotope 
Half-
life(year) 
Abundance 
Decay 
mode 
Cm-242 160 d syn α 
Cm-243 29.1 y syn α/ε 
Cm-244 18.1 y syn α 
Table 6：Main isotopes of curium. syn: synthetic isotope. 
241Am, 244Cm could decays and generate alpha-particle with a mean energies about 4.8–
6.1MeV. Due to the relatively short half-life of 244Cm, the specific activity of 244Cm, 1.3E12 
Bq/g, is 23 times higher than that of 241Am, 1.3E11 Bq/g. Among the actinides, 241Am, 243Cm 
and 244Cm have high power output per unit mass, 0.115, 1.81 and 2.83 in W/g respectively, the 
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power could result in a very large heat releases in the case of these isotopes ,especially for 
243Cm and 244Cm.  
The redox properties of americium in an aqueous medium illustrates the thermodynamic 
instability of Am4+ with respect the very high redox potential of couple Am(IV)/Am(III) (about 
2.34 V/SHE) which makes the element highly unstable in oxidation state +IV (Scheme 2). 
 
Scheme 2 : Latimer diagram of americium in aqueous solution (potentials are expressed 
in a 1 M perchloric acid medium (in V/SHE). 
The thermodynamic and hydrolytic properties of americium can be represented in the form 
of a Pourbaix diagram (Fig. 4). It shows the E/pH diagram of americium for a total 
concentration of Am3+ equal to 10E-10 M at the temperature of 298 K in a non-complexing 
aqueous medium. This diagram shows: 1) the dominance species Am3+ (aq) in the acidic 
condition; 2) the instability of Am4+ (aq). 
 
Figure 4 : Pourbaix diagram of americium a non-complexing aqueous medium. [Am]= 
10E-10 𝐌; T=25.0 °C.29  
Cm(III) oxidation state is very stable due to the half-filled (5f7) configuration. Because 
Cm4+ only exist in the strongest oxidizing conditions, the redox potential for the Cm(IV)/Cm(III) 
couple is 3.1V in a 1 M perchloric acid medium (in V/SHE).  
Among the two oxidation states of americium and curium in aqueous solution, Am(III) and 
Cm(III) are the most important. Indeed, it is these species that are found in the vast majority in 
the environment and in biological environments. In vivo, Am3+ and Cm3+ are the major species. 
It is therefore this single degree of oxidation that focuses the interest for projects such as in vivo 
decorporation of americium and curium. Am(IV) and Cm(IV) are hard acids according to the 
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Pearson classification. 
The aquatic chemistry of trivalent 4f- and 5f-elements has been demonstrated to be very 
similar. Trivalent 4f-elements have a coordination number of 8 to 9 while trivalent 5f-elements 
have the similar number for that in the dilute non-complexation solution.30 
 
  Eu Am 
  3+ 3+ 
CN=6 0,947 0,975 
CN=8 1.066 1.109 
CN=9 1.120 - 
Table 7：Ionic radii (Å) of Eu and Am in different coordination numbers (CN) and at 
oxidation states.31,32 
For americium, the location in the periodic table is under the lanthanide element europium. 
Meanwhile the ionic radii of Eu3+ and Am3+ in coordination numbers equal to 8 and 9 were list 
in table 7.31,32 It is clear that these two elements in di-and trivalent ionic state have similar ionic 
radii. In Fig. 1.5, there is a similar trend that the cohesive energies of the divalent and trivalent 
rear earth elements and actinides. Especially, compared to other rare earth elements Yb-No and 
Eu-Am have significantly low cohesive energy for trivalent form. With the help of ground state 
configuration of 𝑓𝑛𝑠2 and 𝑓𝑛𝑑1𝑠2, the same trend could be found for Eu and Am.33 Due to the 
similarity in chemical and physical properties, ionic radii, cohesive energy and relative energy 
relationship, Eu3+ could be used as analogue of Am3+ in the chemical study. By observing the 
behaviors of natural analogue like the rare-earth metals for trivalent actinides, it is possible to 
reduce the uncertainty in the geochemical study.34 Because americium has radio-toxicity and 
chemo-toxicity, it is difficult to understand the impact of americium in ecotoxicology study. 
And it is pretty hard to do ecological experiments with americium. The much less toxic metal 
europium is also used as chemical analogue in the ecotoxicology investigations to study the 
behavior of americium.35 The metabolisms of 152Eu and 241Am have been measured in both 
carbs and crayfish revealed that it is reliable in the biological study to use europium as a 
chemical analogue of americium. 
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Figure 5 : Cohesive energy for the rare earths (full. curves) and actinides (dashed 
curves). The smooth curves denote the cohesive energy in case these elements had 
remained divalent in their metallic modification, the jagged curves the cohesive energy 
of their trivalent metallic state.36 
Isotope 
Half-life 
(year) 
Abundance 
Decay 
mode 
Eu-151 5×1018 47.8% α 
Eu-153 stable 52.2% - 
 Table 8：Main isotopes of europium. 
Europium is a chemical element with symbol Eu and atomic number 63. It was isolated in 
1901 and is named after the continent of Europe. Europium is composed of 2 isotopes, 151Eu 
and 153Eu, in nature condition (Table. 8). 153Eu is the most abundant, 52.2%. The europium 
atom has the following external electronic configuration: 4f76s2. The charge for the stable or 
unstable oxidation states depends on the conditions: +II (Eu2+), +III (Eu3+). Eu3+ is the main 
species in the acidic condition, then starts to form the hydroxide in the neutron range.   
Toxicology 
The collection of data on the bio-distribution of actinides in the body began with the 
Manhattan project in the late 1940s. It first focused on plutonium and then expanded its interest 
circle to other actinides strategic (uranium, thorium, neptunium ...).  
1.4 The contamination mode 
Depending on these modes of contamination (Fig. 6), the biological path of actinides will 
be different. There are four main entry routes and four excretion route for actinides in the body. 
Chapter 1: Bibliographic study 
17 
 
 
Figure 6 : The main routes of intake, transfer and excretion of radionuclides in the body 
(ICRP 130). 
1.4.1 Main entry routes 
1.4.1.1 Inhalation, when inhaling dust, aerosols or gases containing uranium compounds or 
particles. 
The inhalation is the main gateway into the body of radionuclides, whether in the form of 
dust, aerosol or gas. The fate of the inhaled contaminant in the lungs is strongly conditioned by 
physical parameters such as: the physical state (gas, liquid, solid); the physico-chemical form 
(degree of oxidation and solubility); particle size and surface appearance for solids. 
 
Figure 7 : Uranium particles during inhalation contamination (ICRP 66). 
Depending on the actinide physicochemical properties, the fate of this particle in the lung 
can be multiple: 1) dissolution and released in the bloodstream (Fig. 7, B) 2) endocytosis by the 
epithelial cells (Fig. 7, C); 3) phagocytosis by macrophages (Fig. 7, D); 4) transport as free or 
phagocytic particles and deposition in the lymph nodes until dissolution and transport to the 
lymph (Fig. 7, E, F). 
The purpose of chelating agents is to limit toxicity of soluble forms of actinides by increase 
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the excretion after complex with the chelating agents. 
1.4.1.2 The digestive tract (when ingesting contaminated food), the bloodstream (during an 
accidental injury), the skin (when in contact with the skin). 
The uptake of actinides by the digestive system is mainly performed in intestinal. The 
absorption rate is strongly depending on the element. Studies in humans have shown that this 
absorption is very low (1 to 2.4%) for soluble forms of uranium. This absorption is 10 to 100 
times lower for poorly soluble forms such as U3O8 and UO2. Uranium that has not been absorbed 
is eliminated in the feces in 24 hours. The toxicity of uranium during ingestion contamination 
is therefore very low; the LD50 (in the rodent) is of the order of 114-136g / kg.
37 
1.4.1.3 Contamination following injury 
During an injury, the soluble products will very quickly enter the bloodstream. Absorption 
is usually complete after 24 hours. For moderately or poorly soluble products, such as metal 
particles, the entry of uranium into the bloodstream is gradual. For this kind of contamination 
washing the wounds with a solution containing a chelating agent of uranium may be interesting. 
1.4.1.4 Entry through intact skin 
The contact with the skin of soluble forms is one of the ways of entry of actinides into a 
human body. Animal experiments have shown that the application of soluble forms of uranyl 
ion can cause renal toxicity that can lead to death of the animal.38 In contrast, insoluble forms 
do not induce a toxic effect when these are applied to the skin. In the latter case, a simple 
washing is likely to eliminate any risk of intoxication. 
The mode of airways is considered as the most common way of contamination in the 
industry. After a fire accident or an explosion, a dispersion of radionuclides in the atmosphere 
could be possible then the inhalation of radionuclides will cause an internal contamination. The 
modes of contamination following injury and cutaneous contamination are considered as the 
second most common way of contamination in the industry. After an explosion or improper 
handling of contaminated tools or sharps inside a glove-box, the skin can also be contaminated 
by contact with aerosols or by contact with surfaces contaminated with radionuclides.  
Following internal exposure, the radionuclide is incorporated into the body and the damage 
induced by irradiation of cells or tissues at the vicinity of the element can be of concern, 
whatever the radiation type, and especially in the case of highly ionizing alpha particles which 
transfer their energy more rapidly and at shorter range than gamma radiation for instance. 
Hence, since the major isotopes of the actinides U and Pu are mostly alpha emitters, the 
toxicological consequences related to the incorporation of these elements can be quite 
concerning. This mode of exposure to both actinides mainly depends on the industrial or 
military uses of the different compounds. 
1.4.2 Main excretion routes 
There are four possible excretion routes for human: exhalation, faces excretion, urine 
excretion and sweat. The removal of the actinides which has deposited from the human body 
normally occurs by faces excretion and urine excretion. 
There are two origins of actinides which are excreted by faces. 1) Systemic (endogenous) 
faecal excretion: due to secretions along the alimentary tract and biliary secretion from the liver, 
actinides could be removed with systemic material via the alimentary tract; 2) Direct 
(exogenous) faecal excretion: strictly elimination of the actinides which are unabsorbed through 
the alimentary tract after ingestion and clearance to the throat from the respiratory system after 
inhalation. Urinary excretion is the removal in urine of radionuclides from blood following 
filtration by the kidneys.  
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1.5 The factor which influences the toxicity  
The toxicity of the uranium and americium/curium, are different from normal poison due 
to the radioactivity. It is important to separate chemo-toxicity that acts on all target organs from 
radiation-induced toxicity which is related to the issuer properties and radioactive isotopes that 
concerns the storage organs.  
In order to compare the dose coefficients, or dose per unit intake for radionuclides, ICRP 
classified the compounds into three types according to the absorption rates from the lungs to 
blood , fast (Type F), moderate (Type M) and slow (Type S) in ICRP-66. The default absorption 
parameter values are given in Table 1.9. Generally those soluble compound (Type F &M) could 
rapidly be transferred into the blood as uranyl ion (transfer kinetics of a few minutes to a few 
days) and develop their chemical toxicity on the various target organs while the weakly 
transferable forms (type S) will stay for a long time at the place of contamination. The chemical 
form and solubility are the main factors influencing the chemo-toxicity. 
 
ICRP -66 absorption type F (fast) M (mod.) S (slow) 
Model parameters:         
Initial dissolution rate (d-1) sp 100 10 0,1 
Transformation rate (d-1) spt 0 90 100 
Final dissolution rate (d-1) st - 0,005 0,0001 
Fraction dissolved rapidly fr 1 0,1 0,001 
Approximate dissolution rates:   
Rapid (d-1) sr 100 100 100 
Slow (d-1) ss - 0,005 0,0001 
Fraction to bound state fb 0 0 0 
Uptake rate from bound state 
(d-1) 
sb - - -100 
Table 9：Default absorption parameters for Type F, M and S materials. 
For the radiation-induced toxicity, the isotopic composition and the chemical form of the 
contaminant are also the main factors. For example, only the chemical toxicity of the metal will 
be taken into account during contamination with depleted uranium. While for 
americium/curium, both toxicities need to be considered.  
1.6 The bio-distribution of actinides  
Scientist, nuclear workers and soldiers are the people under risk of contamination with 
actinides. Also a major event (nuclear accident, conflict, terrorism) which could lead to a large-
scale contamination of the civilian population should be taking into account. 
The bio-distribution of actinides is determined by two main factors; the nature of the 
contaminant and the mode of contamination. No matter the exposure route, the pathway for 
actinides transport in human body is similar (Fig. 5). After the transfer via blood, unlike 3H as 
tritiated water which seems uniformly throughout the body and 131I selectively deposit in the 
thyroid, actinides are prefer to concentrate in a few different target organs: the bones, liver and 
kidneys, which present the largest proportion of actinides present in the body for most case.39  
The behavior of an actinide which is a non-essential element after the transfer to blood (e.g., 
232Th, 238U, 239Pu, or 241Am) depends on a number of function of human body to which it can 
be sequestered by the reticuloendothelial (RE) system, its affinity for specific biological ligands, 
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its filterability by the kidneys, and the ability of the body to eliminate it in liver bile or other 
secretions into the gastrointestinal tract. In some cases, the biokinetics of actinides which is a 
non-essential element may showing some similarities with those essential elements due to 
similar chemical affinities for some but not all components of tissues and fluids. For example, 
the behavior of uranium in the skeleton presents some similarities to that of calcium because 
uranium can replace calcium to some extent in bone. While in other tissue or fluid the biokinetic 
behaviors of uranium show greater differences compared with calcium. Nevertheless, the use 
of chemical or biological analogues has its limits.40 
 
Actinides 
 
Thorium 
Uraniu
m 
Neptunium* 
Plutoniu
m 
Americiu
m 
Curiu
m 
Biological  
form 
 
Th4+ UO22+ Np4+ NpO2+ Pu4+ Am3+ Cm3+ 
Ionic  
radius (Å) 
 
1.00 2.80 0.95 2.90 0.93 1.00 0.98 
Blood  
stay 
 
10% 1 day 
25%  
5 min 20%  
1 h 
< 1%  
1 h 
< 1%  
1 day 
< 1% 1 day 
0.3%  
10 days 
1%  
1 day 
Blood  
complexes 
100% Tf 
50% 
HCO3 –,  
30% Tf,  
20% red 
cells 
< 1% 1 
day  
80% Tf 
70% 
free 
100% Tf 100% Tf 
Organ  
retention 
       
Bone 
 
70% 10–15% 
30–
50% 
30–50% 50% 30% 
Liver 
 
5% / 2–10% 2–10% 30% 50% 
Kidneys 
 
3% 12–25% / 1% / / 
Soft tissues 
 
4% 5% 5% 5% 10% / 
Urinary 
 
4–6%  
5 days 
65% 
1 day 
3–4% 
1 h 
15–20% 
1 h 
0.4% 
1 day 
< 1% 1 day 
Excretion 
 
7–9% 20 
days 
70%  
6 days 
15%  
1 day 
20–40%  
1 day 
1.4% 14 days 
 
ICRP 
model 
Type 
M 
5 × 10–4 2× 10-2 5× 10-4 
 
5× 10-4 5× 10–4 
 
Type S 2 × 10–4 2× 10–3 
  
1× 10-5 
  
 
 
69 69 67 * 
 
67 67 
Table 10：Biokinetic data on actinides. Data on the distribution of Np(IV) and Np(V) in 
rat and mouse.41,42 
When the radioactivity is low (the case of 238U and 232Th), chemical toxicity is the main 
concern. But for the high radioactivity isotopes, apart from the chemical toxicity, radioactive 
toxicity also needs to be considered due to the radiation damage for the living cell 43 and heat 
generation. In both cases, the prolonged duration of internal exposure causes damage at the 
cellular level which is carcinogenicity. Table 10 summarizes the biokinetics and bioinorganic 
chemistry of some actinides in ICRP Publications 67 and 69, the proportions of actinides in the 
blood and each target organ with the residence time.44,45 
For the Systemic model which is proposed by ICRP (Fig. 6 & 7), two compartments 
representing short- and long-term retention are considered for the liver. The short-term 
compartment (Liver 1) represents the actinides which enter the liver and may transfer back to 
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blood or intestines by biliary secretion. The actinides which belong to long-term compartment 
(Liver 2) could slowly returns to blood. For kidneys, two compartments, urinary path and other 
kidney tissue, are omitted. Urinary path represents the actinides loses to urine over a period of 
hours or days which other kidney tissue shows slowly returns actinides to blood. Three 
compartments, ST0, ST1 and ST2, were considered for remaining soft tissue other than bone 
marrow. ST0, ST1 and ST2 are the paths of rapid, intermediate, and slow return of actinides to 
blood, respectively. ST0 is the sign to count the actinides rapid build-up of in soft tissues and 
also regarded as part of the actinides circulating in body fluids. After acute input of actinides to 
blood, the rapid feedback to blood is also treating as ST0. The skeleton is separating into cortical 
and trabecular fractions and each of these fractions could be attributing to bone surface, bone 
volume, and bone marrow. Actinides which entering the skeleton is assigned to bone surface 
and subsequently gradually transfer to bone marrow and bone volume by bone remodelling 
processes. Also actinides in bone volume are transferred gradually to bone marrow by bone 
remodelling. Actinides could be lost from bone marrow to blood over a period of months. And 
the subsequently redistributed is in the same mode similar to the original input to blood. The 
transfer from cortical and trabecular bone compartments to all destinations are related with the 
turnover rate of cortical and trabecular bone. The rates from cortical and trabecular bone 
compartments to all destinations are assumed to be 3% and 18% per year, respectively. Other 
parameter values in the model are depends on the nature of each element. After reaching bone 
volume, these elements may migrate back to plasma (via bone surface in the model) or they 
may become fixed in bone volume and are then gradually removed to blood at the rate of bone 
remodelling. For example, the bone-surface seekers (thorium, neptunium, plutonium, 
americium, and curium) diffuse throughout bone volume within hours or days after depositing 
in bone (Fig. 7).  
1.6.1 Uranium  
In nature, uranium which is an inhomogeneous distribution on the planet occurs in granite, 
metamorphic rock, lignite, monazite sand, and phosphate deposits at concentrations on the order 
of 0.5 to 5 ppm. Through food and water mainly46, a large part of population in the world 
absorbs uranium about 1- 5μg/d daily in uncontaminated regions which is 13-18μg/d daily or 
more in uranium mining areas. A 70 kg, non-occupationally exposed 'Reference Man' living in 
Europe has an estimated total body uranium content of about 22μg. Since the quantity of 
uranium which is present in the human body is small, the health risk is negligible.  
Uranium is the most widely used actinide element in the world, therefore plenty study 
which focus on potential risk on health has revealed the bio-distribution of uranium in vitro or 
in vivo on small animals (rats, dogs, etc.) or on the man. 47,48 However, most of the biological 
mechanisms related with uranium are only partially known. 
Besides the other non-soluble or less soluble form of uranium, the contamination by uranyl 
ion is of the interest in this study. The elimination of uranium from human body will be favored 
in this form and the majority of the uranium retained in human body will result from the bio-
distribution of uranyl ion.49 Generally uranyl ion forms complexes with citrate, carbonate, or 
protein in plasma.40 The stability of the carbonate complex and concentration of carbonate 
depends on the pH and nature of the solution which will differ in different parts of the body. 
The bicarbonate uranyl complex can be filtered at the renal glomerulus due to the low molecular 
weight, then depend on the urine pH be excreted in urine (70%).50 The uranium which is 
bounded to the protein in blood (mainly plasma proteins, 30%)51 is harder to filtered due to the 
larger size, thus this part of uranium prefers to remain in blood at the early stage of the uranium 
bio-distribution. The blood serves as the vector which transfers the solubilized uranium to all 
target organs (Fig. 1.8). The bio-distribution of uranium is rapid. After a few hours, the majority 
of uranium in uranyl ion form leaves the blood to be either excreted by the urine (70%) or 
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directed to the skeleton (10-15%) and to the kidneys (12-25%) (Table 10). Although for 
uranium retention, soft tissues could only retain 5% which should also be considered.  
 
 
Figure 8 : Systemic model of the bio-distribution of uranyl ion in human body (ICRP 
72). 
1.6.2 Americium/curium  
Normally americium and curium could be found in the spent fuel, reprocessing process and 
laboratory. Similarly, the elimination of americium and curium will be favored and the majority 
of the americium and curium retained will result from its dissolution in trivalent form. 
Concerning the soluble form of americium and curium, they will bind with proteins and also 
form complex with various inorganic anions, such as carbonate and phosphate, and carboxylic 
acids, such as citrate and lactate (Table 9). These types of interactions would be expected for 
all routes of exposure.  
In the blood, americium and curium is totally complexes with plasma protein, transferrin 
(Table 10). The bio-distributions of americium and curium are rapid. The blood compartment 
is also the vector which distributes americium and curium in all target organs (Fig. 1.9). Bio-
distribution is also rapid. After one hour52, only a few amounts of americium and curium 
excreted by the urine (10%) due to the complexation with transferrin. the majority of the 
americium and curium leaves the blood directed to the skeleton (30%) and to the liver (50%). 
Kidneys (0.9%), gonads (0.045% for 244Cm, 0.037 for 241Am), spleen (0.7% for 244Cm, 0.35% 
for 241Am) and other soft tissues, which may also be affected to a lesser extent (5%) by 
americium and curium retention, should also be considered.52,53 
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Figure 9 : Systemic model of the bio-distribution of the bone-surface seekers, americium 
and curium, in human body (ICRP 72). 
1.7 Human Health Effects 
1.7.1 Uranium 
According to the radioactivity, the uranium could be separate into 2 classes, low radioactive 
uranium (e.g., natural and depleted uranium); high radioactive uranium (e.g., 232U, 233U, 234U 
and 235U). Chemical toxicity is the major concern for low radioactive uranium contamination. 
For high radioactive uranium contamination, both chemical and radiological toxicity need to be 
considered. It is hard to distinguish the two toxicities due to the overlap of etiology and 
manifested effects. 
1.7.1.1 Acute effects 
8.3 and 20.4 mg/kg were found for median lethal dose (LD50) within 14 days continually 
administration for rats and mice, respectively; 204 and 242 mg/kg were found for oral LD50 and 
the death is mainly due to the renal toxicity which is caused by intake of uranyl acetate.54 
1.7.1.2 Long-term effects significant 
As shown in table 8, a majority of uranium will be excreted by urine and then part of the 
uranium will be retained in the kidneys for several months.55 Thus the renal toxicity is the major 
concern for uranium human health effects. The uranium-induced renal toxicity could be 
explained by the following mechanism: the uranyl ion could occupy the binding sites of 
adenosine-5'triphosphate (ATP) which normally provides Mg2+ and Ca2+, and subsequent 
energy transport will be disrupted in the cells of the proximal tubule and associated structures.55 
Besides uranium also has toxic effects on the cardiovascular system, liver, muscle and nervous 
system as well.56  
The toxic effects observed on the bone after the injection of uranyl nitrate has shown that 
the bone activity decreased and in turn the bone resorption increased, and the different doses 
studies indicated that the degree of damage is proportional to the dose employed which means 
the nature of toxicity effect was the same for different radioactivity.57  
Internalized radionuclides that emit alpha-particles are carcinogenic to humans (Group 1), 
so high activity of uranium could also cause cancer. The accumulation of uranium in bone is 
similar to that of radium; therefore the emitting alpha particles would assume to be nearly as 
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effective in the osteogenic sarcomas generation. After exposures to high dose of 232U and 233U, 
sarcomas have been found in mice.58 For the toxicity in the lungs, it mainly related with alpha 
radiation from inhalation of insoluble forms of uranium which is retained in the lungs. Chronic 
uranium exposure during 30 days could cause theneurophysiological perturbations as the 
uranium likely accumulated in the brain.59 An excess of lung cancer deaths among 18,869 white 
male workers and an excess of death from central nervous system (CNS) cancer were found in 
a uranium enrichment factory.58  
International Agency for Research on Cancer considers that inadequate evidence in humans 
was found for the carcinogenicity of natural uranium. And limited evidence in experimental 
animals was found for the carcinogenicity of natural uranium. There is inadequate evidence in 
experimental animals for the carcinogenicity of 233U.60  While American Conference of 
Governmental Industrial Hygienists confirmed that natural uranium ether in soluble or insoluble 
compounds is human carcinogen. 
1.7.2 Americium/curium 
Few studies on the toxicity of the americium and curium radionuclides were done. Due to 
the very high specific activities of all americium and curium isotopes, compared to chemo-
toxicity, the radio-toxicity seems to be main concern for human health. 
1.7.2.1 Acute effects 
LD50 within 60 days study with rat is 2220 Bq/g for 
241Am and 244Cm which is equal to 
about 80 mg 244Cm into a 70kg human for acute effects. The damage to the bone marrow by the 
high dose is the main reason for the death.61 
1.7.2.2 Long-term effects 
The damage to other organ than bone marrow could also cause death or cancer. The study 
with animals was done to prove the carcinogenicity of mixed alpha-particle emitters (241Am, 
244Cm).60 There are two reasons for the carcinogenicity: 1) the alpha-particles emitted by 
americium and curium, 2) secondary ionizations and the same pattern of localized damage. Both 
effects could damage biological molecules which results in DNA doublestrand breaks, 
chromosomal aberrations, gene mutations and cell transformation. The risk coefficients of bone 
tumors after injection of 241Am and 244Cm were increased.62,63  
1.8 Conclusion 
The toxicity of U(VI), Am(III) and Cm(III) has been illustrated in this part. In the case of 
contamination, after transferred by blood, the solubilized actinides are widely distributed to the 
target organs: bone, liver and kidneys, and then these actinides could cause serious damage to 
human health. Since the human body is a dynamic system, the actinides retained in the target 
organs can be released into the bloodstream and then possibly excreted by urine. Chelation 
therapy is considered as the most effect way to decorporate actinides from human body. In the 
next part, several works of chelation agents for decorporate actinides will be described.  
Chelation therapy 
Chelation therapy is focused on reduce the solubilized actinide entered by inhalation, intact 
skin or wound (Table 1) which will decrease acute radiation damage, long-term chemo-toxicity 
and long-term radio-toxicity, hence risks of death, induction of cancer and other diseases could 
be reduced.  
The investigations of actinides chelation therapy till now could be separate into 3 stages:  
1. Starting stage 1938-1950: The investigations to improve actinide excretion began with 
Chapter 1: Bibliographic study 
25 
 
methods to increase radium excretion.64 Except administration of bicarbonate to reduce uranium 
in human body from acute exposures,65 no effective method was found for actinides.66  
2. Early stage 1950-1960: Toxicities of plutonium and other actinides were recognized in 
the middle of the 20th century with the development of Manhattan project. Thus the study to 
find effective decorporation methods began.67,68 Three tasks were enrolled: the metabolism of 
fission products and heavy elements; the acute and long-term toxicity of ionizing radiation from 
external and internal sources; the methods to remove internal deposited radioelements from the 
body.65,68 There are huge improvement on evaluate the first two tasks in the following years.69,70 
But the investigations on the removal of radioelements from human body met plenty of 
problems. In the early stage (1940s), chelation study was focus on hormones, common 
carboxylic acids or complexing agents, or colloidal zirconium citrate, and the rat test with these 
compound proved little effect on the plutonium excretion.67,71 EDTA, synthesis in 1947 as 
calcium analytical agent, and DTPA synthesis in 1954 for multivalent cations, were used in the 
radioelement decontamination study (Fig. 1.10).  
Carboxylic acid 
pKa1 = 4.76 
Phosphonate acid 
pKa2 = 5.6 
Catechol  
pKa1 = 9.2; pKa2 = 13.0 
Me-3,2-HOPO 
pKa1 = 6.1 
1,2-HOPO 
pKa1 = 5.0 
3,4-HOPO 
pKa1 = 9.8  
 
Figure 10 : Structures, abbreviated names, and pKa values of metal-binding units of 
different chelation ligands. Carboxylic acid; phosphoate acid; catecholate (CAM); 
hydroxypyridinonate (HOPO). 
3. Recent stage 1960 to now: Then steady improvement has been made by focusing on the 
design ligands with structural and coordination to have better chelation affinity with actinides. 
As iron (III) and trivalent or tetravalent actinides have similar coordination and these cations 
could defined as hard Lewis acid metals, siderophores which are highly selective chelating 
agents for essential element iron were tested for actinides chelation therapy due the presence in 
the bacterial and well microorganisms study. The catecholates derived from enterobactin, the 
hydrozamic acid derived from desferriozamine and the hydroxypyridinones (HOPOs) derived 
from cepabactin were the most widely used function groups from siderophores (Fig. 10). Plenty 
of chelation agents based on siderophore derives were synthesized after 1960s. Numerous 
works with siderophore on actinides chelation therapy, mainly for plutonium (IV), were done 
by the KN Raymond and PW Durbin groups at Berkeley. The affinities of the ligands which 
originally developed for plutonium (IV) were tested also with uranium. Decorporation for 
uranyl decorporants focused on testing the affinity of ligands developed for plutonium (IV) 
such as DTPA or derivatives of HOPO functions and catecholates. Unfortunately in case of 
contamination with uranium, the toxicity of these ligands, especially at the renal level, prevents 
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their use for the decoration of uranyl.72–74 The bisphosphonate moiety, a structural analogue of 
pyrophosphate, could form strongly binding with hard Lewis acid metals at physiological pH. 
And bisphosphonates are also known to target bones and generally display low toxicity. The 
group of Frédéric Taran at CEA-Saclay synthesized a lot of bisphosphonate ligands which were 
found to be the best uranyl chelation agents among the other actinides chelation agents (Fig. 
10).75  
The main idea is to use those ligands to complex the actinides which has already been 
deposited in the target organs in the complexation form. Therefore the actinide ligand 
complexes as xenobiotics could be transfered by blood from the target organs due to the high 
hydrophilic and water solubility and finally be excreted via urine and bile76. Three important 
points need to be considered: 1) the bio-distribution of chelating agent via different intake 
methods; 2) the chelation affinity of chelating agent with target actinide under physiological 
conditions; 3) the excretion route of actinides ligand complex.  
Therefore several properties for an effective actinide chelating agent under physiological 
conditions were proposed by different authors5,39,40:  
1) Design of the chelating agent: molecular mass limit of chelating agent due to different 
intake methods; bio-distribution of chelating agent in the target organs; the binding affinity of 
metal-binding unit based on Pearson acid-base concept for the actinide of interest; sufficient 
deprotonation of metal-binding unit under biological conditions to chelate the actinide of 
interest; good geometry of chelating ligand for the coordination of the actinide of interest to 
ensure the high selectivity over the other essential elements. 
2) Interaction between agent and organs: low toxicity of the ligand; high bioavailability of 
ligand for different drug delivery system (Intravenous, intraperitoneal, oral, lung, etc); bio-
distribution of sufficient ligand which could transfer to the target organs due to the ligand bio-
distribution; high excretion rate and short retain duration of the actinide-chelating ligand 
according to the lipophilic properties of the chelating ligand. 
3) Practical use of chelating agent: low cost; easy and quickly to be used; high stability 
under normal reserve condition.  
1.9 Actinides chelating agents under studies  
The main families of ligands synthesized and some chelating agents tested for the in vivo 
decorporating efficiency with actinides are listed in table 11. Some of their important properties 
are also referenced. 1) polyaminocarboxylic acids: diethylenetriaminepentaacetic acid (DTPA) 
is effective for Pu; 2) siderophores: catecholates (CAM), hydroxamates, hydroxypyridonates 
(HOPO) are mainly effective for U, Pu and Am; 3) phosphonates ligands :1-hydroxyethane-
1,1′-diphosphonic acid (HEDP) is effective for U, and tris-Bisphosphoniqes displaying a high 
affinity for U; 4) macrocyclic compounds: calixarenes displaying a high affinity for U.  
Thus three families, polyaminocarboxylic acids, siderophores and phosphonates ligands, 
will be illustrating in the following section.  
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Ligand 
family 
Chelating 
agents 
Elemen
ts 
Toxicity or side effects 
State of clinical 
development 
Polyamin
opolycarb
oxylics 
(Ca,Zn,Na) 
DTPA 
Pu(IV), 
Am(III) 
Nephrotoxicity, teratogenicity, 
embryotoxicity, suppressed 
hematopoiesis 
In clinics by 
parenteral and lung 
administration 
Sideroph
ores 
3,4,3-LI-
CAM 
Pu(IV), 
Am(III) 
Nephrotoxicity Preclinical 
 
3,4,3-
LI(1,2-
HOPO) 
Pu(IV), 
U(VI),
Am(III) 
Low acute toxicity in mice and Phase I clinical trial 
 5-LIO(Me-
3,2-HOPO) 
Pu(IV), 
U(VI) 
Low acute toxicity in mice and Preclinical 
Macrocyc
les 
para-tert-
butyl calix 
[6]arene 
U(VI) Not tested Preclinical 
Bisphosp
honics 
HEDP 
U(VI), 
Np(IV) 
Nephrotoxicity, Serum 
calcium drop 
In clinics 
Polyphos
phonates 
tris-
Bisphospho
niqes 
U(VI) Not tested Preclinical 
Table 11：Main families of ligands tested for decontamination/decorporation of Pu ,U 
and Am.5,16 
1.9.1 The poly-amino-carboxylic ligands  
The family of poly-amino-carboxylates (EDTA, DTPA, etc.) is known for its ability to 
complex metals. The multi-dentistry and the strong electron donor character of the carboxylate 
functions (HSAB-based solid bases), makes it possible to form stable complexes with numerous 
cations. 
1.9.1.1 Chemical behaviors of EDTA and DTPA 
H4-EDTA (Fig. 11), a hexadentate amino-carboxylic ligand, has been applied in chemical 
industry since 1949 which has shown much greater stabilities of its metal chelates comparing 
to their complexes with polycarboxylic acids (Table 12).77–80  
Due to the defects of CaNa2-EDTA, H5-DTPA (Fig. 11), an octadentate amino-carboxylic 
ligand, was designed and synthesized. The stabilities of Ca(II) with EDTA and DTPA are 
similar, while the stabilities of the actinides with EDTA complexes are lower than those of their 
DTPA complexes(Table 12).77,78,80–83 
Ethylenediaminetetraacetic acid (EDTA) diethylenetriaminepentaacetic acid 
(DTPA) 
  
Figure 11 : Chemical structure of EDTA and DTPA. 
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Log KMLa 
Metal ion (M) Ca(II) Zn(II) Fe(III) Am(III) Np(IV) Pu(IV) Np(V) U(VI) 
Ligand (L) 
        
Oxalate 2.5b 2.9c 7.5d 5.0e 11f 11c 3.7c 6.1c 
Citrate 3.4b 4.8b 11d 7.8c 15h 16e 3.0e 7.4c 
EDTA 11b 16b 25d 17c 24f 26c 7.2c 11c 
DTPA 11i 18i 28d 23b 29i 37j 11f 16k 
Table 12：Stabilities of some metal complexes relevant to therapeutic actinide removal. 
a Log KML, measured at 0.1 to 0.3 mol/L ionic strength and 20 to 25°C, values rounded 
to two significant figures. Numerical average is shown for two suitable values. Median is 
shown for three or more suitable values; b80; c79; d78; e84; f83; g77; h85; i86; j82; k81.   
1.9.1.2 In vivo tests of EDTA and DTPA 
For H4-EDTA, due to the rapid depletion of serum Ca(II), 100% lethal was reached with 
1.4 mmol/kg injected ip in rats. Because toxicity could be reduced by substituting by the metal 
ion, CaNa2-EDTA, the acute LD50 of one ip injection in mice is 17.4 mmol/kg. Repeated 
injections of CaNa2-EDTA was toxic for renal because the depletion of essential trace metals 
by forming more stable EDTA chelates [e.g., Zn(II), Mn(II)].87,88 CaNa2-EDTA enhanced 
excretion of Pu(IV), and Am(III).71,89,90 
For CaNa3-DTPA, the acute LD50 of one ip injection in mice is 12.5 mmol/kg. So CaNa3-
DTPA is slightly more toxic than CaNa2-EDTA. Although the absorption of CaNa3-DTPA and 
ZnNa3-DTPA from the Gastrointestinal (GI) tract by oral uptake is low (3 to 5%),
91 the actinide 
could be removed by protracted oral administration of a high dosage chelaters. Like CaNa2-
EDTA repeated injections of CaNa3-DTPA lead kidneys and intestinal epithelium toxicities. 
By using CaNa3-DTPA and ZnNa3-DTPA the retention of 
238Pu, 239Pu, 241Am, 242Cm, 252Cf, 
and 253Es could be reduced in experimental animals and for treating actinide-contaminated 
radiation workers.92 Although somewhat less effective for decorporation of foreign metal ions 
than CaNa3-DTPA, the reduced toxicity of ZnNa3-DTPA allows frequent injections and 
continuous infusion over extended time 93–98 
1.9.1.3 Deficiencies of polyaminopolycarboxylic acids. 
Due to the low absorption, CaNa3-DTPA and ZnNa3-DTPA are not orally effective at the 
recommended clinical dosage. DTPA couldn’t remove Pu(IV) from bone mineral. Octadentate 
DTPA satisfies the coordination requirements of An(III), thus DTPA could be used as chelation 
agents for Pu(IV), Am(III).39,99 But DTPA does not satisfy the coordination requirements of 
An(IV). They are not effective chelation agents for Th(IV), U(VI), or Np(IV,V).39,92,99–103 And 
hexadentate EDTA couldn’t satisfy the coordination requirements of An(III) and An(VI). The 
stabilities of EDTA with An(III) and An(VI) (Table 1.12) are not large enough to compete 
successfully at the recommended clinical dosage with the bio-ligands which could bind metal 
ion in the tissues and bone.  
1.9.2 Siderophores analogues: CAM & HOPO 
Siderophores are the iron chelating agents which normally exist in the bacteria. 
Siderophores have high binding affinity and selectivity with iron. 
1.9.2.1 Chemical behaviors of siderophores analogues 
Hydroxamic acid is the binding unit which could be found in desferrioxamine, the linear 
hexadentate trishydroxamic acid. Catecholamide (CAM) is the binding unit which presents in 
enterobactin, the hexadentate triscatecholate. Hydroxypyridinonate (HOPO) is the binding unit 
Chapter 1: Bibliographic study 
29 
 
which was discovered in a few siderophores and plant products. Binding units’ structures of 
siderophores were presented in Fig. 12. 
Catechol hydroxamic acid
Me-3,2-HOPO 1,2-HOPO
3,4-HOPO
 
Figure 12 : Binding unit’s structures and abbreviated names of siderophores. 
catecholate (CAM); hydroxypyridinonate (HOPO). 
 pKa1 pKa2 
Catechol 9,2 13 
1, 2 HOPO -0,8 5,8 
3, 2 HOPO 0,1 8,7 
3, 4 HOPO 3,4 9 
Table 13：pKa of the catechol and hydroxypyridinone groups.39 
The three units, hydroxamic acid, CAM and HOPO, could provide “hard” oxygens as the 
electron donors for the coordination which preferred by actinide ions.104 1,2-HOPO and 3,2-
HOPO (Fig. 12), HOPO isomers, are structural and electronic analogs of hydroxamic acid and 
catechol, respectively. The amides of two isomers could deprotonate at pH 6.1 (Table 13), and 
the stability constants of two isomer with Fe(III) is higher than those of divalent cations 
complexes. For this reason, they considered as the promising binding unit for An(III) and An(IV) 
in the range of physiological pH.105  
The group of Professor Kenneth N. Raymond synthesized fifty-five multidentate ligands 
which are composed by the molecular backbones as linear or cyclic and binding groups from 
siderophores. The affinities of these ligand with Pu(IV) or U(VI) were evaluated in vivo.39,106  
The crystal structures of uranyl 5-LIO(Me-3,2-HOPO) complex and Gd(III) TREN(Me-
3,2-HOPO) complex were show in Fig. 13. The crystal structures of uranyl 5-LIO(Me-3,2-
HOPO) complex has similarities with the U(VI) complexes with several linear tetradentate Me-
3,2-HOPO ligands. The coordination of uranyl ion is composed by the ligand molecule and one 
water molecular.107 The uranyl ion has five coordination numbers in the equatorial plan. Due to 
the similar coordination properties of Am(III) and Gd(III), the structures of Am(III) TREN-
(Me-3,2-HOPO) complex are similar to one of their respective Gd(III) analogs. The stability 
constant log K110 of Am(III) TREN-(Me-3,2-HOPO) complex is 20.3.
108 
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Figure 13 : Crystal structures of uranyl 5-LIO(Me-3,2-HOPO) complex107 and Gd(III)  
In vivo tests of siderophores analogues 
For the siderophores analogues, the acute toxicities in mice of the most effective HOPO 
ligands are different depending on the structure of ligand. Acute toxicity was primarily due to 
chemical nephrosis.102,106 It ranges from absent or very mild [5-LIO(Me-3,2-HOPO), 5-LI(Me-
3,2-HOPO), TREN-(Me-3,2-HOPO)], to moderate [(3,4,3-LI(1,2-HOPO), 3,4,3-LI(1,2-Me-
3,2-HOPO)] to severe [4-LI(Me-3,2-HOPO)]. The efficient removal of actinides which are 
deposited in the liver by the HOPO ligands is due to the direct access to the hepatic cells, after 
the actinide HOPO ligand complex could be substantial fecal excreted.106,109,110 the toxicity of 
ligand was further proved by the 24 hours renal residence times of moderately toxic, 3,4,3-
LI(1,2-HOPO) and 3,4,3-LI(1,2- Me-3,2-HOPO), which are about midway between those of 
the least and most toxic ligands.111 
3,4,3-LI(1,2-HOPO) 
5-LIO(Me-3,2-HOPO) 5-LICAM(S)  
Figure 14 : chemical structures of 3,4,3-LI(1,2-HOPO), 5-LIO(Me-3,2-HOPO)  and 5-
LICAM(S). 
For U(VI) in vivo decoporation tests, tetradentate 5-LICAM(S) and 5-LIO(Me-3,2-HOPO) 
and octadentate 3,4,3-LI(1,2-HOPO) (Fig 14) are the three ligands which have good 
performance among the twenty multidentate ligands which consist with 1,2-HOPO, Me-3,2-
HOPO and CAM. The U(VI) in kidney and body could deceased 24 and 54% of control. With 
5-LIO(Me-3,2-HOPO) and 3,4,3-LI(1,2-HOPO) the best reductions of U(VI) in kidney could 
be reached. With 5-LICAM(S) U(VI) in skeleton was reduced to half of control. Cocktail 
chelation investigations were done by different ligands which more efficient for kidney and 
skeleton respectively. Equal mole ration of 5-LIO(Me-3,2- HOPO) and 5-LICAM(S) are more 
effective for reducing U(VI) in all tissues which is about twice as much of either ligand alone.  
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For Am(III) in vivo decoporation tests, the first attempts were done with multidentate 
ligands containing catecholate or hydroxamate. The results shown that these ligands are not 
effective for Am(III) decorporation,112,113 The reason is due to the low charge density of Am(III) 
(30.8 e nm-1) which hardly deprotonates sufficient numbers of the OH groups of binding units 
at physiological pH.41,112,114 Then four HOPO ligands were tested in vivo. Octadentate 3,4,3-
LI(1,2-HOPO) has shown the best reduction of Am(III) in the skeleton and tissues which is as 
effective as CaNa3-DTPA. Due to the insufficient denticity, the other ligands are not as good 
as 3,4,3-LI(1,2-HOPO).115,116  
Mixed oxide (MOX) particles was injected im into rats, after 3,4,3-LI(1,2-HOPO) was 
repeatedly injected into the wound site. The retention of 241Am, the decay product of 241Pu, in 
bone and tissues are translocated from the wound. The amount of 241Am, which has been 
removed, was more important than the one obtained by the same treatment with CaNa3-
DTPA.11  
1.9.2.2 Deficiencies of siderophores analogues 
The linear octadentate catecholates offer the advantages of oral activity and effectiveness 
at low dosage, but they are defective. It dissociates at the reduced pH of the kidneys depositing 
Pu(IV), and a stable Pu(IV) chelate may not form in the slightly acidic environment of the 
lungs.95,113,117–120 The charge density (e nm-1) of Pu(IV) is not great enough to deprotonate more 
than six of the eight OH groups of the octadentate catecholate ligands at pH 7.4.112,113 For the 
hydroxypyridinonate, special care need to be considered due to the ligand toxicity.  
1.9.3 Phosphonate ligands  
1.9.3.1 Chemical behaviors of phosphonate ligands 
 
Phosphate gourp Bisphosphate gourp
 
Figure 15 : Structure of phosphonate group and bisphosphonate group. 
Phosphonate group and bisphosphonate group also provide “hard” oxygen and form 
monodentate bond with actinides under biological conditions (Fig. 15). 
1-hydroxyethane-1,10-diphosphonic acid (HEDP) (Fig. 16) could inhibits bone resorption, 
and was used for some skeletal disorders treatment. The group of Frédéric Taran synthesized 
fifty-three multidentate ligands for uranyl chelation therapy which are composed by the 
molecular backbones and bisphosphonate binding group groups from HEDP.75  
The stability constant of uranyl with HEDP 1:1 complex is 7.7 at pH 7. The structures of 
the uranyl HEDP complex were proposed (Fig. 17).121 For the bisphosphonate ligands which 
were synthesized by the group of Frédéric Taran, a displacement method of the uranyl 
sulfochlorophenole (scp) complex by competition ligand (bisphosphonate ligands in this case) 
with UV-visible spectroscopy was developed for fast conditional stability constant 
determination of the uranyl ligand complex at pH 5.5 and 7.4 which are the pH of kidneys and 
blood respectively.122 The example of displacement method was listed in Fig 18. This method 
provides the estimation of chelation affinity of ligand with uranyl ion at the pH of kidneys and 
blood by adding two equivalence of candidate ligand to uranyl SCP 1:1 complex in 112.5 mmol 
nBu4
+Cl- solution with respect buffer, CHES for pH 5.5, HEPES for pH 7.4, to maintain the pH. 
Due to the complexation of sulfochlorophenole with sodium ion, it is important to use the ionic 
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liquid as the ionic strength.  
HEDP
L4
2H
3C
7B
 
Figure 16 : Structure of 1-hydroxyethane-1,10-diphosphonic acid (HEDP), three 
bisphosphonate sequestering ligands (2H, 3C, 7B) and polyaminophosphonates ligand 
(L4).75 
 
Figure 17 : Proposed Structure of the Uranyl-HEDP Complex. 
Polyaminophosphonates ligands have proved to be efficient chelating agents for 64Cu and 
99mTc which are widely used in Positron Emission Tomography (PET) and Single Photon 
Emission Computed Tomography (SPECT).12,123–125 A series of ployphosphonated pyridine 
ligands were synthases by the group of Prof. Loïc J. Charbonnière in Université de 
Strasbourg.12,13,126–130 The test with polyaminophosphonates ligand L4 and europium proved the 
high stability in aqueous solution which logKEuL is 25.7. The coordination of europium is 
composed by 3 nitrogen atoms and 4 oxygen atoms from the ligand and 1 oxygen atom from 
the water molecular.13 As europium is the chemical analogue of americium, this ligand could 
be used as the actinides(III) chelating agents.  
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Figure 18 : Example of displacement method: Displacements (%) of the uranyl SCP 
complex are presented in a color-coded format for clarity reason. logKcond (estimates) 
were calculated by using the HYSS program supposing that the complex competitive 
uranyl/ligand is 1:1.122 
1.9.3.2 In vivo tests of phosphonate ligands 
Twenty polyphosphonic or phosphinic acids and derivatives were injected at t=30 min 
(molar ratios 1.6/104) in rats that had been injected with 233U(VI) nitrate. Immediate injection 
of the compounds DTPMP, EDTMP, or HMTMP reduced 233U in kidneys and enhanced urinary 
233U excretion. Compounds DDMT, CDTT, or BCPBP injected at 30 min reduced 233U in 
kidneys and body, and compound E enhanced 233U excretion.131  
Rats, injected with a 50% lethal amount of U(VI) nitrate, were promptly injected with 
HEDP (molar ratio 124). Survival was 100% at 60 d, and kidney structure was within normal 
limits.132 Rats were injected im with 233U(VI) nitrate, and EHBP was injected im at the wound 
site at 5 or 30 min (molar ratio 5,000) or injected ip (molar ratio 2,500). Injection of HEDP im 
or ip at 5 min significantly reduced 233U in kidneys and increased urinary 233U excretion.133 The 
bio-distribution of uranyl with 25 bisphosphonate ligands, dipodal bisphosphonates with 
Kcond>10
17 and tripods with Kcond>1018 at pH 7.4, was investigate (Table 14). Among them, 
three bisphosphonate ligands, 2H, 3C, and 7B, could increase the uranyl ligand complex 
excretion. This result might suggest that this hepatic deposition is avoided when N-methyl-
amide moieties are present. A uranium removal study was done with HEDP, 5-LICAM(S), 2H, 
3C, and 7B in mice. Only 3C have the similar ability like HEDP to promote the uranyl excretion 
about 50% in the 5 days after 233U(VI) injected ip.   
Ligand Percent of injected 233U(VI)±SD at 5 days 
 Retention Excretion 
 Kidneys Skeleton Liver Urine Feces 
No (controls) 8.0±2.3 34.2±4.5 0.4±0.0 40.7±3.4 1.8±1.0 
HEDP 5.5±0.5 30.2±1.2 0.4±0.1 50.1±4.3 2.9±1.7 
5-LICAM(S) 6.3±0.8 22.8±4.7 0.5±0.1 48.0±5.7 2.2±1.2 
2H 6.7±1.3 41.8±3.9 2.8±0.5 31.6±7.8 4.9±1.3 
3C 3.6±0.6 32.4±1.5 0.3±0.0 53.5±2.7 2.3±0.5 
7B 3.4±0.6 23.9±0.5 1.5±0.6 29.7±5.1 1.4±0.6 
Table 14：Effect of a prompt injection of bisphosphonate ligands on the biodistribution 
and excretion of 233U(VI). Ligands were injected ip (30 mmol/kg, molar ratio 100) 5 min 
after injection of 9.2 kBq of 233U(VI); animals were sacrificed 5 days later. Data are 
expressed as % of injected radioactivity, discrepancies are due to rounding. Bold means 
are significantly different than control mean.75 
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The 99mTc SPECT/CT of mice images shown that the complex of 99mTc with four 
phosphonate groups ligand L4 rapidly accumulated in the kidneys after 5 minutes, and part of 
complex could be found in the bladder after 2 h. But part of the complex is accumulated in bone 
tissues after 4 h. For the case of complex of 99mTc with two phosphonate groups ligand, part of 
the complex could be found in the kidneys after 7 min, and then transferred to the bladder after 
1 h 10 min. 
1.10 Methods for in vitro study  
In order to perform study under the bio-conditions, a number of biology-relevant actinide 
ligands, minerals, organics, proteins and amino acids, and metals, present in a few media within 
the human body (saliva and blood serum) and their concentrations are listed in table 15, together 
with the composition of a cell culture medium used for in vitro experiments that simulate 
actinide behavior.  
 
Components (M) Blood serum Saliva 
pH 7.4 5.6–7.6 
E (mV) 200–300 200–300 
“Mineral”   
Carbonate 2.5 × 10−2 6.6 × 10−3 
Phosphate 1.1 × 10−3 3.7 × 10−3 
SCN–  2.1 × 10−3 
F-  7.3 × 10−6 
SO42- 3.3 × 10−4 3.3 × 10−4 
Cl– 9.0 × 10−2 2.9 × 10−2 
NH4+  2.6 × 10−3 
“Organic”   
Ascorbate  8.0 × 10−6 
Citrate 1.6 × 10−4 5.4 × 10−5 
Lactate 1.5 × 10−3 1.4 × 10−6 
Oxalate 9.2 × 10−6  
“Proteins + amino-acids” 10−4 to 10−5 10−4 to 10−5 
Albumin 6.3 × 10−4  
Transferrin 3.7 × 10−5  
Urea  3.0 × 10−3 
     HEPES buffer “Metals”  
Ca2+ 1.4 × 10−3 1.5 × 10−3 
Mg2+ 5.6 × 10−4 2.7 × 10−4 
Na+ 9.0 × 10−2 1.0 × 10−2 
K+ 4.9 × 10−4 2.0 × 10−2 
Fe2+ 3.0 × 10−5  
Table 15：Major actinide ligands (M) present in selected in vivo human biological 
media.134  
1.11 Conclusion 
Due to the affinity difference of the binding groups at the biological pH of blood and 
kidneys, 7.4 and 5.5 respectively, the actinide ion which are complexed by the chelation agent 
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could be dissociated, e.g. Pu(IV) catecholates complex. Carboxylic group, HOPO and 
phosphonate group showed the affinity to complex the actinide ions under different biological 
pHs. 
For the actinides chelation agents which have been studied in the past, the structure contains 
two parts, the binding group and the backbone. The binding group can be carboxylic group, 
CAM & HOPO or phosphonate group which have been reviewed in the previous chapter. The 
backbone influences the stability of the metal chelate by the spatial arrangement of the binding 
groups.66 It has no ability to coordinate the metal ion, and impact the solubility and toxicity. 
This phenomenon confirmed be the study of different siderophore analogues39,74,102,110,112 and 
bisphosphonate ligands75,122.  
 
Figure 19 : Structure illustration of actinides chelation agents 
Phosphonated pyridine ligands, new design of chelation agents, have offered another 
possibility with structural and coordination properties suitable for actinide chelation. The 
binding group is a phosphonate group which could complex the actinide ion at biological pH. 
By using pyridine group as the backbone, the ligand structure is more compact which promotes 
the selectivity.   
For this study, polyaminophosphonates pyridine ligands with 5 donors from phosphonate 
groups, amine part and pyridine group at the equatorial planar will be synthesized for uranium 
decorporation investigations.  
Chelation study for biology simulation with 
calmodulin 
It is important to understand to possible behavior of the ligand in the actinide chelation 
therapy. Because plenty of work on the interactions between uranyl ion and calmodulin was 
done by Dr. Florian BRULFERT from Institut de Physique Nucléaire d'Orsay, a ternary system 
with uranyl ion, ligand and calmodulin was chosen for a preliminary test for the chelation study 
for biology simulation.    
1.12 Description of the protein 
Intracellular calcium, a secondary messenger, is playing an important role in extracellular 
stimulus. The increasing of calcium in the cytoplasmic could lead to the complexation between 
this metal and the intracellular regulatory protein. One of the many proteins responsible for the 
regulation of Ca2+ is calmodulin (CaM). It is a ubiquitous, multifunctional protein which can 
active several enzymes such as phosphodiesterase, ATPase, calmodulin kinases.135 
Calmodulin is a small globular protein consisting of a peptide chain of 148 amino acids for 
a total mass of about 16700 Da by amino acid sequence.136 It contains a large proportion of 
aspartate and glutamate (35%) which provides plenty of acidic amino acid carboxylate groups. 
Thus it is a relatively acidic protein. This amino acid sequence forms two similar globular ends 
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which contain two calcium binding domains. Each complexation site is described as helix-loop-
helix “EF-Hand” region (EF-1, EF-2, EF-3 and EF-4 numbered from the N-terminal domain). 
The EF-3 and EF-4 binding domains of the C-terminal domain have an affinity for calcium 10- 
20 times higher than the EF-1 and EF-2 binding domains of the N-terminal domain.137–139 The 
complexation affinity of calcium by each pair of binding domains is cooperative.140,141  
Calmodulin (CaM) is found in almost all eukaryotic cells.142,143 It believed to be involved 
in intracellular Ca2+ homeostasis, cell proliferation, smooth muscle contraction, microtubular 
function, exocytotic secretion of cellular products, and cell motility.144 The primary structure 
has been remarkably conserved which suggest that each binding domains of calcium and each 
structural parameter of the protein is useful for its various functions. Thus different occupation 
degrees of the binding domains can translate a quantitative calcium concentration difference 
into a qualitatively different cellular response by interaction with different types of enzymes or 
molecules depending on the calcium concentration.140  
Calmodulin, thanks to its various roles in the human body, represents a subject of study of 
particular interest in the radioactive decontamination investigation. 
1.13 Interaction between calmodulin and calcium 
 
Figure 20 : Schematic of the calcium binding site 1 of Paramecium tetraurelia 
calmodulin.145 
Calcium is a divalent ion which preferentially forms bonds with oxygen donor ligands. The 
preferential coordination of the ion comprises seven ligands arranged either in distorted 
octahedron or bipyramidal pentagon. The main-EF motif is responsible for the complexation of 
calcium in proteins.146 It is composed of two orthogonal α-helices that flanks a flexible 
complexation site that provides the residues involved in coordination at positions 1, 3, 5, 7, 9 
and 12 (Fig. 20). 
In CaM site 1 (Fig. 20), the coordination sphere of calcium is composed of three 
monodentate aspartates at positions 1, 3, 5, a bidentate glutamate at position 12, a carbonyl 
from the main chain at position 7 and a water molecule stabilized by threonine at position.147,148 
The composition of the calcium coordination site (hard and acid ligands) could form 
complexation with other metals such as uranyl or minor actinides148,149. Meanwhile a 
competition between uranyl and calcium for the occupation of the calcium binding domains of 
certain proteins has been confirmed .150,151 Lanthanides could occupy the calcium binding 
domains also.146 Ln3+ binds to the N-terminal of calmodulin first, while Ca2+ binds to the C-
terminal domain of the protein first.152 
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Figure 21 : Fractional species calculation for 𝐂𝐚𝐱
𝟐+(calmodulin) as a function of [Ca2+]. 
The total calmodulin concentration is 15𝛍𝐌.153 
The four similar binding domains of calcium present some different ability on calcium 
complexation. The sequential stability constants are as follows: K1 = 1.3E5
 M-1, K2 = 3.7E5
 M-
1, K3 = 3.2E5
 M-1, K4 = 3.2E5
 M-1.153 A large excess of calcium is required for the four sites of 
the protein to be loaded (Fig. 21). 
1.14 Interactions between calmodulin and actinides 
There isn’t sufficient information over the complexation of actinides by CaM. However, 
Pu(III) could be complexed by this protein, and also occupy the complexation site of calcium 
and therefore can replace it in case of internal contamination.154 Uranyl ion has been the subject 
of several affinity studies and the results obtained show that it also present a high affinity for 
CaM (Kd = 32 ± 7 nM
145). Uranyl also occupies the calcium site149, as is the case of other 
proteins150,155, which it is therefore required to replace in case of internal contamination. The 
EXAFS data could fit well with the DFT calculations for the synthesized CaM motif (Fig 22).149 
Further work on trivalent ions (such as lanthanides which are americium analogs) has 
shown that these lanthanides have a high affinity and even greater than calcium for CaM. The 
ionic radius of these ions is similar to calcium.156 And a study by Song et al157 showed that 
complexation of these lanthanides by CaM could also active the target enzymes which is similar 
when complexed with calcium.  
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Figure 22 : Theoretical models and electronic density of the U(VI) interaction sites on 
the CaMWT calculated by DFT (oxygen: red, carbon: blue, nitrogen: light green, 
uranium: yellow and neptunium: dark green).149 
Calmodulin with a relatively high affinity towards uranyl, is therefore chosen on 
decorporation study.155,157 In this study, fluorescence study on uranyl, while the chelation agent 
and calmodulin are present, was done to investigate the evolution of decorporation rate.  
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1 General strategy  
Although uranium is used as colorants since Roman times158, and widely used in the nuclear 
industry and for military applications for now, there is only a few people which contaminated 
by this metal. Consequently, uranium poisoning is not currently a major public health issue. 
Thus, the development of ligands which has a strong affinity towards uranium is slowly 
promoting. The groups of Prof. K. N. Raymond of the University of Berkeley and Frédéric 
Taran of CEA Saclay, reweld by some teams all over the world, are the main actors which focus 
on the uranyl decoperation agent research. There are a few ligands which could effective 
complex uranyl in vivo.  
Based on this situation, the ligand for the MRI contrast which has been extensively studied 
is a promising candidate.130,159–163 Normally these ligands, molecular mass is between 300 and 
600, could provide 7-8 coordination for lanthanide and have a really strong complexation 
affinity. Meanwhile the excretion of metal ligand complex is pretty fast, hours to days. The 
toxicity is relatively low.  
Among all the MRI contrast ligands, polyaminophosphonates ligands have been chosen for 
this study. The synthesis of polyaminophosphonates ligands was developed by the group of 
Prof. Loïc Charbonniaire from IPHC.12 The main idea is by using phosphonated groups which 
shown hard base character and high negative charge to functionalized the position 2 and 6 of 
pyridine. In this way the stability of uranyl-ligand complex could be increased.  
Due to the different coordination of uranyl and lanthanide, several synthesis routes have 
been tested to have a new polyaminophosphonates ligand with 5 coordinations (Figure 23). 
Three new ligands L1-L3 with 2 phosphonated groups were successfully synthesized. In order 
to understand the coordination processes of L1, another analogue (L4), synthesis by the group 
of Loïc Charbonniaire, has been used for the further study. The structures of the L1, L2, L3 and 
L4 are shown in figure 23.  
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Figure 23 : Chemical structure of ligands L1, L2, L3and L4.  
Synthesis of precursor  
To get polyaminophosphonate ligands L1-L3, is required prior synthesis of the pyridinic 
platform 1 which carry the phosphonate arms (Figure 24). The phosphonate arms precursors 
are compounds 3 and 5 (Figure 24). 
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Figure 24 : Chemical structure of precursors.  
1.1 Synthesis of pyridinic platform 
2,6-dibromomethylpyridine 1 was obtained in a single step by reaction of PBr3 with 2,6-
hydroxymethyl-pyridine in DMF at 0°C (scheme 3).164 
PBr3
 1
DMF
0°C
95%  
Scheme 3 : Synthesis of 2,6-dibromomethylpyridine. 
1.2 Synthesis of amine monophosphonate  
Diethyl (aminomethyl)phosphonate 3 was obtain from diethyl phosphate by the 
Kabachnik−Fields reaction in a two steps reaction (scheme 4).165 The first step is by adding 
dibenzylamine and formaldehyde to a solution of diethyl phosphite in THF to get Diethyl 
((dibenzylamino)methyl)phosphonate 2. Then a palladium-carbon catalyzed hydrogenation 
reaction has been performed to yield the desired compound 3 (scheme 4).166 
 2  3
H2,Pd/C
reflux70°C
91%60%
 
Scheme 4 : Synthesis of diethyl (aminomethyl)phosphonate. 
Diethyl ((benzylamino)methyl)phosphonate 5 was obtain from benzylamine in two step 
(scheme 5). To a stirred solution of benzylamine, formaldehyde was added to get 1,3,5-
Tribenzylhexahydrotriazine 4.167 The desired compound 5 was synthesized by react with 
diethylphosphite.168  
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Scheme 5 : Synthesis of diethyl ((benzylamino)methyl)phosphonate. 
Synthesis of bisphosphonate ligand L1 
The ligand L1 was synthesized in 2 different routes. But due to low yield and byproduct, 
two synthesized routes were not possible to get the precursor. The synthesis of ligand L1 cannot 
be done.  
First synthesized route:  
In this synthesis route (Scheme 6), precursor compound 6 was obtained by reacting 
dibrominated pyridine 2 with compound 3 in acetonitrile in the presence of K2CO3. But due to 
the polynuclear reaction between the residues N-H with bromine, the yield was below 10% for 
various conditions. So that we tried the second route to get L1.12 
 
Scheme 6 : First synthesized route of bisphosphonate ligand L1. 
Second synthesized route:  
In this synthesis route (Scheme 7), compound 7 was obtained by dibrominated pyridine 2 
with compound 5 in acetonitrile in the presence of K2CO3. Then a palladium-carbon catalyzed 
hydrogenation reaction has been performed to yield the precursor compound 6. Due to the 
cleavage of the carbon chain between nitrogen with benzyl group, there are several ways to 
break carbon chain which could form different byproduct; this route was not acceptable.  
 
Scheme 7 : Second synthesized route of bisphosphonate ligand L1. 
Synthesis of bisphosphonate ligand L2 
Compound 8 was obtained by dibrominated pyridine 2 with less equivalence compound 5 
in acetonitrile in the presence of K2CO3 (Scheme 7). Precursor compound 9 was obtained by 
 1  6
K
2
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3
,MeCN 10%
50°C
 1  6
H
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18%K
2
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3
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compound 8 with compound 3 in acetonitrile in the presence of K2CO3. The yield of two steps 
reaction to get precursor was low (10%). Thus the synthesis of bisphosphonate ligand L2 was 
abandoned.  
 8 1  9
K
2
CO
3
,MeCN 55% K
2
CO
3
,MeCN 20%
50°C 50°C
 
Scheme 8: Synthesized route of bisphosphonate ligand L2. 
Synthesis of bisphosphonate ligand L3 
Compound 7 was getting in the same way in second synthesized route of bisphosphonate 
ligand L1. In this synthetic route, the deprotection of the ethyl groups is carried out in 
concentrated HCl medium. There are three ligands, L1, L2 and L3 which were found in the crude 
after purified with revise phase chromatography. The yields for each compound are 9% for L1, 
13% for L2 and 52% for L3. The total efficiency of this deprotection is 74%. The reason of 
generation of L1 and L2 was not found in the literature.  
 1  7
 L 1  L 2  L
 3
9% 13% 52%
K
2
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3
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Scheme 9: Synthesized route of bisphosphonate ligand L3. 
The L1-L3 ligands synthesized were all characterized by 1H NMR, 13C NMR and 31P NMR. 
L2 and L3 were further analyzed by elementary analysis and ESI-MS mass spectrometry in 
negative mode.  
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Figure 25 : 1H RMN spectrum of ligand L2 (D2O, 400 MHz, t.a.). 
The 1H NMR spectra of the L1-L3 ligands are characterized by a splitting of the alpha 
phosphorus proton signals explained by a coupling with the phosphorus atom 31P of spin S = 
1/2. By the example above, we perform the attribution of proton spectrum of ligand L2 (Figure 
25). The 3 protons of pyridine appear in the form of two doublets associated with a triplet with 
weak fields. The protons of benzyl group appear as multiple peaks at high chemical shift range. 
The -CH2 protons of gamma phosphonates are come out in the form of a doublet from 2.3 to 
2.7 ppm. 
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Figure 26 : 13P RMN spectrum of ligand L2 (D2O, 161.9 MHz, t.a.). 
The NMR spectrum of phosphorus exhibits two triplet peaks at 16 and 16.4 ppm 
respectively for the ligands L2 because of the asymmetric (Figure 26). In contrast to the L2, the 
31P NMR spectra of the L1 and L3 ligands, which are symmetric, have only one triplet peak at 
16.5 ppm and 8.5 ppm respectively. 
Conclusion  
In this chapter, the synthesis of a new family of acyclic polyaminophosphonate ligands is 
shown. This ligand family is based on the pyridine platform which carries two phosphonate 
groups. 
The synthesis of these ligands is based on three main reactions: the first is the N-alkylation 
with amino-methylphosphonate groups and ((benzylamino)methyl)phosphonate on a dibromed 
derivative of pyridine. The second is the palladium-carbon catalyzed hydrogenation reaction to 
remove the benzyl group. The third is the deprotection reaction of the phosphonic esters in HCl 
(6M). 
It is interesting to note that the benzyl group will be removed while the deprotection of the 
phosphonic esters in HCl (6M) to get the final product. Ligand L3 is obtained with acceptable 
yield. L1 and L2 were obtained as byproduct.  
To obtain these polyaminophosphonate ligands, the prior synthesis of two diphosphonate 
precursors is required. Sequently three acyclic ligands, synthesized from a pyridinic 
chromophore and phosphonate groups, could provide sufficient donors for the equatorial 
complexation of uranyl (UO2
2+). The next chapter will be devoted to the determination of the 
coordination properties and thermodynamic constants in aqueous medium of uranyl complexes 
for chelation therapies. The structural studies of Eu3+, as analogue of Am3+, with ligands also 
investigated in the following chapter.  
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Experimental part  
Synthesis of ligand L1  
First route: 
 
1 
2,6-Bis(bromomethyl)pyridine 1. To a solution of 2,6-pyridinedimethanol (3.36 g, 24.1 
mmol) in DMF (20 mL) at 0 °C, PBr3 (5.22 mL, 55.6 mmol) was added dropwise. The mixture 
was stirred at room temperature for 6 h, then water was added (300 mL) to solubilize the formed 
solid. After extraction with CH2Cl2 (3 × 100 mL), the organic layer was dried with Na2SO4 and 
the solvent was removed in vacuo to yield a yellow solid. The crude product was purified by 
flash chromatography (CH2Cl2) to give compound 1 as a pure white solid (5.26 g, 82 %). 
1H NMR (400 MHz, CDCl3): δ 7.64 (t, J = 7.7 Hz, 1H), 7.31 (d, J = 7.7 Hz, 2H), 4.47 (s, 
4H).  
 
 
2 
Diethyl ((benzylamino)methylphosphonate 2. To a solution of diethyl phosphate (5.07 g, 
36.7 mmol) in THF (15.7 mL), dibenzylamine (6.09 g, 30.8 mmol) and formaldehyde (1.81 g, 
60.3 mmol) were added. The mixture was heated to 60 °C for 16 h. The solvent was removed 
in vacuo and the crude oil was dissolved with cyclohexane (150 mL). The solution was washed 
three times with water (75 mL). After evaporation of the solvent, compound 2 was obtained as 
a colorless oil (5.26 g, 60 %).  
1H NMR (400 MHz, CDCl3): δ 7.21 (m, 5H), 3.97 (qd, J = 7.2 Hz, J = 7.2 Hz, 4H), 3.69 
(s, 4H), 2.80 (d, J = 10.4 Hz, 2H), 1.20 (t, J = 7.1 Hz, 6H). 31P NMR (162 MHz, CDCl3): δ 25.7. 
 
3 
Diethyl aminomethylophosphonate 3. A solution of compound 2 (5.26 g, 15.7 mmol) in 
dry EtOH (200 mL) was hydrogenated in presence of Pd/C catalyst (280 mg, 5% Pd). After 16 
h at reflux, the reaction was complete. After filtration, the solvent was evaporated to dryness to 
afford compound 3 as an oily product (2.3 g, 91 %). 
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1H NMR (400 MHz, CDCl3) δ: 4.17 – 3.99 (m, 4H), 2.95 (d, J = 10.3 Hz, 2H), 1.40 (s 
broad, 2H), 1.28 (t, J = 7.1 Hz, 6H). 
 
6 
Tetraethyl (((pyridine-2,6-
diylbis(methylene))bis(azanediyl))bis(methylene))bis(phosphonate) 10. To a solution of 
amine 8 (3.5 g, 21 mmol) in MeCN (40 mL), under a nitrogen atmosphere, freshly flame-dried 
K2CO3 (3.4 g, 26 mmol) was added. The mixture was heated to 70 °C. And then a solution of 
2,6-bis(bromomethyl)pyridine 2 (1.4 g, 5.3 mmol) in MeCN (100 mL) was added dropwise 
over a 3 hours period. The reaction mixture was monitored by TLC (CH2Cl2/MeOH 95/5). 
After filtration, the solvent was removed in vacuo and the crude oil was purified by flash 
chromatography (CH2Cl2/MeOH 100/0 to 95/5). Compound 10 was obtained as an oily product 
(230 mg, 10 %).  
1H NMR (400 MHz, CDCl3): δ 7.55 (t, J = 7.7 Hz, 1H), 7.13 (d, J = 7.7 Hz, 2H), 4.16 – 
4.03 (m, 8H), 3.90 (s, 4H), 2.95 (d, J = 12.6 Hz, 4H), 2.23 (s, 2H), 1.28 (t, J = 7.1 Hz, 12H). 
13C NMR (101 MHz, CDCl3): δ 158.5, 137.1, 120.8, 62.3 (d, J = 6.6 Hz), 56.0 (d, J = 15.5 Hz), 
44.7 (d, J = 156.1 Hz), 16.6 (d, J = 5.7 Hz). 31P NMR (162 MHz, CDCl3): δ 26. 
Second route: 
 
4 
1,3,5-Tribenzylhexahydrotriazine 4. To a stirred solution of benzylamine (20.7 g, 193 
mmol) at 0 °C, 37 % aqueous formaldehyde solution (19.4 mL, 60.7 mmol) was slowly added 
keeping the temperature below 5 °C. 1M aqueous sodium hydroxide solution (5 mL) was added 
to the resulting precipitated gum and the mixture was under ultrasonic treatment for 1 h at 0 °C. 
Diethyl ether (190 mL) was added and then the aqueous phase was extracted with diethyl ether 
(3 × 50 mL). The organic layer was dried with Na2SO4 and the solvent was removed under 
reduced pressure to yield a colorless oil. The crude product was purified by flash 
chromatography (Cyclohexane/Ethyl Acetate 100/0 to 85/15). Compound 4 was obtained as a 
colorless oil (21.1 g, 91%).  
1H NMR (300 MHz, CDCl3): δ 7.33 – 7.05 (m, 15H), 3.59 (s, 6H), 3.34 (s broad, 5H). 
 
5 
Diethyl ((benzylamino)methyl)phosphonate 5. Compound 4 (4 g, 11.2 mmol) was added 
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to diethyl phosphite (5.1 g, 36.9 mmol), under nitrogen and the mixture was heated at 100°C 
for 16 h. The resulting product was purified by flash chromatography (Ethyl Acetate) to give 
compound 5 as an oily product (3.65 g, 79 %).  
1H NMR (300 MHz, CDCl3): δ 7.33 – 7.09 (m, 5H), 4.07 (m, 4H), 3.80 (s, 2H), 2.88 (d, J 
= 12.6 Hz, 2H), 1.61 (s broad, 1H), 1.26 (t, J = 7.1 Hz, 6H). 31P NMR (162 MHz, CDCl3) δ: 
25.7.  
 
7 
tetraethyl (((pyridine-2,6-
diylbis(methylene))bis(benzylazanediyl))bis(methylene))bis(phosphonate) 7. Under a 
nitrogen atmosphere, amine 5 (1.1 g, 4.3 mmol) and freshly flame-dried K2CO3 (1.2 g, 9.1 
mmol) were added to a solution of 2,6-bis(bromomethyl)pyridine 2 (600 mg, 2.26 mmol) in 
MeCN (20 mL). The mixture was heated for 16h at 70 °C. After filtration, the solvent was 
removed in vacuo and the crude oil was purified by flash chromatography (Ethyl 
Acetate/MeOH 100/0 to 90/10). Compound 7 was obtained as an oily light-yellow product (1.1 
g, 79 %). 
1H NMR (400 MHz, CDCl3): δ 7.59 (t, J = 7.7 Hz, 1H), 7.38 (d, J = 7.7 Hz, 2H), 7.34 – 
7.10 (m, 10H), 4.05 – 3.93 (qd, J = 7.2 Hz, J = 7.2 Hz, 8H), 3.85 (s, 4H), 3.73 (s, 4H), 2.88 (d, 
J = 10.6 Hz, 4H), 1.21 (t, J = 7.1 Hz, 12H). 13C NMR (100 MHz, CDCl3): δ 158.6, 138.6, 137.0, 
129.2, 128.4, 127.3, 121.5, 61.9 (d, J = 6.7 Hz), 61.2 (d, J = 8.3 Hz), 59.8 (d, J = 9.0 Hz), 49.1 
(d, J = 161.5 Hz), 16.6 (d, J = 6.0 Hz). 31P NMR (162 MHz, CDCl3): δ 25.4. ESI+/MS (CH2Cl2): 
m/z = 618.3 ([M + H]+, 100 %). 
 
6 
Tetraethyl (((pyridine-2,6-
diylbis(methylene))bis(azanediyl))bis(methylene))bis(phosphonate) 10. A solution of 
compound 7 (0.2 g, 1.52 mmol) in dry EtOH (30 mL) was hydrogenated in presence of Pd/C 
catalyst (20 mg, 10 % Pd). After 6h at reflux, the reaction was stopped. After filtration, the 
solvent was evaporated to dryness to afford compound 10 as an oily product (25 mg, 18 %). 
1H NMR (400 MHz, CDCl3): δ 7.55 (t, J = 7.7 Hz, 1H), 7.13 (d, J = 7.7 Hz, 2H), 4.16 – 
4.03 (m, 8H), 3.90 (s, 4H), 2.95 (d, J = 12.6 Hz, 4H), 2.23 (s, 2H), 1.28 (t, J = 7.1 Hz, 12H). 
13C NMR (101 MHz, CDCl3): δ 158.5, 137.1, 120.8, 62.3 (d, J = 6.6 Hz), 56.0 (d, J = 15.5 Hz), 
44.7 (d, J = 156.1 Hz), 16.6 (d, J = 5.7 Hz). 31P NMR (162 MHz, CDCl3): δ 26. 
 
Synthesis of ligand L2  
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8 
Diethyl ((benzyl((6-(bromomethyl)pyridin-2-yl)methyl)amino)methyl)phosphonate 
11. To a solution of 2,6-bis(bromomethyl)pyridine 2 (1.09 g, 4.1 mmol) in MeCN (20 mL), 
amine 5 (1.17 g, 4.5 mmol) in MeCN (20 mL) and freshly flame-dried K2CO3 (1.07 g, 8.3 mmol) 
were added under a nitrogen atmosphere. The reaction mixture was heated at 70 °C for 16 h. 
After filtration, the solvent was removed in vacuo and the crude oil was purified by flash 
chromatography (Ethyl Acetate/MeOH 100/0 to 90/10) to give compound 13 as an oily product 
(1 g, 55 %).  
1H NMR (400 MHz, CDCl3): δ 7.67 (t, J = 7.7 Hz, 1H), 7.51 (d, J = 7.8 Hz, 1H), 7.41 – 
7.20 (m, 5H), 4.52 (s, 2H), 4.12 – 4.03 (m, 4H), 3.94 (s, 2H), 3.82 (s, 2H), 2.97 (d, J = 10.6 Hz, 
2H), 1.29 (t, J = 7.1 Hz, 6H). 13C NMR (101 MHz, CDCl3): δ 159.5, 155.9, 138.3, 137.6, 129.2, 
128.4, 127.4, 122.6 121.9, 62.0 (d, J = 6.7 Hz), 60.8 (d, J = 8.0 Hz), 59.8 (d, J = 8.6 Hz), 49.0 
(d, J = 158.7 Hz), 34.0, 16.6 (d, J = 6.1 Hz). 31P NMR (162 MHz, CDCl3): δ 25.3. ESI+/MS 
(CH2Cl2): m/z = 441.1 ([M + H]
+, 98 %), m/z = 443.1 ([M + H]+, 100 %), m/z = 463.1 ([M + 
Na]+, 50 %), m/z = 465.1 ([M +Na]+, 50 %), m/z = 479.0 ([M + K]+, 19 %), m/z = 481.0 ([M + 
K]+, 19 %).  
 
9 
Diethyl ((((6-((benzyl((diethoxyphosphoryl)methyl)amino)methyl)pyridin-2-
yl)methyl)amino)methyl)phosphonate 12. Under a nitrogen atmosphere to a solution of 
compound 11 (809 mg, 1.83 mmol) in MeCN (10 mL), amine 8 (734 mg, 4.4 mmol) in MeCN 
(10 mL) and freshly flame-dried K2CO3 (720 mg, 5.5 mmol) were added. The reaction mixture 
was heated at 70 °C for 16 h. After filtration, the solvent was removed in vacuo and the crude 
oil was purified by flash chromatography (CH2Cl2/MeOH 100/0 to 95/5). Compound 11 was 
obtained as an oily product (200 mg, 20 %).  
1H NMR (400 MHz, CDCl3): δ 7.56 (t, J = 7.7 Hz, 1H), 7.40 (d, J = 7.6 Hz, 1H), 7.34 – 
7.13 (m, 5H), 7.10 (d, J = 7.5 Hz, 1H), 4.13 – 3.95 (m, 8H), 3.90 (s, 2H), 3.88 (s, 2H), 3.73 (s, 
2H), 2.96 (d, J = 12.6 Hz, 2H), 2.91 (d, J = 10.6 Hz, 2H), 1.28 (t, J = 7.0 Hz, 6H), 1.23 (t, J = 
7.0 Hz, 6H).13C NMR (101 MHz, CDCl3): δ 158.8, 157.7, 138.2, 136.7, 128.9, 128.1, 127.0, 
121.3, 120.4, 61.9 (d, J = 6.6 Hz), 61.6 (d, J = 6.7 Hz), 60.8 (d, J = 8.2 Hz), 59.5 (d, J = 9.0 
Hz), 55.7 (d, J = 15.9 Hz), 48.7 (d, J = 161.4 Hz), 44.4 (d, J = 156.3 Hz), 16.3 (d, J = 5.6 Hz). 
31P NMR (162 MHz, CDCl3): δ 26.0, 25.2. ESI+/MS (CH2Cl2): m/z = 528.3 ([M + H]
+, 100 %), 
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m/z = 550.2 ([M +Na]+, 33 %), m/z = 566.2 ([M + K]+, 19 %). 
Synthesis of ligand L3  
 
L3 
(((pyridine-2,6-
diylbis(methylene))bis(benzylazanediyl))bis(methylene))diphosphonic acid L3. Compound 
7 (1.7 g, 2.79 mmol) was dissolved in 6 M HCl (36.5 mL) and the mixture was heated at reflux 
for 16 h. The solvent was removed under reduced pressure. After completion of the reaction, 
the mixture was evaporated to dryness, and the crude product was purified by flash 
chromatography with a C18 reverse phase column (eluent system H2O/ACN 0.1 % TFA), to 
give ligand L3 (0.74 g, 52 %).  
 1H NMR (400 MHz, MeOD) δ 7.84 (t, J = 7.8 Hz, 1H), 7.74 – 7.64 (m, J = 8.6, 3.8 Hz, 
4H), 7.49 – 7.38 (m, 6H), 7.34 (d, J = 7.8 Hz, 2H), 4.76 (s, 4H), 4.67 (s, 4H), 3.37 (d, 4H).13C 
NMR 13C NMR (101 MHz, MeOD) δ 150.07 (s), 139.18 (s), 131.98 (s), 130.01 (s), 128.95 (s), 
128.63 (s), 122.85 (s), 59.42 (d), 57.05 (d, J = 6.1 Hz), 50.30 (d, J = 136.4 Hz). 31P NMR (162 
MHz, MeOD) δ 8.48. ESI+/MS (CH2Cl2): m/z = 506.2 ([M + H]
+, 100 %), m/z = 1011.3 ([2M 
+ H]+, 23. Calc. for C23H29N3O6P2·TFA: C, 50.5; H, 5.64; N, 7.43; Found: C, 48.5; H, 4.88; N, 
6.78. 
 
L1 
(((pyridine-2,6-diylbis(methylene))bis(azanediyl))bis(methylene))bisphosphonic acid 
L1. The crude product was purified by flash chromatography with a C18 reverse phase column 
(eluent system H2O/ACN 0.1 % TFA), to give ligand L1 (0.08 g, 9 %).  
1H NMR (400 MHz, D2O) δ 7.74 (t, J = 7.8 Hz, 1H), 7.27 (d, J = 7.8 Hz, 2H), 3.82 (s, 4H), 
2.53 (d, J = 12.5 Hz, 4H).13C NMR (101 MHz, D2O) δ 158.13, 138.76, 121.34, 48.31, 46.95. 
31P NMR (162 MHz, D2O) δ 16.50.  
 
L2 
((((6-((benzyl((diethoxyphosphoryl)methyl)amino)methyl)pyridin-2-
yl)methyl)amino)methyl) diphosphonic acid L2. The crude product was purified by flash 
chromatography with a C18 reverse phase column (eluent system H2O/ACN 0.1 % TFA), to 
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give ligand L2 (0.15 g, 13 %).  
1H NMR (400 MHz, D2O) δ 7.64 (t, J = 7.8 Hz, 1H), 7.33 (d, J = 7.7 Hz, 1H), 7.25 – 7.04 
(m, 6H), 3.78 (d, J = 21.9 Hz, 4H), 3.63 (s, 2H), 2.58 (d, J = 11.6 Hz, 2H), 2.51 (d, J = 12.7 Hz, 
2H).13C NMR (101 MHz, D2O) δ 163.10 (s), 158.72 (s), 138.56 (s), 138.56 (s), 129.86 (s), 
128.18 (s), 127.08 (s), 122.89 (s), 120.84 (s), 60.28 (d), 59.24 (d, J = 8.2 Hz), 55.19 (d, J = 12.8 
Hz), 54.12 (d, J = 140.4 Hz), 47.70 (d, J = 137.0 Hz).31P NMR (162 MHz, D2O) δ 16.39, 
15.91.ESI+/MS (CH2Cl2): m/z = 416.1 ([M + H]
+, 100 %); m/z = 831.2 ([2M + H]+, 15 %). 
Calc. for C16H23N3O6P2·TFA: C, 41.6; H, 5.77; N, 8.66; Found: C, 40.9; H, 4.57; N, 7.94. 
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1 Acid-base properties of 
polyaminophosphonates ligands 
It is important to know the acid-base properties of organic ligand before any 
thermodynamic study of metal-ligand complexation. There is a competition between the 
protons and the metal during the complexation at the basic donor sites such as the phosphonate 
and amine groups of polyaminophosphonates ligands in this study. Thank to potentiometric 
titration, it is possible to precisely determine the protonation constants of synthesized ligands 
whose structures are shown in figure 27. 
L2 L
3
 
Figure 27 : Chemical structures of ligands L2 and L3 (fully deprotonated forms). 
1.1 Potentiometric study 
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Figure 28 : Potentiometric curve of ligand L3. Solvent: H2O; I = 0.1 M (NaClO4); T = 
25.0(2) °C; [L3]tot = 8.168E-4 M. 
The determination of the stability constants of the metal complexes requires the 
characterization of the acid-base properties of the L2 and L3 ligands. The synthesized 
polyaminophosphonate ligands were consist by a pyridinic chromophore and two tertiary 
amines. L2 and L3 ligands have two phosphonic acid groups respectively. A potentiometric 
titration of ligand L3 which carried out in water with 0.1 M NaClO4 as ionic strength at 25 ° C 
was shown in figure 28.  
Four protonation constants on the seven possible could be determined for L2 and L3 
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respectively in the studied pH range (2<pH <12). Thus the other non-characterized ionizable 
sites are associated with much lower protonation constants (log KLHx << 2) which couldn’t be 
detected under our experimental conditions. The two most basic protonation constants KLH and 
KLH2 for L2 and L3 can be attributed to tertiary amines, in agreement with data that exist in the 
literature for many polyaminomethanephosphonate analogues (Table 16).12,126,169–174 The 
following protonation constants determined for the L2 and L3 ligands are associated with the 
first protonation constants for each of the methanephosphonate groups. 
 
Equilibrium 
log KLHx (3σ) 
 
 L2 L3 
L + H+
KLH
⇔  LH 
 
9,5(1)a 9,28(5)a 
LH + H+
KLH2
⇔  LH2 
 
9,15(1)a 8,91(6)a/8,80b 
LH2 + H
+
KLH3
⇔  LH3 
 
6,17(6)a 6,36(8)a 
LH3 + H
+
KLH4
⇔  LH4 
 
4,6(2)a 4,45(5)a 
Solvent: H2O; I = 0.1 M; T = 25.0 (2) °C. Error = 3 𝛔  with  𝛔 = standard 
deviation.KLHx = [LHx] / [[LHx-1] [H]. The charges have been omitted for reasons of 
clarity. a Potentiometric titrations. b Spectrophotometric titrations vs. pH. 
Table 16：Summarizes the values of the protonation constants determined by 
potentiometry of ligands L2 and L3 represented in their logarithmic form (log KLHx with 
1 ≤ x ≤ 7). 
The log KLH and log KLH2 values of the synthesized L2 and L3 ligands are more than one 
order of magnitude higher than those measured for the LC analogue (log KLCH = 8.95 and log 
KLCH2= 7.85) which have terminal carboxylate units (Figure 29).
174 Meanwhile due to the 
interfere of benzyl group, the log KLH and log KLH2 values is about two orders of magnitude 
lower than those measured for the LF, LG and L4.12  
LC  
Figure 29 : Chemical structure of the analogue pyridine tetracarboxylate (noted LC). 
There are more electrostatic effects in doubly negatively charged phosphonate 
units(−PO3
2−) than negatively charged carboxylate groups (−CO2
−) which could explain the 
increase of basicity. The electrostatic effects may predominate over inductive factors.173 
Furthermore, the length of the spacer which connects the two symmetrical sites amino-N,N-bis 
(methanephosphonate) (ligands: LB, LC, LD and LE, Table 3.2) could affect the values of the 
protonation constants of the amine functions for a series of polyaminomethanphosphonate 
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derivatives. Actually, there is a strong interactions when a short spacer is present (EDTPA or 
LB, n = 2). Hydrogen bond inter-units between the ammonium unit and the amine unit 
(NH+⋯N) take place within the monoprotonated species.173 As a result, the (Δ log 𝐾𝐿𝐻𝑥) 
difference of tertiary amine sites indicates this phenomenon. The difference between the 
protonation constants between the two tertiary amine functions decreases and tends towards a 
value close to statistical processes when the length of the spacer increases (n = 3 for LC or 6 for 
LD, Table 17) and these interactions flexibility increases consequently.169 
n
ame 
Ligand  structure Tertiary Amines  methanephosphonate 
  
log 
KLHx 
Δlog 
KLHx 
log 
KLHx 
log 
KLHx avg 
Δlog 
KLHx 
LA 
 
12,1 - 6,1/4,95/1,3 5,52 1,15 
LB 
 
13,5 10,2 3,3 8,08/6,41/5,08
/ 2,71 
5,59 1,67/ 
1,33/ 2,37 
LC 13,0 
11,15 
1,85 6,99/6,07/5,18
/ 4,37 
5,65 0,92/ 
0,89/ 0,81 
LD 
 
13,3 
13,0 
0,3 6,88/6,13/5,29
/ 4,61 
5,73 0,75/ 
0,84/ 0,68 
LE 
 
10,89 
9,38 
1,5 7,69/6,97/6,46
/5,32 
6,61 0,72/ 
0,51/ 1,14 
DO2P 
 
12,80(8) 
10,92(2) 
 
8,47(2)/ 
6,39(2) 
7,43 2,08 
LF  
 
 
11,04(1) 
10,4(1) 
0,64 6,9(2)/5,7(3)/ 
4,5(3) 
5,7 1,2/1,2 
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LG 
 
11,8(2) 
 
8,3(3) /6,5(5)/ 
5,1(6) 
6,63 1,8/1,4 
L2  9,5(1) 
9,15(1) 
0,35 6,17(6)/4,6(2) 5,4 1.54 
L3  9,28(5) 
8,91(6) 
0,36 6,36(8)/ 
4,45(5) 
5,4 1,92 
L4 
 
11,21(2) 
10,29(2) 
0,39 8,04/6,49/ 
5,53/4,19 
6,06 1,55/ 
0,96/ 1,34 
Table 17：Successive protonation constant (log KLHx) of derivatives 
polyaminophosphonates from the literature compared to data measured for L2 and L3. 
Because of their long alkyl spacer (n = 6), the two amino units N,N-bis 
(methanephosphonate) LD ligand behave than of one another. The value of  (Δ log𝐾𝐿𝐻𝑥 =
0.3) is close to the expected statistical deviation (Δ log𝐾𝐿𝐻𝑥 = 0.6) for two identical and 
independent sites for the derivative LD ((hexamethylenedinitrilo) tetra 
(methanephosphonate)).169 Pyridyl groups (L2, L3, LF, LG and L4)12 or cyclohexyl (LE)171 are 
inserted as rigid spacers which constraint structure and geometry. As a result the hydrogen 
bonds ( NH+⋯N ) is weaken compare to previous molecules. The values 
of Δ log𝐾𝐿𝐻𝑥 associated with tertiary amines deviate significantly from the statistical value, but 
are nevertheless attenuated.  
The hydrogen bridges between pyridine nitrogen and protonated tertiary amines has been 
found by the sharp increase in the acidity of pyridine.12 The protonation constant of pyridine 
and the second constants of protonation of phosphonate groups could not be determined under 
our experimental conditions (log K << 2). The first protonation constants for each 
methanephosphonate group are the least basic protonation constants which determined from 
this series of ligands studied. These values are comparable to those determined for the LA and 
LF (Table 17).  
The average basicity does not vary significantly for L2 and L3, the Δ log𝐾𝐿𝐻𝑥 for both 
ligands are the same due to structure and geometry similarity. These differences reflect inter-
unit interactions by hydrogen bridges that may exist between the methanephosphonate group 
of one tertiary amine unit and the ammonium site of the other adjacent unit for the deprotonated 
species (the two amines tertiary are protonated). A solid-state structure of EDTPAH8 
demonstrates solid-state inter-unit hydrogen bonds.175 Thus, the  Δ log𝐾𝐿𝐻𝑥  values of the 
phosphonate functions decrease with length of the spacer and indicate the attenuation of these 
interactions by hydrogen bridges when the spacer is longer and more flexible within the 
polyaminomethanephosphonate series (Table 17). The deviations Δ log𝐾𝐻 then tend towards 
expected statistical values for four identical and independent sites (Δ log𝐾𝐻= 0.35 and 0.43).169 
The log Δ log𝐾𝐿𝐻𝑥values obtained for L
2 and L3 seem to indicate strong inter-unit interactions 
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in accordance with the topology of our systems. For the four systems studied, the other 
protonation constants (protonation of −PO3H
− and protonation of pyridine units) could not be 
determined under these experimental conditions and their logarithmic values were estimated 
<< 2, in agreement with data from literature.176–178 
The distribution diagrams of protonated species of ligands L2, L3 and L4 were calculated 
using the HYSS179 software and are presented in Figure 30. Negatively charged species (L2H3
- 
and L2H2
2-), (L3H3
- and L3H2
2-) and (L4H3
4- and L4H2
5-) coexist under conditions of 
physiological pH. 
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Figure 30 : Distribution curves of protonated species of ligands L2, L3 and L4. Solvent : 
H2O; T = 25,0 °C ; I = 0.1 M (NaClO4) ; [L2]tot , [L3]tot and [L4]tot = 1E-4 M. 
1.2 Spectrophotometric study according to the pH 
A spectrophotometric titration (220 nm <λ <350 nm) as a function of the pH was done to 
evaluate the spectrophotometric properties of polyaminophosphonates ligand L3 and protonated 
species. The obtained variation spectral is shown in figure 31. Pyridine is the main chromophore 
of the synthesized ligand. 
We observe that the titration of ligand L3 as a function of the pH exhibit similar behavior 
of ligand LF.12 A hyperchromic effect is observed on the absorption spectra after pH 7. This 
effect can be explained by the presence of hydrogen bond between the pyridine nitrogen and 
the different protonated units formed by protonation of the first two methanephosphonate units. 
The processing of the data by HypSpec180,181 allowed us to determine a single protonation 
constant for the L3 bisphosphonate ligand. The values obtained are in very good agreement with 
those determined by potentiometry (Table 16). 
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These data thus confirm the values determined previously by pHmetry and suggest that the 
aforementioned hydrogen bonding networks also involve the pyridinic chromophore. Indeed, 
the nitrogen of pyridine is likely to interact by hydrogen bonding with protonated ammonium 
sites, which leads to the most significant effects (hypochromic effect of π-π* transitions under 
the effect of protonation) and allows to explain its low protonation constant that could not be 
determined under our experimental conditions. The involvement of methanephosphonate units 
in the establishment of "cross” hydrogen bonds also seems to influence the chromophore but in 
a more modest way. 
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Figure 31 : Spectrophotometric titration of L3 as a function of pH. Solvent: H2O; T = 
25.0 (2) °C; I = 0.1M (NaClO4); l = 1 cm; [L3] tot = 1.02E-4 M. 
The calculated electron spectra of protonated species of ligands L3 is shown in figure 32. 
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Figure 32 : Electronic spectra of the protonated species of ligand L3. Solvent: H2O; 
T = 25.0 (2) °C; I = 0.1M (NaClO4); l = 1 cm. 
The spectrophotometric characteristics of protonated species of ligand L3 is presented in 
Chapiter 3: structural and thermodynamic study of uranyl with polyaminophosphonates 
ligands 
 
 
 
Table 18. 
 𝝀𝒎𝒂𝒙(nm) 𝛆𝒎𝒂𝒙(× 𝟏𝟎
𝟑 𝐌−𝟏 𝐜𝐦−𝟏) 
H(L3)3- 266 6.45 
H3(L3)
- 263 4.95 
Table 18：Spectral characteristics of protonated species of ligand L3.  
1.3 Conclusion 
With the help of potentiometric and spectrophotometric study, it is possible to calculate 
and determine different values of protonation constants for the synthesized ligands L2 and L3. 
The two tertiary amine functions are the most basic sites. Pyridine, main chromophore, is the 
most acidic site in synthesized ligand L2 and L3. Due to the π-π * transitions centered on 
pyridine and benzene, the ligands have an absorption band at about 266 nm. The deprotonation 
constants variations are mainly due to the change of hydrogen bonding between pyridine 
nitrogen, protonated tertiary amines and methanephosphonate group for the deprotonated 
species. 
The formation of hydrogen bridges between pyridine nitrogen and tertiary amines 
protonated has been evidenced by a sharp increase in the acidity of pyridine. The protonation 
constant of pyridine, secondary amine and the second constants of protonation of phosphonate 
groups could not be determined under our experimental conditions (log K << 2). The 
protonation constants determined by spectrophotometry are in very good agreement with those 
determined by potentiometry. 
2 Uranium/ligands interactions studied by 
Time-resolved laser fluorescence spectroscopy 
(TRLFS) and UV-visible spectroscopy 
2.1 Time-resolved laser fluorescence spectroscopy (TRLFS) and UV-visible 
spectroscopy 
Photoluminescence process consists by phosphorescence and fluorescence. After the 
absorption of a photon by a molecule, a complex or an ion, phosphorescence and fluorescence 
occur. Fluorescence is particularly interesting for our study because of its significant selectivity 
and its very low detection limit (μM). The lifetimes of the fluorescence species are modified 
according to the environment of the metal studied (here uranyl). Moreover, the lifetime, 
although sensitive to the temperature and the composition of the solution (ionic strength, buffer) 
182–184, are generally specific to the desired species 185,186. Therefore it is possible to follow the 
evolution of uranium complexation with the ligand and to determine its speciation. The detailed 
principle, the specificities of the systems studied and the experimental parameters are listed in 
Appendix. The lifetime and spectral characteristics specific to each species will also be reported 
in Appendix. 
The samples were also measured with UV-visible spectrometer to verify the ligand 
absorption change which reflects the change on uranyl coordination and uranyl-ligand complex.   
2.2 Experimental conditions selection  
Due to the hydrolysis of uranium (Fig. 33), it is important to have the measurement for the 
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uranyl alone to have a preliminary idea over the complexation without uranyl hydroxide. There 
is mainly hydrogen phosphonate at pH 3, and free uranyl ion is major species at this pH, the 
measurement at pH 3 was chosen for the free uranyl-ligand study.  
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Figure 33 : Species diagram of uranyl ion; [U] = 5E-5 M in 0.1M NaClO4. 
According to the biochemical condition of human, the pH range is from 7 to 7.5 for most 
organs. For saliva, blood, bone, all have a pH of about 7.4. The kidney is an important organ 
for long-term regulation of pH. The pH of urine is between 4.0 and 8.0. Then it is hard to define 
the pH of kidney. As the uranyl ion is transferred by blood after contamination, meanwhile 
bone and kidney are the main target organ for resist uranyl ion, the measurement at pH 7.4 was 
chosen to simulate the possible complexation between uranyl ion and ligand at biochemical 
condition.  
For the Study, the ligand concentration is fixed at 5E-5M, the uranyl concentration is from 
0 to 1eq. Normally the decorporation agent was much over equivalence in the biology study, 
~100eq.75 Moreover there is polynuclear species after 1eq of europium which forms base on 
the study of similar ligand.13 The polynuclear species could also formed with uranyl ion because 
of the complexation affinity difference of different donors from the multidentate ligands.  
2.3 Solubility test with uranyl-ligand complex  
Because of the low solubility of metal-phosphonate complex at acidic condition in H2O, 
different ionic strength solutions, NaCl, NaClO4 and NaNO3, were prepared. Different ionic 
strength solutions with different concentration were used to solubilize 5e-5M uranyl-ligand 
complex at pH 3 and 7.4. The solubility of complex was checked after preparation and 12 hours 
with the help of bright light. There is no problem with the samples at pH 7.4 in different ionic 
strength solution. But for test at pH 3, the uranyl-ligand compound only solubilize in NaCl 
solution. 
Another solubility test was done for L3 and L4 to test the solubility at pH 3. The method is 
to decrease the uranyl-ligand complex sample pH in NaClO4 from 7.4 to 3 to verify the possible 
complexation mode difference. Indeed, for the uranyl-ligand complexation, the first step should 
be the interaction between uranyl ion with phosphonate group, then the uranyl ion is moved 
into the pocket part of the ligand, take place of the proton which attach to the nitrogen atom of 
the amine part and finally form complexation with the 3 nitrogen atoms and 2 oxygen atoms 
from the ligand. For the sample at pH 7.4, the uranyl ion has already located in the pocket part, 
after decrease the pH the complexation mode should remain the same. The sample doesn’t form 
precipitation after decrease pH, after 12 hours, the precipitation presented.   
The uranyl-ligand complex precipitation in different concentration of NaClO4 and NaNO3 
at pH 3 is might due to the neutral charge of complex. L3 and L4 is mainly hydrogen 
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phosphonate at pH3. Then the complex charges are 0 for uranyl- L3 and -2 for L4. The uranyl-
ligand complex is solubilized in 0.1M NaCl at pH 3. It might due to the complexation of 
chloride which changed the charge of uranyl-ligand complex. At pH 7.4, the uranyl-ligand 
complex is soluble in all ionic solution at different concentration.  
For this study, sample with 0.1M NaCl was selected for the study at pH 3 and 7.4; sample 
with 0.1M NaClO4 was selected for pH 7.4 study for comparison.  
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Figure 34 : Fluorescence study of uranyl in each ionic solution at different pH; a [U] = 
5E-5 M, pH 3, 0.1M NaCl; b [U] = 5E-5 M, pH 7.4, 0.1M NaCl; c [U] = 5E-5 M, pH 7.4, 
0.1M NaClO4.     
The TRLFS test was done for the uranyl ion at each condition (Fig. 34). The center peak 
position of uranyl fluorescence in 0.1M NaCl at pH 3 (Fig. 34 a) is at 524nm. It is different 
from the center peak position of free uranyl which is at 510nm. So the uranyl ion is complexed 
with chloride ion. For the measurement at pH 7.4, the fluorescence is much lower in 0.1M NaCl 
(Fig. 34 b) compare to the one in 0.1M NaClO4 (Fig. 34 c). And the shapes of spectra are 
different. This is due to the quenching and complexation by chloride ion. The center peak 
position at pH 7.4 is at 525nm for sample with 0.1M NaCl and 522nm for sample 0.1M NaClO4. 
2.4 Stability test with uranyl-ligand complex for sample preparation   
The first slope tests at pH 3 and 7.4 were done by mixing the ligand, ionic strength solution 
and uranyl solution in sequence, then the pH was adjusted to corresponding pH, the volume 
was fixed at 2 mL by adding ionic strength solution, the final pH was recorded, then samples 
were reserved for 12 hours and measured with UV-Vis absorption spectroscopy and time-
resolved laser fluorescence spectroscopy.  
a. Study of uranyl-L3 complex at pH 3 in 0.1M NaCl 
Owning to the benefit of nitrate present in the uranyl solution, it is pretty easy to identify 
uranyl concentration in each sample by the UV absorption at 220nm of nitrate. The trend of the 
aromatic absorption (Fig. 35 left) is hard to verify with the uranyl concentration increased. The 
shapes of curves remain the same for the titration. 
For the fluorescence spectra (Fig. 35 right), the intensity was increasing for the first four 
samples. The center peak position is at 522nm which is a sigh for the tight complexation. The 
intensity was decreased for the 0.99eq sample after excited the sample for a period under the 
beam.  
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Figure 35 : Study of uranyl-L3 complex, absorption measure (left); TRLFS measure 
(right); [L3] = 5E-5 M, [U] 0-1 eq, pH 3, 0.1M NaCl.  
There might be decomposition in the solution after preparation. And after excitation with 
the beam, there might be quenching happening; the lifetime measurement is not reliable in this 
case.   
The same test with L4 was done and has the same phenomenon.  
b. Study of uranyl-L3 complex at pH 7.4 in 0.1M NaCl and NaClO4 
The aromatic absorption (Fig. 3.36 left) is keep increasing with the uranyl concentration 
increase. Meanwhile the shapes of the curves are changed from multipeaks to a broadband 
absorption. The fluorescence spectrum (Fig. 3.36 right) was remain the same which shown the 
uranyl-L3 complex in 0.1M NaClO4 is non-fluorescence.  
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Figure 36 : Study of uranyl-L3 complex, absorption measure (left); TRLFS measure 
(right); [L3] = 5e-5 M, [U] 0-1 eq, pH 7.4, 0.1M NaClO4.  
Similar study was done in 0.1M NaCl ionic strength solution (Fig. 37). The absorption 
evolution and fluorescence change of uranyl-L3 complex have the same trend and shape with 
the measurement in 0.1M NaClO4.  
For this reason, there is no degradation happened for the samples at pH 7.4 after sample 
preparation. And for the samples at pH 7.4, the preparation will remain the same without any 
further improvement.  
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Figure 37 : Study of uranyl-L3 complex, absorption measure (left); TRLFS measure 
(right); [L3] = 5e-5 M, [U] 0-1 eq, pH 7.4, 0.1M NaCl.  
The same test with L4 was done and has the same phenomenon.  
At the beginning of the nineteenth century, the photochemistry of the uranyl ion has 
enrolled the curiosity of researchers.178,179 The figure 38 shows the mechanism which could 
happen for uranyl photolysis.    
 
Figure 38 : Steps in the photocatalyzed H-atom abstraction from hydrocarbons by the 
uranyl dication.187 
The UO2
2+ absorbs visible light ( λmax 414 nm, ε𝑚𝑎𝑥 = 7.70  M
−1 cm−1 
in 0.1MHCl𝑂4)
188,189 to form *UO2
2+ which is unreactive towards O2. The reaction rates for the 
quenching of *UO2
2+ by aliphatic compounds respond to the energy of the weakest C-H bond(s) 
in these molecules.190 The bond dissociation energy (BDE) of the PhC(H2)-H bond (368 kJ/mol) 
is lower than BDE of the C-H bonds in several reactive aliphatic compounds studied so far.190 
UO2
2+ serves as a selective catalyst for the oxidation of organic substrates by molecular oxygen 
in presence of visible light (Fig. 39 & 40).191 
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Figure 39 : HPLC chromatograms of air-saturated solutions of 0.5 mM 𝐔𝐎𝟐
𝟐+ and 5 mM 
PhCH3 in 0.01M H3PO4 after irradiation with visible light in 15 min intervals. The 
monitoring wavelength was 254 nm.191  
 
Figure 40 : Plot showing increase in [PhCHO] with irradiation time. Data from Figure 
13.191 
The sunlight spectrum is present in figure 41. The spectral irradiance of sunlight in the 
range from 300 to 500nm is relatively high. And the absorption of photon by uranyl in this 
energy range could form *UO2
2+. Then H atom abstraction with *UO2
2+ by (eq 1) generates 
UO2
2+ and C-centered radicals, both of which react with molecular oxygen (eq 2 and 3). There 
are about 5e-4M molecular oxygen in the fresh water and ~ 4E-4M molecular oxygen in the 
seawater (Fig. 42). Reaction 3 regenerates  UO2
2+ , and the photooxidation of RH becomes 
catalytic. This scheme has been proved for a number or organic compounds, including alkanes, 
alkenes, and side-chain aromatics.192 Benzene, on the other hand, reacts with * UO2
2+ 
exclusively by exciplex formation and no oxidation took place when O2 was used as oxidant. 
A different reaction scheme, in effect a photoinduced Fenton-like reaction, was devised to 
oxidize benzene to phenol with use of H2O2 as terminal oxidant.
193 Normally the substrate 
activation reactions are generally carried out in water. So any hydrocarbon will have limited 
solubility, and be competing directly with the solvent water molecules in the reaction. 
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Figure 41 : Sunlight spectrum in space as a function of wavelength. Public Domain 
Image, image source: Christopher S. Baird, data source: American Society for Testing 
and Materials Terrestrial Reference. 
*𝐔𝐎𝟐
𝟐+ + RH → 𝐔𝐎𝟐
+ + R• + H+                                        Equation 1  
 R• + O2 → RO2• → products                               Equation 2 
2𝐔𝐎𝟐
+ + O2 + 2H
+ → 2𝐔𝐎𝟐
𝟐++ H2O2                                Equation 3                                   
For this study, the possible reason for the uranyl-ligand degradation at pH 3 is due to ligand 
degradation by uranyl ion with the presence of molecular oxygen in the solution and light. 
Meanwhile the uranyl-ligand complex slope test at pH 7.4 doesn’t suffer from this phenomenon. 
The possible reason might relate with the fluorescence property difference at pH 3 and 7.4. The 
uranyl-ligand complex doesn’t fluorescence at pH 7.4 which means the uranyl coordinations 
for pH 3 and 7.4 are not the same. The quenching of uranyl fluorescence minimize degradation 
of ligand by restrict H atom abstraction (eq 1). For study at pH 7.4, only the absorption spectra 
before the TRLFS study will be used for the Study. The fast fluorescence spectra will be 
recorded for the Study. The lifetime measurement cannot be done due to non-fluorescence 
uranyl-ligand complex.          
 
Figure 42 : Solubility of oxygen in water 
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2.5 Stability test of uranyl-ligand complex with TRLFS 
Another sample preparation method was used to prepare the uranyl-ligand sample at pH 3 
which aims to avoid the degradation during the sample preparation. First the NaCl ionic strength 
solution was degased with argon flow to remove the molecular oxygen. Then mixing the ligand, 
ionic strength solution and uranyl solution in sequence in a small brown bottle to minimize the 
effect of sunlight in a room with weak light, the pH was adjusted to neutral pH first, and reserve 
for 12hours. After the pH was adjust to 3 and the volume was fixed at 2 mL by adding ionic 
strength solution, the final pH was recorded. After 30mins, the samples were measured with 
UV-Vis absorption spectroscopy before and after the TRLFS test. And the time-resolved laser 
fluorescence spectra was recorded twice, the first measure was done just after the UV-Vis 
absorption spectroscopy measurement, the second was done after exciting the sample for 
10mins with 430nm laser beam. This test is to confirm the effectiveness and feasibility of time 
resolve study of the uranyl species.   
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Figure 43 : Comparison of uranyl-L3 complex by two preparation method, absorption 
measure (left); TRLFS measure (right); [L3] = 5E-5 M, [U] 0.8&1 eq, pH 3, 0.1M NaCl.  
A Study was done to determine the effectiveness of new sample preparation method. The 
results of absorption spectra and TRLFS spectra at 0.8eq and 1eq are shown below (Fig. 43). 
The samples which were prepared by minimize the impact of molecular oxygen and sunlight 
present higher absorption rate, about 2 times, on the ligand absorption range compare to the 
sample which prepared by previous method. Meanwhile the fluorescence intensity is also higher 
at 2 different equivalences. The degradation during the sample preparation has been minimizing 
by the new sample preparation method. 
The comparison with L4 was done and has the same phenomenon. 
a. Study of uranyl-L3 complex at pH 3 in 0.1M NaCl 
The evolution of ligand absorption in the UV range (Fig. 44 left) is reasonable in this study. 
The absorption at 262nm was increasing with the increase of uranyl equivalence. The intensity 
of uranyl fluorescence (Fig. 44 right) was also increasing. Degradation by uranyl photolysis 
with molecular oxygen and sunlight was minimized. The samples preparation for uranyl-ligand 
complex at pH 3 will remain the same without any further improvement. 
The same test with L4 was done and has the same phenomenon.  
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Figure 44 : Study of uranyl-L3 complex, absorption measure (left); TRLFS measure 
(right); [L3] = 5E-5 M, [U] 0-1 eq, pH 3, 0.1M NaCl. 
Then the stability under the laser excitation has been evaluated (Fig. 45). It is clear that 
both the absorption rate of aromatic part (Fig. 45 left) and fluorescence intensity (Fig. 45 right) 
decreased after 10mins under 430nm laser excitation. So the uranyl-ligand complex was 
changed. The uranyl-ligand complex lifetime measurement cannot be done for this reason.  
The same test with L4 was done and has the same phenomenon.  
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Figure 45 : Study of uranyl-L3 complex under 430nm laser excitation, absorption 
measure (left); TRLFS measure (right); [L3] = 5E-5 M, [U] 0.8 &1eq, pH 3, 0.1M NaCl. 
The UO2
2+could absorb light in the range of 350 to 490 nm to generate a long-lived, strongly 
oxidizing excited state, *UO2
2+ (E0 = 2.6 V),
194,195 which can be considered as a reactive oxygen-
centered radical coordinated to UV. 196,197 Depending on the identity of nearby substrates, 
different decay routes are possible for the long-lived *UO2
2+ ion (Fig. 38), H atom abstraction, 
addition to multiple bonds, oxygen atom transfer, and exciplex formation.197–200  
Many inorganic ions quench the luminescence of uranyl in aqueous solutions.201–203 It has 
been postulated that the quenching takes place according to a charge-transfer mechanism with 
the formation of radical-ion quenching agents. The energy levels of the quenching ions are 
located significantly higher than the lowest excited level of the uranyl ions,201,202 and the 
observed effective quenching of the luminescence of uranyl, therefore, cannot be attributed to 
the transfer of energy from the excited uranyl ions to the quenching ions. 
The quenching of excited uranyl ions by Hg2
2+, Ti+, Ag+, CNS-, CI-, I-, and Br- in water, 1 
mole/liter HNO3, and 1 mole/liter H3PO4 takes place according to a mechanism of 
Chapiter 3: Structural and thermodynamic study of uranyl with polyaminophosphonates 
ligands 
71 
 
intermolecular electron transfer. The complexation of the uranyl ions with anions of the medium 
facilitates the electron-transfer process, if the electron donors are cations, and hampers the 
electron-transfer process, if the donors are anions.204 Photooxidation of substrates by *UO2
2+ is 
thought to occur by both atom199,205–208 and electron-transfer192,201,204,209–217 processes. 
Uranyl iodide complexes are known to possess charge-transfer-to-metal (CTTM) bands 
between 350 and 530 nm, the actual position of the bands depending upon the extent of 
complexation.218 And the uranyl iodide system is any permanent change observed on 
photolysis.219 In all of these systems, halide anion radicals, X2
∗−, have been observed by flash 
photolysis.202,204,220–224 
*𝐔𝐎𝟐
𝟐+  → 𝐔𝐎𝟐
+ + 𝒉𝒗 + ∆                                             Equation 4  
*𝐔𝐎𝟐
𝟐+ + 𝐗− → 𝐔𝐎𝟐
+ + 𝐗∙                               Equation 5                                 
*𝐗− + 𝐗∙ → 𝐗𝟐
∗−                                                                  Equation 6 
𝐔𝐎𝟐
+ + 𝐗𝟐
∗− → 𝐔𝐎𝟐
𝟐+ + 𝟐𝐗−                                         Equation 7 
Reaction 4 includes both radiative and nonradiative decay of the excited uranyl ion.  
For this study, the possible reason for the uranyl-ligand degradation at pH 3 is due to ligand 
degradation by uranyl with the presence of chloride ion in the solution and 430nm laser. 
Because of the low solubility of uranyl-ligand complex in 0.1M NaClO4 solution, 0.1M NaCl 
solution was used as the ionic strength solution. The *UO2
2+ which generate by the 430nm laser 
excitation could react with chloride and then form chloride radical by eq 5 and 6. The chloride 
radical could decompose organic molecules. Meanwhile *UO2
2+  could cause the organic 
compound photooxidation. The decrease of UV absorption of uranyl-ligand complex is mainly 
due to these two reasons. The degradation compound of uranyl-ligand complex could be the 
complex of uranyl ion with organic monophosphonates. It is known that the complex of uranyl 
ion with organic monophosphonates did not show fluorescence properties. It seems that the 
fluorescence properties of uranyl ion with organic phosphonates depend on the structure of the 
ligand.225 The fluorescence of uranyl-ligand complex decreased due to the generation of 
degradation compound. For the study at pH 3, only the absorption spectra before the TRLFS 
study will be used for the Study. The fast fluorescence spectra will be recorded for the Study. 
The lifetime measurement cannot be done due to the degradation of uranyl-ligand complex and 
non-fluorescence degradation compound.     
b. study of uranyl-ligand complex at pH 7.4 in 0.1M NaCl and 0.1M NaClO4 
A test with uranyl-L2 1:1 complex at pH 7.4 in two ionic solutions was done to determine 
the stability under 430nm laser excitation (Fig. 46). Owing to the benefit of non-fluorescence 
species of uranyl-L2 complex, the absorption of aromatic part didn’t change in two ionic 
solutions which means the ligand didn’t decompose under for this condition.  
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 Figure 46 : Study of uranyl-L2 1:1 complex under 430nm laser excitation, absorption 
measure (left); TRLFS measure (right); [L2] = 5E-5 M, [U] = 5E-5 M, pH 7.4. 
The same test with L3 and L4 was done and has the same phenomenon.  
2.6 Study of uranyl-ligand complex 
The Study of uranyl-ligand complex was done with the sample preparation method and 
experiment conditions which settled by previous test. The change over the UV absorption is 
mainly due to the aromatic part and amine branches. The fluorescence change is mainly due to 
the concentration and coordination of uranyl. Due to the problem with quenching and 
degradation, the lifetime measurement was not performed.  
a. Study of uranyl-L3 complex at pH 3 in 0.1M NaCl 
For the study of uranyl-L3 complex at pH 3, the major species of ligand alone in the solution 
at this condition is monophosphonate, thus the two phosphonate groups and pyridine group 
could provide 2 oxygen atoms and 1 nitrogen atom for the uranyl coordination. For the amine 
part, the proton still attach to the nitrogen at this pH, so there is a competition between the 
uranyl ion with hydrogen atom. For uranium alone in the solution, uranyl ion alone is the 
dominate species. 
The absorption of aromatic part (Fig. 47 left) is increased for the Study. The evolution of 
the absorption ratio at 262nm is shown in figure 48 (left). The center peak position of uranyl 
fluorescence spectra (Fig. 47 right) is shift from 524nm (0.1M NaCl) to 522nm (0.1M NaCl). 
The center peak of uranyl fluorescence spectra in 0.1M NaClO4 is at 524nm. The emitted 
intensity at 522 nm is shown in figure 48 (right). 
For the first two samples, 0 and 0.2eq, the absorption of aromatic part doesn’t change which 
means the aromatic part doesn’t play a role in the coordination and the amine branches doesn’t 
change. Due to the quenching of chloride ion, the fluorescence intensity of 0.2eq  UO2
2+ is too 
low and the spectrum is noisy; it is pretty hard to identify the shift of fluorescence spectra. The 
uranyl may complex by chloride ion at low concentration which has been found in the previous 
study (Fig. 34). So for the sample with 0.2eq UO2
2+, the uranyl ion might not form complex with 
the ligand due to the relatively low concentration at acidic condition. For the middle two 
samples, 0.4 and 0.6eq, the absorption at 262nm slightly increased, the shapes of the curves 
don’t change, so the amine branches changed lot and the pyridine group might not be involved 
in the coordination. The fluorescence intensity at 522nm increased a lot; the shapes of the curves 
don’t change. This means the uranyl ion is complexed by the ligand; the coordination of uranyl 
contains oxygen from phosphonate group. The binding mode of uranyl-L3 at pH 3 in this ratio 
range might be 2 ligands and 1 uranyl ion. The coordination of uranyl is consisting by 4 oxygen 
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atoms from four phosphonate groups and 1 oxygen atom from water molecular. For the last two 
samples, 0.8 and 1eq, the absorption at 262nm increased significantly, the shapes of the curves 
still don’t change, so the amine branches and the pyridine group involve in the coordination. 
The fluorescence intensity at 522nm still increased, and the slope of fluorescence intensity at 
520 nm is increased which suggest there might be a changing of binding mode. The shapes of 
the curves don’t change. This means the uranyl ion is complexed by the ligand; the coordination 
of uranyl contains oxygen atoms from phosphonate group. The binding mode of uranyl-L3 at 
pH 3 in this ratio range might be 1 ligand and 1 uranyl ion. Uranyl ion is located in the pocket 
part of ligand. The coordination of uranyl is consisting by 2 oxygen atoms from two 
phosphonate groups, 2 nitrogen atoms from two amine branches and 1 nitrogen atom from 
pyridine group.  
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Figure 47 : Study of uranyl-L3 complex, absorption measure (left); TRLFS measure 
(right); [L3] = 5E-5 M, [U] 0-1 eq, pH 3, 0.1M NaCl. 
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Figure 48 : Evolution of the absorption ratio at 262nm (left) and the emitted intensity at 
522 nm (right) as a function of uranyl/L3; [L3] = 5E-5 M, [U] 0-1 eq, pH 3, 0.1M NaCl.  
b. Study of uranyl-L4 complex at pH 3 in 0.1M NaCl 
For the study of uranyl-L4 complex at pH 3, the major species of ligand alone in the solution 
at this condition is monophosphonate, thus the four phosphonate groups and pyridine group 
could provide 4 oxygen atoms and 1 nitrogen atom for the uranyl coordination. For the amine 
part, the proton is still attached to the nitrogen at this pH, so there is a competition between the 
uranyl with hydrogen. For uranium alone in the solution, uranyl ion alone is the dominate 
species. 
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The aromatic part absorption (Fig. 49 left) is increased for the Study. The evolution of the 
absorption ratio at 262nm is shown in figure 50 (left). The center peak position of uranyl 
fluorescence spectra (Fig. 49 right) is shift from 510nm (0.1M NaClO4) to 520nm (0.1M NaCl). 
The center peak of uranyl fluorescence spectra in 0.1M NaCl is at 524nm. The emitted intensity 
at 520 nm is shown in figure 50 (right). 
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 Figure 49 : Study of uranyl-L4 complex, absorption measure (left); TRLFS measure 
(right); [L4] = 5E-5 M, [U] 0-1 eq, pH 3, 0.1M NaCl. 
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Figure 50 : Evolution of the absorption ratio at 262nm (left) and the emitted intensity at 
520 nm (right) as a function of uranyl/L4; [L4] = 5E-5 M, [U] 0-1 eq, pH 3, 0.1M NaCl.  
For the first two samples, 0 and 0.2eq, the absorption evolution of aromatic part doesn’t 
change like the other samples which means the presence of free uranyl or that the binding is 
mainly between uranyl ion and phosphonate groups. For the rest, the absorption at 262nm 
increased significantly, the shapes of the curves still don’t change, so the amine branches and 
the pyridine group should be involved in the coordination. The evolution of absorption at 
262nm is linear which suggest the same coordination. The evolution of fluorescence intensity 
at 520nm is almost linear. The fluorescence of 1eq UO2
2+ might be affected by the degradation 
during the laser excitation due to the relatively high concentration of uranyl. So below 
0.2eq  UO2
2+ , the coordination of uranyl might mainly be related with the oxygen from 
phosphonate groups. Above 0.2eq, uranyl ion is located in the pocket part of ligand. The 
coordination of uranyl is consisting by 2 oxygen atoms from two phosphpnate groups, 2 
nitrogen atoms from two amine branches and 1 nitrogen atom from pyridine group. 
c. Study of uranyl-L3 complex at pH 7.4 in 0.1M NaClO4 
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For the study of uranyl-L3 complex at pH 7.4, the major species of ligand alone in the 
solution at this condition is phosphpnate group, thus the two phosphpnate groups and pyridine 
group could provide 2 oxygen atoms and 1 nitrogen atom for the uranyl coordination. For the 
amine part, the proton is still attached to the nitrogen atom at this pH, so there is a competition 
between the uranyl with hydrogen. For uranium alone in the solution, multispecies of uranyl 
hydroxide are present. 
The aromatic part absorption (Fig. 51 left) is increasing for the Study and there is an 
evolution over the shapes of absorption spectra. The evolution of the absorption ratio at 262nm 
is shown in figure 52 (left). Normally uranyl ion could generate strong fluorescence at this pH. 
The center peak position of uranyl fluorescence spectra in 0.1M NaCl is at 525nm (Fig. 34). 
There is a broad intense peak of uranyl fluorescence spectra in 0.1M NaClO4. The center peak 
position of uranyl fluorescence spectra in 0.1M NaClO4 is at 522nm. (Fig. 34) But to this uranyl-
L3 complex, there is no fluorescence in each spectrum. This non-fluorescence property at 25 °C 
is similar to the uranyl carbonate complex [UO2(CO3)3]
4-.226,227 
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  Figure 51 : Study of uranyl-L3 complex, absorption measure (left); TRLFS measure 
(right); [L3] = 5E-5 M, [U] 0-1 eq, pH 7.4, 0.1M NaClO4. 
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Figure 52 : Evolution of the absorption ratio at 263nm as a function of uranyl/L3; [L3] = 
5E-5 M, [U] 0-1 eq, pH 7.4, 0.1M NaClO4. 
The evolution of absorption at 263nm is almost linear (Fig. 52). But the shape of the 
aromatic part is changing from a narrow peak at 263nm with a shoulder peak to a broad peak. 
This evolution shows the stepwise species changing of uranyl ion. And the non-fluorescence 
uranyl-ligand complex confirmed that there is only one binding mode. Uranyl ion is located in 
the pocket part of ligand. The coordination of uranyl ion is consisting by 2 oxygen atoms from 
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two phosphonate groups, 2 nitrogen atoms from two amine parts and 1 nitrogen atom from 
pyridine group.   
d. Study of uranyl- L4 complex at pH 7.4 in 0.1M NaClO4 
For the study of uranyl-L4 complex at pH 7.4, the major species of ligand alone in the 
solution at this condition is phosphonate group, thus the four phosphonate groups and pyridine 
group could provide 4 oxygen atoms and 1 nitrogen atoms for the uranyl coordination. For the 
amine part, the proton is still attached to the nitrogen atom at this pH, so there is a competition 
between the uranyl with hydrogen. For uranium alone in the solution, multispecies of uranyl 
hydroxide are present.  
240 260 280 300 320 340
0.0
0.1
0.2
0.3
0.4
0.5
A
b
s
Wavelength (nm)
 0 eq
 0,23 eq
 0,42 eq
 0,62 eq
 0,81 eq
 0,95 eq
 
350 400 450 500 550 600 650 700
15000
20000
25000
30000
35000
in
te
n
s
it
y
wavelength (nm)
 0 eq
 0,23 eq
 0,42 eq
 0,62 eq
 0,81 eq
 0,95 eq
 
Figure 53 : Study of uranyl-L4 complex, absorption measure (left); TRLFS measure 
(right); [L4] = 5E-5 M, [U] 0-1 eq, pH 7.4, 0.1M NaClO4. 
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Figure 54 : Evolution of the absorption ratio at 263nm as a function of uranyl/L4; [L4] = 
5E-5 M, [U] 0-1 eq, pH 7.4, 0.1M NaClO4. 
The absorption of aromatic part (Fig. 53 left) is increasing for the study and there is an 
evolution over the shapes of absorption spectra. The evolution of the absorption ratio at 262nm 
is shown in figure 54.There is non-fluorescence from the uranyl-ligand complex (Fig. 53 left) 
which compare to the free uranyl spectra in 0.1M NaClO4. The very weak fluorescence of 
uranyl might reflect the presence of a very small amount of other bonding mode (Fig. 53 right).  
The shape of the aromatic part is changing from a narrow peak at 263nm with a shoulder 
peak to a broad peak. This evolution of spectra suggests the uranyl is directly complexed by the 
ligand. And the non-fluorescence uranyl-ligand complex confirmed that there is only one 
binding mode. Uranyl ion is located in the pocket part of ligand. The coordination of uranyl is 
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consisting by 2 oxygen atoms from two phosphonate groups, 2 nitrogen atoms from two amine 
parts and 1 nitrogen atom from pyridine group.   
2.7 Conclusion  
At pH 3, there are two degradation paths throw the measurement. The degradation with 
molecular oxygen and sunlight could be minimized by prepare the sample under dark condition. 
But degradation with laser excitation cannot be avoided.  
There are 3 steps for the uranyl-L3 complex study at pH 3. The uranyl is mainly complex 
by chloride ion in the first step (0-0.2eq). For second step (0.2-0.6eq), the major species is 
uranyl complex with phosphonate groups from two L3. The dominate species is uranyl complex 
with L3 in the pocket part for the third step (0.6-1eq).  
There are 2 steps for the uranyl-L4 complex study at pH 3. There is mainly uranyl complex 
with phosphonate groups from L4 in the first step (0-0.2eq). For second step (0.2-1eq), the 
dominate species is uranyl complex with L3 in the pocket part.  
The protonated monophosphonate organic ligands limit the complexation affinity of uranyl 
at low concentration. The species difference between the two slope studies is mainly due to the 
ligand structure difference. The steric effect of two benzyl group of L3 might limit the freedom 
of uranyl coordination. 
At pH 7.4, the two degradation paths are minimized throw the measurement by non-
fluorescence uranyl-ligand complex. For both ligands, uranyl ion is directly complexed with 
the ligand. There is only one species throughout the whole Study. The deprotonated 
phosphonate organic ligands are easier to form complexation with uranyl ion. The coordination 
environment of uranyl-ligand complex might be the same according to the non-fluorescence 
property.   
3 IR characterization of two ligands with 
uranium in aqueous solution 
3.1 IR spectra of ligands 
Based on the species diagrams of two ligands, hydrolysis of uranium and biochemical 
condition of the serum, IR spectra of two ligand solutions at pH 3 (red) and 7.4 (black) were 
recorded.   
With the help from previous study, the deprotonation happened mainly due to the 
phosphonate group and ternary amine unit. For phosphonate group, hydrogen phosphonate 
group (PO3H
−) is the major species at pH 3 while deprotonated phosphonate group (PO3
2−) is 
the majority at pH 7.4. The ternary amine unit is protonated under experiment condition.  
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Figure 55 : FT-IR spectra of pH 3 in H2O. Spectra of L4 in red and L3 in black. 
Difference spectra L3 minus half L4 (blue). 
In order to determine the contribution of pyridine group and benzene fragment, it is possible 
to identify each peak by compare the two spectra of two ligands at the same pH. Due to the 
ratio difference between phosphonate group and pyridine group of two ligands, a comparison 
was done by normalized on the aromatic ring carbon-carbon stretching vibrations at 1580 cm-
1. The difference curve was done by spectra L3 minus half of L4 which aims to remove the 
absorption from phosphonate group.   
From figure 55 above, the νas(P − OH) at 914cm
-1 couldn’t be found on the difference 
spectra. Thus the vibrational modes of aromatic units could be identified in the difference 
spectra (Fig. 55 blue). The bands at 1200cm-1, 1176cm-1, 1133cm-1 and 1000cm-1 reflect the 
pyridine backbone and benzyl group which are coherent with FT-IR spectra of 2,6-
Bis(bromomethyl)pyridine and [(phenylmethyl)imino]bis(methylene)]bisphosphonic acid. 
Those vibration modes are out-of-plane bending vibration b2g, in-plane bending vibrations b2g, 
and C-H in-plane bending a1g and C-C ring breathing aig. For the bands at 1180cm
-1, 1084cm-1 
and 914cm-1 in the spectrum record from L4 at pH 3 (Fig. 55 red ) are assigned to νas(P − O), 
νs(P − O), and νas(P − OH), respectively.
228 From the characteristic pattern, the symmetry of 
the organic phosphonate group could be identified as  C2ν  symmetry which means the 
monoanionic species, PO3H
−, is the dominant species at pH 3.229 It confirms the potentiometric 
titration results.  
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Figure 56 : FT-IR spectra of pH 7.4 in H2O. Spectra of L4 in red and L3 in black. 
Difference spectra L3 minus half L4 (blue). 
The same procedure was done to get the difference spectra for pH 7.4 comparison. At pH 
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7.4, the pyridine backbone and benzyl group have absorption at 1208cm-1, 1180cm-1, 1135cm-
1 and 1062cm-1 in the difference spectrum (Fig. 56 blue) which shown a blue shift compared to 
the spectra at pH 3. From the species diagram of each ligand, it’s known that the major species 
is phosphonate group (PO3
2−). The small peak at 913cm-1 is due to the presence of minor 
species, PO3H
−. The band at 1090 cm-1 and 979 cm-1 refer to νas(P − O), and  νs(P − O) (Fig. 
56 red)24.  
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Figure 57 : FT-IR spectra of difference spectrum at pH 3(red) and 7.4(black). Difference 
spectra L3 minus half L4 at each pH. 
By comparing the difference spectra L3 minus half of L4 at each pH (Fig. 57), the 
absorption of vibration mode of aromatic units in the middle infrared range increased with the 
pH increase, which the aromatic in-plane C–H bending changed.     
From the potentiometric titration results of L4, the protonated phosphonate group could be 
sensed because of the pattern of the band, namely hydrogen phosphonate group (PO3H
−) at pH 
3. At pH 7.4, the deprotonated phosphonate group (PO3
2−) could be detected, since ternary 
amine doesn’t have absorption in this range. Contributions from vibrational modes of the 
pyridine unit can also be neglected due to the ratio between aromatic units and phosphonate 
groups. In the region below 1200 cm−1 (Fig. 58), the distinctive spectral features at 1192 cm−1 
(negative), 1118 cm−1, 1034 cm−1 (negative), 981 cm−1, and 932 cm−1 (negative) represent the 
deprotonation of the phosphonate groups, which provide an important spectral reference for the 
further study of uranyl complexation.  
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Figure 58 : FT-IR spectra of L4 in H2O. Spectra recorded at pH 7.4 (red) and pH 3 
(black). Difference spectrum pH 7.4 minus pH 3 (blue). 
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Figure 59 : FT-IR spectra of L3 in H2O. Spectra recorded at pH 7.4 (red) and pH 3 
(black). Difference spectrum pH 7.4 minus pH 3 (blue). 
Base on the study of FT-IR spectra of L4 and potentiometric titration of L3, mainly 
contributions from phosphonate groups are expected. It is confirmed that the aromatic in-plane 
C–H bending changed with pH increase from previous comparison. In the range from 1250 cm-
1 to 900 cm-1 in figure 59, the modes of vibration from organic phosphonate group, benzyl group 
and pyridine backbone could be detected in the region. A difference spectrum (Fig 59. blue line) 
was calculated by using spectra at pH 7.4 minus spectra pH 3 in order to determine the changing 
of vibration bands due to the species variation. The distinctive spectral features at 1200 cm−1 
(negative), 1135 cm−1, 1034 cm−1 (negative), 980(0) cm−1, and 936 cm−1 (negative) represent 
the deprotonation of the phosphonate groups. The distinctive spectral features difference 
between L3 with L4 is due to the vibration mode of aromatic group which is present in the same 
range. The distinctive spectral features at 1209 cm−1, 1176 cm−1 (negative), 1085 cm−1 (negative) 
and 1000cm−1 (negative) represent the vibration mode of aromatic group, out-of-plane bending 
vibration b2g, in-plane bending vibrations b2g, and C-H in-plane bending a1g and C-C ring 
breathing aig respectively.  
3.2 IR spectra of uranyl-ligand complexation  
The infrared spectroscopic tests on uranyl  complexation with ligand were down to 
investigate the complexation mode at two pHs. Each sample in this study was prepared with 
same molar equivalence of uranyl and ligand base on the studies of UV-Vis absorption 
spectroscopy and fluorescence study. All the spectra were normalized at 1580 cm-1 with carbon 
stretching vibrations eg. 
Because the benzene groups of L3 are not in the coordination of uranyl, the vibration modes 
of benzene group have the same contribute in samples with and without uranyl. In contrast, the 
IR absorption of phosphonate group and pyridine group for both ligands involved in the 
coordination of uranyl should change significantly. 
A similar symmetry of monoanionic phosphonate group in two samples was confirmed 
with the phosphonate groups vibration modes νas(P − O),νs(P − O) and νas(P − OH) for the 
aqueous L3 sample and UO2
2+ −L3 sample recorded at pH 3 (Fig. 60). The distinctive spectral 
features at 1201 cm−1, 1178 cm−1, 1156 cm−1, 1069cm−1, 1020cm−1,  1104cm−1, 997cm−1 and 
913 cm−1 represent the deprotonation of the phosphonate groups and pyridine group vibration 
change. Positive bands at ν̌= 1201 cm−1, 1156 cm−1,1104 cm−1 and 997 cm−1 are related with 
pyridine group vibration change. Positive bands at ν̌= 1178 cm−1, 1069 cm−1, 1020cm−1 and 
997 cm−1 are assigned to νas(P − O),  νs(P − O) ,  νs(P − O) and νs(P − O). The band at ν̌= 
913 cm−1 is due to νas(UO2) mode. Thus both pyridine group and phosphonate groups are 
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present in the coordination of uranyl which suggests uranyl ion located in the ligand pocket 
with 3 nitrogens and 2 oxygens.   
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Figure 60 : FT-IR spectra of uranyl-L3 at pH 3 in H2O. Spectra of uranyl-L3 in red and 
L3 in black. Difference spectrum uranyl-L3 minus L3 (blue). 
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Figure 61 : FT-IR spectra of uranyl-L4 (right) at pH 3 in H2O. Spectra of uranyl-L4 in 
red and L4 in black. Difference spectrum uranyl-L4 minus L4 (blue). 
A similar pattern of bands is observed in the spectrum of the aqueous L4 sample and 
UO2
2+ −L4 sample recorded at pH 3 (Fig. 61) and were assigned to the νas(P − O),νa(P − O) 
and νas(P − OH) modes of the phosphonate groups, suggesting a similar symmetry of 
monoanionic phosphonate group in two samples. The distinctive spectral features at 1176 cm−1, 
1074 cm−1, 1020 cm−1 and 906 cm−1 (0) represent the deprotonation of the phosphonate groups. 
Because of the vibration mode at 1217 cm−1 is different from the νas(P − O) modes at 1176 
(Fig. 61 black), there might be a pyridine vibration change which present at 1217 cm−1 
(negative), 1114 cm−1, 998(0) cm−1 and 940 cm−1 (negative). Due to the negative band of 
νas(P − OH) in the same range, the value is about zero for the νas(UO2) mode at 906 cm
−1. 
Positive bands at ν̌= 1074 cm−1, 1020 cm−1 are related with νs(P − O) and νs(P − O). So for 
L4, it is found that the phosphonate groups are present in the uranyl coordination at pH 3. 
Meanwhile pyridine group might involve in the coordination of uranyl ion also.   
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Figure 62 : FT-IR spectra of of uranyl-L3 at pH 7.4 in H2O. Spectra of uranyl-L3 in red 
and L3 in black. Difference spectrum uranyl-L3 minus L3 (blue). 
The distinctive spectral (Fig 62 blue) of uranyl−L3 at pH 7.4 has bands at 1208 
cm−1(negative), 1185 cm−1(negative), 1134 cm−1(negative), 1063cm−1(negative), 1045cm−1, 
1003 cm−1(negative),  982 cm−1, 937 cm−1 and 907 cm−1. Bands at 1208 cm−1 (negative), 1134 
cm−1(negative), 1045cm−1, 1003 cm−1(negative) and 937 cm−1 are related with pyridine group 
vibration change. Meanwhile bands at 1185 cm−1(negative), 1063cm−1(negative) and 982 cm−1 
are assigned to the phosphonate modes,  νas(P − O), νs(P − O) and νs(P − O) . The band at 
ν̌=907 cm−1 is due to νas(UO2) mode. It is the same for L
3 at pH 7.4, both pyridine group and 
phosphonate groups are present in the coordination of uranyl ion which suggests uranyl ion is 
located in the ligand pocket with 3 nitrogen atoms and 2 oxygen atoms.   
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Figure 63 : FT-IR spectra of uranyl-L4 (right) at pH 7.4 in H2O. Spectra of uranyl-L4 in 
red and L4 in black. Difference spectrum uranyl-L4 minus L4 (blue). 
A similar symmetry of dianionic phosphonate group group in two samples was confirmed 
with the phosphonate group vibration modes. A similar pattern of bands is observed in the 
spectrum of the aqueous L4 sample and UO2
2+ −L4 sample recorded at pH 7.4 (Fig. 63 red & 
black). The distinctive spectral (Fig. 63 blue) features at 1150 cm−1, 1088 cm−1(negative), 969 
cm−1 and 918 cm−1(negative) represent the phosphonate modes, νas(P − O) , νs(P − O) , 
νs(P − O) and νas(P − OH). Bands at ν̌= 1200 cm
−1(negative), 1149 cm−1, 1037 cm−1 and 1000 
cm−1 are related with pyridine group vibration change. The band at ν̌=888 cm−1 is due to 
νas(UO2) mode. The large shift of νas(UO2) mode (906 cm
−1 to 888 cm−1) is due to the negative 
band of νas(P − OH) in the same range. Then for L
4, it is found that the phosphonate groups 
and pyridine group are present in the uranyl coordination at pH 7.4. 
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3.3 Conclusion 
The FT-IR absorption comparison between each sample can be done by standardize with 
the aromatic C-C structural vibration. The vibration attribution of two ligands, L3 and L4, are 
done first with the help of difference spectrum. The vibration of phosphonate groups and 
pyridine group could be found in the range of 850 to 1300 cm-1. But the ternary amine doesn’t 
have absorption in the infrared range. Besides due to the coupling of phosphonate groups, amine 
parts and pyridine group, the FT-IR spectra are difficult to analyze.  
At pH 3, phosphonate groups are involved in the uranyl coordination for both ligands. For 
the pyridine group, it is clearly play a role in the uranyl coordination for L3 which is hard to 
identify for L4. 
At pH 7.4, phosphonate groups and pyridine group are involved in the uranyl coordination 
for both ligands. 
4 Structural study of uranyl-ligand complexes 
4.1 Possible structure of uranyl-ligand complexes 
Previous experiments (TRLFS, UV-visible absorption spectroscopy, FT-IR) have shown 
that uranyl ion is located in the pocket of ligands at high equivalence above 0.6eq at pH 3. 
Meanwhile for pH 7.4, uranyl ion wills directly complex with ligands and located in the pocket 
of ligand. And due to the uranyl ligand fluorescence difference at pH 3 and 7.4, the uranyl 
coordinations are not the same for two pHs.  
ESI-MS test was done with uranyl-L3 and uranyl-L4 at pH 7.4 to determine the complex 
formation. But only the fragments were found in the data. 15N-NMR test was done with uranyl- 
L3 and uranyl-L4 at pH 3 to determine presence of nitrogen in the coordination. But the signal 
is too low to detect.  
At pH 3, two possible structures for uranyl-L3 1:1 complex are proposed. First, the possible 
structure is that with uranyl ion located in the pocket part of the ligand which consist 3 nitrogens 
and 2 oxygens. The second possibility is that where there is an extra water molecule in the 
coordination. Two similar uranyl coordination methods are suggested for uranyl-L4 complex 
(due to the similar structure of ligands and previous results). 
At pH 7.4, two possible structures for uranyl-L3 1:1 complex are proposed. First, the 
possible structure is that with uranyl ion located in the pocket part of the ligand which consist 
3 nitrogens and 2 oxygens. The second possibility is that where there is an extra hydroxide 
group in the coordination. Two similar uranyl coordination methods are suggested for uranyl-
L4 1:1 complex (due to the similar structure of ligands and previous results). 
4.2 Possible structure optimized by DFT  
In order to adjust the data obtained in EXAFS, it is necessary to construct a model 
describing the structure of complexes between uranyl ion and ligands. Constructed structures 
are then optimized for energy through calculations using the Functional Theory of Density 
(DFT). The geometry of the systems was optimized using RECP (Relativistic Effective Core 
Potential) at the B3LYP level and solvation effects were introduced using a polarized 
continuum model (PCM). The possible structures of uranyl-ligand complexes were optimized 
by DFT. Many of these models were eliminated because of the steric hindrance caused by 
complexation in the equatorial plane, specific to uranyl ion. Other structures were discarded as 
unstable energy, following the processes of minimization of energy. Structures from the most 
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energy-efficient DFT calculations were therefore used for the adjustment of EXAFS data. 
Finally, the most stable energetically stable environment for uranyl which provide by ligand is 
composed of two oxygen atoms from monodentate phosphonate (Oph), two nitrogen atoms from 
amine (Namine), one nitrogen atom from pyridine (Npyr). Besides due to the uranyl coordination 
difference at two pHs which confirm by UV-vis absorption study & TRLFS, two different 
models were built: for pH 3 (Fig. 64), a model without a water molecule in its coordination 
sphere and a model with the water molecule; for pH 7.4 (Fig. 65), a model without a hydroxide 
in its coordination sphere and a model with a hydroxide. The coordination sphere of uranyl for 
two ligands at pH 3 is different with or without the water molecular thus satisfying the 
coordination number of five or six in the equatorial plane. For pH 7.4, it is the same. The 
energetic optimization of the uranyl-ligand complex structures allowed us to determine the most 
stable.  
 
L3/UO22+ pH=3 
 
L3/UO22+  with 1 H2O  pH=3 
 
L4/UO22+ pH=3 
 
L4/UO22+  with 1 H2O pH=3 
Figure 64 : Theoretical models optimized by DFT and electronic density of L3 & L4 
interaction sites with uranyl at pH 3 (Oxygen: red, carbon: blue, nitrogen: light green, 
uranium: yellow). 
distance(Å) [L3-U] [L3-U-H2O] [L4-U] [L4-U-H2O] 
U-Oyl 1.79 1.78 1.79 1.78 
U-Op 2.30 2.34 2.29 2.32 
U-Owater ~ 2.72 ~ 2.66 
U-Npyr 2.87 2.75 2.59 2.72 
U-Namine 2.93 2.88 2.74 2.88 
U-P 3.55 3.61 3.53 3.61 
Table 19：Distances calculated by DFT for the four complexes 
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According to our calculations the ligand provides a symmetrical coordination of the uranyl 
ion due to the symmetrical structure of two ligands. As expected the average bond lengths of 
the uranyl-ligand complexes without H2O increase in the following order (Table 19): U-Oyl < 
U-Op < U-Npyr < U-Namine. For the uranyl-ligand complexes with H2O, on the other hand, the 
water molecular is a little bit further to the metal center compare to the Oyl and Op, which gives 
binding lengths that follow the order: U-Oyl < U-Op < U-Owater <U-Npyr < U-Namine. These 
theoretical results are in agreement with the other result.230 Both model for two ligands at pH 3 
are stable in DFT calculation.    
 
L4/UO22+ pH=7.4  
 
L4/UO22+ with OH- pH=7.4   
Figure 65 : Theoretical models optimized by DFT and electronic density of L4 
interaction sites with uranyl at pH 7.4 (Oxygen: red, carbon: blue, nitrogen: light green, 
uranium: yellow). 
distance(Å) [L4-U] [L4-U-OH] 
U-Oyl 1.81 1.82 
U-OOH ~ 2.28 
U-Op 2.23 2.31 
U-Npyr 2.62 3.09 
U-Namine 2.75 3.34 
U-P 3.53 3.63 
Table 20：Distances calculated by DFT for the two complexes. 
Then the DFT calculation was done only for L4 at pH 7.4 due to the distance similarity at 
pH 3 to reduce the amount of calculation. The average bond lengths of the uranyl-L4 complexe 
increase in the following order (Table 20): U-Oyl < U-Op < U-Npyr < U-Namine. For the uranyl-
L4-OH complex, on the other hand, the OH- group is much closer to the metal center, which 
gives binding lengths that follow the order: U-Oyl < U-OOH < U-Op <U-Npyr < U-Namine. These 
theoretical results are in agreement with the more covalent nature (more intense interaction) of 
the oxygen of the OH- group compared to the oxygen of the water molecule. Since the OH- ion 
is much closer to the metal, an increase in the U-Oyl and U-Op distances is observed in the 
uranyl-L4-OH complex relative to the uranyl-L4-H2O complex, indicating a weakening the 
complexation between the ligands and uranyl due to the very strong bond existing between OH 
and the metal center.  
These structures were then used to adjust the EXAFS data and compare theoretical 
distances to experimental distances 
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4.3 EXAFS data analysis  
However, a lack of information remains on the chemical function groups involved in the 
complexation of uranyl ion. EXAFS (Extended X-ray Fine Structure) is an X-ray spectroscopic 
technique that determines the composition of the coordination sphere of metals. These analyzes 
give us the possibility of knowing the environment of uranyl ions when they are complexed by 
ligands. In addition, this technique gives us the opportunity to confirm the existence of extra 
water molecular or hydroxide ion in the case of uranyl coordination. The effect of pH on the 
coordination sphere of the metal is therefore studied in this chapter for the four uranyl-ligand 
complexes. pH 3 and 7.4 were chosen due to the same reason. The principle of the EXAFS, the 
acquisition and analysis parameters as well as the details of the DFT calculations is summarized 
in the appendix. 
4.4 EXAFS data analysis of the uranyl-ligand complex 
A comprehensive structural study to determine the composition of the coordination sphere 
has not been conducted. Preliminary experiments of UV-vis absorption spectroscopy and 
TRLFS studies showed that at pH 3 and pH 7.4 the complexes between uranyl and L3 are largely 
in the majority. The changes in fluorescence property which observed in this study suggest a 
change in the coordination of uranyl. The measurement results of FR-IR shown the uranyl ion 
is located in the pocket of two ligands at 1:1 ratio. Since the presence of a single species is 
imperative for obtaining significant results, the EXAFS data were therefore collected at these 
two pHs of interest. The purpose of these experiments is to determine the composition of the 
coordination sphere of uranyl in these two conditions and thus to determine the impact of 
hydrolysis of uranyl on its complexation with the ligand. 
4.4.1 Uranyl-ligand study at pH 3 
The most stable adopted model at pH 3 includes two axial oxygen atoms (Oyl), two 
equatorial oxygen atoms (Op), three equatorial nitrogen atoms (Npyr & 2Namine) with or with 
Owater. The Op atom represents the oxygen atom of the monodente phosphonate group; Owater 
represents the oxygen atom of the water. Npyr atom represents the nitrogen atom of pyridine 
group; Namine represents the nitrogen atom from amine units. An additional layer representing 
the phosphors atoms associated with the above-mentioned phosphonate oxygen atoms has also 
been taken into account. 
During the adjustment procedure, the triple diffusion paths relating to the two axial oxygens 
of the uranyl have been taken into account. The U-P single scattering pathway and U-P-Oax 
multiple scattering pathway were also necessary to perform the fit of the experimental data.  
A Hanning adjustment window in k3 (2; 12.9) was used and the adjustment of spectra was 
in R (1; 5). Adjustment parameters such as passive electron reduction factor (S0²) and ΔE0 are 
given for each experiment. The adjustment factor R (r) and the reduced quality factor (χ²i ln) are 
both provided as an indicator of the quality of the fit. 
Taking into consideration the number of paths and the constraints geometric, the floating 
parameter number is 12 for the experiment pH 3. The fits of uranyl-ligand with 1 H2O cannot 
converge. Fits of uranyl-ligand without H2O are the best obtained. All the results of the 
adjustments are summarized in table 21 and table 22. The EXAFS k3 spectra and their Fourier 
corresponding are shown in Figure 66. 
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path RDFT(Å) Ndeg sigma^2(× 10−3 Å2) RFIT(Å) 
U-Oyl 1,81 2  3,67 1,80 
U-Op 2,21 2 2,92 2,30 
U-Npyr 2,56 1 2,08 2,44 
U-Namine 2,85 2 9,93 2,96 
U-P 3,62 2 14,95 3,69 
U-Oax1-U-Uax2-U 3,63 2 7,33 3,59 
U-P-Oax 4,65 4 6,59 4,61 
Table 21：Description of the paths used to fit the EXAFS data of the L3-U complex 
determined at pH 3. S0² = 1.19; ΔE0 = 6.50 eV. R = 0.03; χ²i ln = 115.8. 
The fitting result of L3-uranyl complex is not so good. Actually this test was performed 
twice. There is a bubble and precipitation which formed during the sample measurement for the 
first time. And the U LIII edge k
3–weighted EXAFS spectra showed a little difference. For this 
reason a fast scan was implementing by decrease the accuracy and changed the position of 
sample to have a better reproducibility. For the uranyl-L4 complex, the fitting result is rather 
good.  
Similar EXAFS spectra were obtained with the uranyl-L3 complex and uranyl-L4 complex 
at pH 3, which is a good indication that a unique uranyl binding site is probed under the 
experimental conditions used for EXAFS.  
path RDFT(Å) Ndeg sigma^2(× 10−3 Å2) RFIT(Å) 
U-Oyl 1,81 2 3,87 1,81 
U-Op 2,21 2 4,04 2,32 
U-Npyr 2,56 1 2,92 2,50 
U-Namine 2,85 2 27,17 2,83 
U-P 3,62 2 19,48 3,69 
U-Oax1-U-Uax2-U 3,62 2 7,75 3,61 
U-P-Oax 4,65 4 7,92 4,59 
Table 22 : Description of the paths used to fit the EXAFS data of the L4-U complex 
determined at pH 3. S0² = 1.27; ΔE0 = 5.67 eV. R = 0.02; χ²i ln = 4.35. 
The Fourier transforms (FT) represents a pseudo-radial distribution function of the uranium 
near-neighbor environment. The peaks appear at lower R values relative to the true near-
neighbor distances as a result of the EXAFS phase shift, which is different for each neighboring 
atom (φ =0.2 to 0.5 Å).  
For uranyl-L3 complex and uranyl-L4 complex at pH 3, the results show that UVI has two 
Oyl atoms at a distance of 1.79 and 1.80 Å, two Oph at 2.30 and 2.32 Å, one Npyr at 2.44 and 
2.50 Å and two Namine at 2.85 and 2.85 Å. The distance between U and Oyl is typical for the 
uranyl ion.231 The U-Oph bond length is within the range of previously reported values for the 
oxygen atom of phosphonate groups bound to uranyl in a monodentate fashion.145,232 These four 
types of atoms at equatorial plane thus could correspond to the presence of monodentate 
phosphonate groups and interaction with the pyridine group as deduced from the FTIR data and 
UV-vis absorption data. The best fit was obtained with a coordination number of two for the U-
Oph bond, one for Npyr and two for U- Namine bond, which is in accordance with the presence of 
two monodentate binding of the phosphonate. 
The other FT components were fitted with phosphors shell P at 3.69 and 3.69 Å and 
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multiple scattering with U-P-Oyl at 4.61 and 4.59 Å. The U-P distance of 3.69 Å is consistent 
with a monodentate phosphonate coordination in meta-autunite.233 
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Figure 66 : U LIII edge k3–weighted EXAFS spectra (left) and the corresponding Fourier 
transforms (right) of the L3-U complex (lower traces) and L4-U (upper traces) complex 
formed at pH 3. The experimental spectra are given in dash line and the fits are given in 
line. 
EXAFS data collected for the uranyl-L3 complex and uranyl-L4 complex at pH 3 are 
consistent with a uranyl fivefold coordination at equatorial plane involving two monodentate 
phosphonate groups, one nitrogen atom from pyridine group and two nitrogen atoms from the 
amine parts. These experimental data are in line with and UV-vis absorption data, TRLFS data 
and FTIR data with model of uranyl-ligand without H2O at pH 3, Figure 64, issuing from the 
DFT simulations. The shape of first shell of uranyl-L4 complex at pH 3 is slight larger than the 
case in L3-uranyl complex. This might due to the structure difference of two ligands.  
4.4.2 Uranyl-ligand study at pH 7.4 
The most stable adopted model at pH 7.4 includes two axial oxygen atoms (Oyl), two 
equatorial oxygen atoms (Op), three equatorial nitrogen atoms (Npyr & 2Namine) with or with 
OOH. The Op atom represents the oxygen atom of the monodente phosphonate group; OOH 
represents the oxygen atom of the hydroxide. Npyr atom represents the nitrogen atom of pyridine 
group; Namine represents the nitrogen atom from amine units. An additional layer representing 
the phosphors atoms associated with the above-mentioned phosphonate oxygen atoms has also 
been taken into account. The assignment is slightly different. OOH represents the hydroxide 
present in the coordination sphere; the oxygen of the hydroxide was grouped together with the 
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oxygen of the phosphonate oxygen in the same layer because they are at roughly the same 
distance from the metal (resolution of EXAFS ~ 0.1 Å)). 
The EXAFS data could be fit with both models with and without hydroxide well. But due 
to results of TRLFS study, the coordination for two pHs are not the same. Thus the model of 
uranyl-ligand with hydroxide was used. The paths of U-L4 complex is used in the fitting of U-
L4 complex. 
During the adjustment procedure, the triple diffusion paths relating to the two axial oxygens 
of the uranyl have been taken into account. The U-P single scattering pathway is also necessary 
to perform the fit of the experimental data.  U-P-Oax multiple scattering pathway is not used. 
A Hanning adjustment window in k3 (2; 12.9) was used and the adjustment of spectra was 
in R (1; 5). Adjustment parameters such as passive electron reduction factor (S0²) and ΔE0 are 
given for each experiment. The adjustment factor R(r) and the reduced quality factor (χ²i ln) are 
both provided as an indicator of the quality of the fit. 
path RDFT(Å) Ndeg sigma^2(× 10−3 Å2) RFIT(Å) 
U-Oyl 1,78 2 2,78 1,81 
U-Op 2,28 2 6,97 2,37 
U-OOH 2,31 1 6,97 2,40 
U-Npyr 2,93 1 8,4 3,03 
U-Namine 3,24 1 9,3 3,39 
U-P 3,56 1 2,81 3,81 
U-Oax1-U-Uax2-U 3,57 2 5,55 3,62 
Table 23 : Description of the paths used to fit the EXAFS data of the L3-U-OH complex 
determined at pH 7.4. S0² = 1.20; ΔE0 = 7.20 eV. R = 0.01; χ²i ln = 5.22. 
path RDFT(Å) Ndeg sigma^2(× 10−3 Å2) RFIT(Å) 
U-Oyl 1,79 2 4,02 1,82 
U-Op 2,28 2 8,2 2,28 
U-OOH 2,31 1 8,2 2,31 
U-Npyr 2,93 1 4,85 3,09 
U-Namine 3,24 2 10,46 3,20 
U-P 3,57 1 9,14 3,59 
U-Oax1-U-Uax2-U 3,57 2 8,03 3,63 
Table 24 : Description of the paths used to fit the EXAFS data of the L4-U-OH complex 
determined at pH 7.4. S0² = 1.22; ΔE0 = 3.62 eV. R = 0.01; χ²i ln = 27.3. 
Taking into consideration the number of paths and the constraints geometric, the floating 
parameter number is 12 for the experiment pH 7.4. All the results of the adjustments are 
summarized in table 23 and table 24. The EXAFS k3 spectra and their Fourier corresponding 
are shown in figure 67. 
Both fitting results of uranyl-ligand complex are good. Actually this test was performed 
twice. There is a uranium redox reaction happened during the sample measurement for the first 
time for uranyl-L4 compelx at pH 7.4. The charge of uranium was decreased from 6+ to 4+. For 
this reason a fast scan was implementing by decrease the accuracy and changed the position of 
sample to have a better reproducibility.  
Similar EXAFS spectra were obtained with the uranyl-L3 complex and uranyl-L4 complex 
at pH 7.4, which is a good indication that a unique uranyl binding site is probed under the 
experimental conditions used for EXAFS.  
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The Fourier transforms (FT) represents a pseudo-radial distribution function of the uranium 
near-neighbor environment. The peaks appear at lower R values relative to the true near-
neighbor distances as a result of the EXAFS phase shift, which is different for each neighboring 
atom (φ =0.2 to 0.5 Å). 
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Figure 67 : U LIII edge k3–weighted EXAFS spectra (left) and the corresponding Fourier 
transforms (right) of the L3-U-OH complex (lower traces) and L4-U-OH (upper traces) 
complex formed at pH 7.4. The experimental spectra are given in dash line and the fits 
are given in line. 
For uranyl-L3 complex and uranyl-L4 complex at pH 7.4, fitting shows that UVI has two 
Oyl atoms at a distance of 1.81 and 1.78 Å, two Oph at 2.37 and 2.28 Å, one OOH at 2.40 and 
2.31, one Npyr at 3.03 and 2.93 Å and two Namine at 3.38 and 3.24 Å. The distance between U 
and Oyl is typical for a uranyl ion.
231 The U-Oph bond length is within the range of previously 
reported values for the oxygen atom of phosphonate groups bound to uranyl in a monodentate 
fashion.145,232 These five types of atoms at equatorial plane thus could correspond to the 
presence of monodentate phosphonate groups and interaction with the pyridine group as 
deduced from the FTIR data and UV-vis absorption data. The best fit was obtained with a six 
coordination number at equatorial plane of two for the U-Oph bond, one for U-OOH bond, one 
for U-Npyr bond and two for U-Namine bond, which is in accordance with the presence of two 
monodentate binding of the phosphonate. 
The other FT components were fitted with phosphors shell P at 3.81and 3.59 Å. The U-P 
distance is consistent with a monodentate phosphonate coordination in meta-autunite.233 
EXAFS data collected for the uranyl-L3 complex and uranyl-L4 complex at pH 7.4 are 
consistent with a uranyl six-fold coordination involving two oxygen atoms from monodentate 
phosphonate groups, one hydroxide, one nitrogen atom from pyridine group and two nitrogen 
atoms from the amine parts. These experimental data are in line with UV-vis absorption data, 
TRLFS data and FTIR data with model of uranyl-ligand with OH at pH 7.4, Figure 3.39&3.40, 
Chapiter 3: Structural and thermodynamic study of uranyl with polyaminophosphonates 
ligands 
91 
 
issuing from the DFT simulations. Uranyl-L3 complex at pH 3 is slight larger than the case in 
uranyl-L4 complex. This might due to the structure difference of two ligands. The difference of 
U-OOH bond for two uranyl-ligand complexes might result in the thermodynamic constants 
difference at neutral pH.  
4.4.3 Comparison of uranyl-ligand study at two pHs 
The EXAFS spectra and FT are not the same for two pHs, 3 and 7.4. This showed that the 
uranyl binding sites are not the same for two pHs, which is comparable with the TRLFS results.    
For the four fitting the Debye–Waller factor σ2 are relatively high for the path of U-Npyr, 
U-Namine and U-P. This is due to the relatively long distance compare to the oxygen atoms.  
The uranyl ion is moving forward from the pyridine group from pH 3 to pH 7.4 due to the 
increasing of hydroxide concentration. The attraction of oxygen atom from hydroxide strongly 
altered the uranyl coordination, five-fold coordination at pH 3 to six-fold coordination at pH 
7.4.  
4.5 Conclusion  
With the help of UV-vis absorption study, TRLFS study and FT-IR measurement, the 
possible environments of uranyl ion are proposed. Then these structures are calculated by DFT 
to find the stable structure. Finally the EXAFS experiment is done to determine the coordination 
of uranyl ion.   
 
L3/UO22+ pH=3 
 
 
 
 
L3/UO22+  with 1 OH pH=7.4 
 
L4/UO22+ pH=3 
 
L4/UO22+  with 1 OH pH=7.4 
Figure 68 : Theoretical models optimized by DFT and electronic density of L3 & L4 
interaction sites with uranyl at pH 3 and 7.4 (Oxygen: red, carbon: blue, nitrogen: light 
green, uranium: yellow). 
  
For pH 3, the environments of uranyl ion are the same for both ligand, L3 and L4. (Fig. 68) 
The coordination is consist by two oxygen atoms from monodentate phosphonate groups, one 
Chapiter 3: structural and thermodynamic study of uranyl with polyaminophosphonates 
ligands 
 
 
 
nitrogen atom from pyridine group and two nitrogen atoms from the amine parts. 
For pH 7.4, the environments of uranyl ion are the same for both ligand, L3 and L4. (Fig. 
68) The coordination is consist by two oxygen atoms from monodentate phosphonate groups, 
one hydroxide, one nitrogen atom from pyridine group and two nitrogen atoms from the amine 
parts. 
Due to the presence of hydroxide in the coordination at pH 7.4, the uranyl ion is moving 
forward from the pyridine group.  The stoichiometry of uranyl-ligand complexes at pH 7.4 are 
1:1 within 0-1 eq uranyl. 
5 Thermodynamics study by displacement 
titration 
According to the uranyl-ligand complex fluorescence Study at pH 7.4, there is only one 
uranyl-ligand complex at 1:1 ratio. By using HYSS software, it is possible to estimate the 
stability constants of uranyl-L2 complex, uranyl-L3 complex and uranyl-L4 complex are higher 
than 13.3.   
Due to the difficult of degradation and precipitation in 0.1M NaClO4 solution of uranyl-L3 
complex and uranyl-L4 complex at acidic pH, a displacement titration which developed by Dr. 
Taran group was done.122,234 Sulfochlorophenol (SCP) in the figure below was use as a 
reference ligand, which complexes uranyl ion with a visible absorbance. The addition of a 
stronger ligand compare to SCP displaces the equilibrium towards the formation of UO2L, 
decreases the absorbance value and changes the color of the medium. Measurements were made 
at 690 nm for pH = 5.5 and 7.4 or 640 nm for pH = 9.0. For our study, the titration was done at 
pH 7.4 (biological pH).  
All experiments were carried out at room temperature in buffers with a fixed ionic strength 
of 0.1M prepared as follows: HEPES (for pH 7.4) (12.5 mmol) and n-Bu4N+Cl- (112.5 mmol) 
were dissolved in 1 L of Millipore quality water. 234 
SCP  
5.1 Fast screening 
 A fast screening was done to determine the affinity of the three ligands (Fig. 69). The 
protocol is followed the way which design by Dr. Taran group.122 The detail on the procedure 
is written in the appendix. The test was done by measuring the displacements (%) of the uranyl-
SCP complex with adding 2 eq of ligand. The affinity range was list in table 25.122  
Chapiter 3: Structural and thermodynamic study of uranyl with polyaminophosphonates 
ligands 
93 
 
L4L2 L3   
Figure 69 : Structure of three ligands. 
0-20% 15.3＞ log Kcond 
20-40% 16.2 ＞ log Kcond＞15.3 
40-60% 16.8 ＞ log Kcond＞16.2 
60-80% 17.7 ＞ log Kcond＞16.8 
80-100% log Kcond＞17.7 
Table 25 : Displacements (%) of the uranyl-SCP complex with logKcond (estimates) at pH 
7.4 were calculated by using the HYSS program supposing that the complex competitive 
uranyl-ligand is 1:1. For details on the procedure, see the appendix. 
Supposing that the complex competitive uranyl-ligand is 1:1, the displacement of uranyl-
SCP complex by L2, L3 and L4 are 86%, 17% and 2% (Fig. 70). Thus L2 has the highest rate 
among the three ligands. For L2, the ligand complexation constants is between 16.8 and 17.7; 
for L3 and L4, the constant is lower than 15.3.  
Due to the low displacement of L4, the determination of the ligand complexation constants 
was done for L2 and L3. Because uranyl ion has the same coordination for the three ligands at 
pH 7.4, the ligand complexation constants differences should relate with the molecular structure. 
Owing to the lack of one benzyl group, L2 is an asymmetric structure ligand which might 
decrease the steric effect compare to L3. So the affinity of L2 is higher. For L4, the two 
unbounded phosphonate group might weaken the ability to complex uranyl ion.  
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Figure 70 : Screening results of three ligands; [ligand] = 8E-5 M, [SCP] = [U] =4E-5 M, 
HEPES buffer=12.5 mmol, [nBu4N+Cl-] =112.5 mmol at pH 7.4. 
5.2 Determination of the ligand complexation constants 
Ligand complexation constants towards uranyl ion were determined through a competitive 
displacement between the ligand and uranyl-SCP complex. The binding abilities for uranyl ion 
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with water-soluble two ligands were determined by UV spectrophotometry in aqueous media 
under neutral pH conditions (pH 7.4). This method is essentially based on the spectral behaviour 
and complexation properties of a chromophoric probe with respect to the uranyl cation.235 The 
addition of a stronger ligand than SCP displaces the equilibrium towards the formation of UO2-
ligand (eq 8), decreasing the absorbance value at 690 nm and changing the color of the medium. 
The detail on the procedure is written in the appendix.  
SCP-UO2 + L  →  SCP + L-UO2                             Equation 8 
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Figure 71 : Competition displacement titration of uranyl-SCP complex by L2; [SCP] = 
[UO] =4e-5 M, [L2] 0-8E-4 M, HEPES buffer=12.5 mmol, [Bu4N+Cl-] =112.5 mmol. 
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Figure 72 : Competition displacement titration of uranyl-SCP complex by L3; [SCP] = 
[U] =4e-5 M, [L3] 0-8E-4 M, HEPES buffer=12.5 mmol, [nBu4N+Cl-] =112.5 mmol. 
For L2, the titration was done in the range of 0 to 10 eq due to the relatively high affinity 
(Fig. 71). While for L3, the titration was done in the range of 0 to 20 eq (Fig. 72). The ligand 
complexation constant (Kconcd) was evaluated in comparison to values of complexes Kconcd 
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SCP/UO2. It appears that polyaminophosphonates ligands exhibits sufficient affinities with 
respect to uranium decorporation at physiological blood pH (pH 7.4). Ligand complexation 
constants (Kconcd) are 17.08 for L2 and 15.2 for L3 at pH7.4. 
A comparison was done with 5-LICAMS and 3,4,3-LI(1,2-HOPO), which are well-known 
ligands, which displays in vivo uranyl-removal capabilities235,236. The complexation constants 
are 17 for 5-LICAMS237 and 16.87 for 3,4,3-LI(1,2-HOPO)122. Thus the 
polyaminophosphonates ligands, synthetized in this study, have similar complexation constants 
towards the two ligands which have been well studied.  
6 Selectivity study with cation  
Because most study on actinide biokinetics focuses on blood, three cations, Ca2+, Mg2+ and 
Fe3+,40 were chosen for the selectivity study. Owing to the nonfluorescence uranyl-ligand 
complex at neutral pH, the selectivity of the ligand was then investigated using TRLIF and UV-
vis absorption experiments which consist in adding a competing metal cation (M+) in the 
presence of the uranyl-L3 complex. An increase of the fluorescence signal will be observed if 
those metals form a new complex with L3. Competing metal cations, Ca2+, Mg2+ and Fe3+, have 
been added to the solution of the 1:1 uranyl-L3 complex at pH 7.4. There is precipitation formed 
for samples with Fe3+. Thus the selectivity study was done with Ca2+ and Mg2+. The sample 
was prepared by fresh deionized water to minimize the possible formation of CaUO2(CO3)3
2- 
and  Ca2UO2(CO3)3
2-. 
For this study, the 1:1 uranyl-L3 complex concentration is set at 5e-5 M. The concentrations 
of Ca2+ and Mg2+ in blood are 1.4E-3 M and 5.6E-4 M which are about 280 eq and 112 eq of 
uranyl-L3 complex for each metal. 
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Figure 73 : Selectivity study of 1:1 uranyl-L3 complex by Ca2+, absorption spectrum 
(left); fluorescence spectrum (right); [L3] = [U] =5E-5 M; [Ca2+] =0-350 eq; 
[NaClO4]=0.1 M. 
The absorption peak (Fig. 73 left) of sample with Ca2+ decreased a little bit with the Ca2+ 
concentration increase. So there is a small amount of uranyl ion which is replaced by Ca2+. The 
fluorescence intensity (Fig. 73 right) of uranyl ion also increased slightly. At 280 eq of Ca2+, 
which is the concentration in blood, the intensity seems at zero. So the uranyl-L3 complex 
presents a good stability for calcium.  
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Figure 74 : Selectivity study of 1:1 uranyl-L3 complex by Mg2+, absorption spectrum 
(left); fluorescence spectrum (right); [L3] = [U] =5E-5 M; [Mg2+] =0-150 eq; 
[NaClO4]=0.1 M. 
The absorption (Fig. 74 left) of sample with Mg2+ didn’t change with the Mg2+ 
concentration increase. So the uranyl ion is still in the coordination of L3. The fluorescence 
intensity (Fig. 74 right) of uranyl ion also didn’t increase. So the uranyl-L3 complex presents a 
good stability for magnesium.  
 
7 Chelation affinity of ligand towards 
Calmodulin - uranyl complex  
Calmodulin (CaM) is a metal protein which plays an important role in extracellular 
stimulus. The interaction between uranyl ion and protein has been well studied by Dr. Florian 
Brulfert in our lab.149,232,238,239 .Thus the chelation affinity of ligand was done with this protein.  
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Figure 75 : Species diagram of Ca-UO2-CaM complex from pH 5 to 8; [CaM] = [U] =5E-
5 M; [Ca2+] =2E-4 M; [NaClO4]=0.1 M.  
According to the structure of CaM, 4 times of calcium ion was used to occupy the four sites 
of CaM.137–139 Due to the affinity difference of 4 sites of CaM, 1 times of uranyl ion was added 
to compete with calcium ion for one site. Considering hydrolysis of uranyl and stability 
constants of the uranyl-calmodulin complexes (Fig 75), pH 5.5 was chosen for the chelation 
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study due to the dominant species, Ca3UO2CaM(OH), Ca3UO2CaM and UO2(OH)2. MES 
buffer was used to maintain the pH during the study.  
Due to the multiple species of uranyl, it is better to use the nonfluorescence affinity of 
uranyl-ligand complex in the neutral range to overcome this difficult. For the three ligands, L3 
and L4 didn’t shown fluorescence after complexes with uranyl at pH 5.5 which L2 has. Thus the 
L3 was used in this study owing to the relatively high affinity and nonfluorescence property.  
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Figure 76 : Chelation study of L3 towards Ca-UO2-CaM complex, absorption spectrum 
(left); fluorescence spectrum (right); [CaM] = [UO22+] =2.5E-5 M; [Ca2+] =2E-4 M; 
[L3]=0, 1 and 5eq ; [NaClO4]=0.1 M ; [MES]= 5 mmol ; pH 5.5. 
For the fluorescence spectra, an 8 nm red shift of the uranyl fluorescence spectrum was 
found for the Ca-UO2-CaM complex (Fig. 76 right). The lifetime study was done with the help 
of lifetime reference data.232 Three lifetimes with 0.4 μs  for Ca3UO2CaM, 4 μs  for 
Ca3UO2CaM(OH) and 24μs  for UO2OH2 were found. It confirmed the species simulation 
results. After adding 1eq L3, the sample was stirred for 10 mins, then the TRLFS measurement 
was done. There is no more fluorescence from uranyl which means the uranyl is almost complex 
by L3. Another 4eq was added to check the stability after 1day. Both the absorption spectra and 
fluorescence spectra didn’t change after 1day. So the stability is pretty good. Note that then the 
ligand complex (for the similar bisphosphonates ligand) with Tc, the obtained complex was 
rapidly excreted through the kidneys and bladder after injection to mice. The fast kinetic, good 
stability and possible rapidly excrete of uranyl- L3 complex provide the possible application in 
the chelation therapy.  
Due to the absorption of CaM in the UV range, the absorption of the sample was hard to 
directly analyze. Because the CaM spectrum is unknown, two deconvolutions were done for 
Ca-UO2-CaM complex with 1 eq and 5 eq L3 to determine the CaM spectrum, which could 
further investigate the formation of uranyl ion species (Fig. 77). The deconvolution of Ca-UO2-
CaM complex with 1eq L3 was done with 1 eq of CaM and 1 eq of uranyl-L3 (Fig. 77 left).. The 
deconvolution of Ca-UO2-CaM complex with 5 eq L3 was done with 1 eq of CaM, 1 eq of 
uranyl- L3 and 4 eq of L3 (Fig. 77 right). 
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Figure 77 : Devolution study of L3 towards Ca-UO2-CaM complex, 1eq L3 (left); 5eq L3 
(right). [CaM] = [U] =2.5E-5 M; [Ca2+] =2E-4 M; [L3]=0, 1 and 5eq ; [NaClO4]=0.1 M ; 
[MES]= 5 mmol ; pH 5.5. 
There is a difference on the absorption in UV range between the record UO2-CaM spectrum 
with the two CaM spectra from deconvolution. The black line of CaM1 is from the 
deconvolution of Ca-UO2-CaM complex with 1eq L3 which red line of CaM5 is for Ca-UO2-
CaM complex with 5eq L3 (Fig. 78). The similar spectra of CaM confirmed the CaM didn’t 
complex with uranyl ion in these two conditions. Thus the uranyl was complexed with L3. This 
result is coherent with the fluorescence measurement.  
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Figure 78 : Comparison of CaM spectra from two devolutions. CaM1 in black; CaM5 in 
red; UO2-CaM in blue.  
8 Conclusion  
This chapter presented the work on the structural and thermodynamic study of uranyl-
ligand complex. From the structural study, it demonstrates the coordination of uranyl ion at pH 
3 and 7.4 which provide by the ligand is as expected with the design. From thermodynamic 
study, the significant affinity of three ligands, L2, L3 and L4, for uranyl ion is due to the 
phosphonate groups and well molecular design. The uranyl- L3 complex shows a good stability 
in the presence of excess of calcium and magnesium. Especially by adding just equal mole of 
L3, the uranyl ion could be removing from calmodulin and forming complex with L3. Thus for 
these ligands the potential application as uranyl chelation agents is promising.   
Combine UV-vis absorption study with TRLFS measurements allowed the preliminary 
Chapiter 3: Structural and thermodynamic study of uranyl with polyaminophosphonates 
ligands 
99 
 
characterization of the coordination sphere of the metals in the complexation site of the protein 
and provided information for the experiment condition of the other study. By using FT-IR, the 
groups which plays a role in the coordination could be detect. Finally the DFT calculations 
followed with EXAFS measurements provide the accurate characterization of the coordination 
sphere of uranyl ion in the complexation site of the ligand. All these studies were done at two 
pHs, pH 3 and 7.4. The experimental / theoretical approaches proved to be very interesting for 
comparing the coordination properties of uranyl ion in solution at different pH on the uranyl 
ion coordination sphere and the stability of the uranyl-ligand complexes. 
The complexation constants of uranyl-ligand complex are measured by competition 
displacement titration with SCP. The stability of uranyl-ligand complex with competition cation 
is strong enough for biochemistry condition. The chelation affinity test with protein provides a 
possible interaction path in the human body.  
The complexation of uranyl ion with ligand is now proven and the uranyl ion coordination 
sphere is known, the next chapter will describe the complexation of europium, the analogue of 
curium, with ligand. The different structure of europium (spherical for europium and linear 
structure for uranyl ion) requires a different coordination with the ligand. 
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1 Thermodynamics study of europium-L3 
complex 
The thermodynamic study with europium L3 complex was done with potentiometry first. 
But when the pH of europium L3 complex (1mM) increased to around 3.2, a precipitation 
occurred. Thus this measurement can’t be done.  
Then another test was done with UV-Vis spectroscopy to determine the formation constants. 
The absorption of europium L3 complex doesn’t change, therefore it is not possible to use 
HypSpec software to deduce the formation constants.  
L3 L
4
L3*  
Figure 79 : Chemical structures of bis-phosphonated ligand L3 & L3* and tetra-
phosphonated ligand L4 
 La Nd Eu Gd Tb Er Lu 
𝐥𝐨𝐠𝑲𝑴𝑳𝟒
[𝒃] 25.5(4) 27.1(3) 25.7(3) – 29.7(6) 29.7(1) 29.3(4) 
𝐥𝐨𝐠𝑲𝑴𝑳𝟒𝑯
[𝒃] 9.4(4) 8.8(3) 9.4(3) – 7.6(7) 7.8(1) 7.4(6) 
𝐥𝐨𝐠𝑲𝑴𝑳𝟒𝑯𝟐
[𝒃] 7.3(6) 6.6(4) 7.5(4) – [c] [c] [c] 
𝐥𝐨𝐠𝑲𝑴𝑳𝟐∗ 10.14(4) 10.66(5) – 11.22(5) – 11.15(3) [c] 
𝐥𝐨𝐠𝑲𝑴𝑳𝟐∗𝑯 9.19(5) 9.35(6) – 9.16(6) – 9.25(4) [c] 
𝐥𝐨𝐠𝑲𝑴𝑳𝟐∗𝑯𝟐 7.42(5) 7.40(6) – 7.21(6) – 7.90(4) [c] 
𝐩𝐋𝐧𝑳𝟒 20.6 21.3 20.9 – 22.6 22.7 21.9 
𝐩𝐋𝐧𝑳𝟐∗ 7.3 8.0 – 8.2 – 8.3 [c] 
Table 26 : Thermodynamic stability constants and protonation constants for the 
complexes formed with ligands L2 and L4 and various LnIII cations along the series and 
corresponding values of pLn. [a] pLn values are defined by pLn=-log[LnIII]free at pH 7.0 
for [LnIII ]=1 𝛍𝐦 and [L]=10 𝛍𝐦;240 [2] According to reference 13. [c] Precipitationof the 
complexes precludes accurate determination. The hydrolysis con- stants of the free Ln3+ 
cations have been taken into account in the statistical processing (logKLaOH=-8.83; 
logKNdOH=-8.20; logKEuOH=-7.78; logKGdOH=-7.85; logKTbOH=-7.66; logKErOH =-7.54; log 
KLuOH=-7.29). 
The formation constants of similar bis-phosphonated ligand L3* (Fig. 79) and tetra-
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phosphonated ligand L4 (Fig. 79) which were determined by potentiometry were listed in the 
table 26.13,130 With the increasing number of terminal phosphonates groups in the ligand, the 
binding constants increased. The loss of two phosphonate functions leading to L3* resulted in 
the decrease of stability. Thus the loss of phosphonate groups will lead to a weak chelator ((pLn 
~8).241  
For this study, a similar trend of formation constants of L3 with LnIII could be expected due 
to the structure similarity of two bis-phosphonated ligand. Therefore, L3 molecule show a weak 
binding affinity with LnIII comparing to the L4 ligand. 
2 Europium/ligands interactions studied by 
Time-resolved laser fluorescence spectroscopy 
(TRLFS) and UV-visible spectroscopy 
The detail of time-resolved laser fluorescence spectroscopy (TRLFS) and UV-visible 
spectroscopy has been described in chapter 3. 
2.1 Experimental conditions selection  
As for bis and tetra-phosphonated ligands, the formation of a one to one metal to ligand 
complex was confirmed in the other study.130 The species diagram of europium (Fig. 80 right) 
is much simpler than the one of uranium. Europium hydroxide starts to form at pH 5.7.  
The formation constants of europium L4 complex were reported in the work of Dr. Sabah 
Abada by potentiometric measurements.13 The coordination of Eu is composed by 4 oxygen 
atoms from phosphonate group, 2 nitrogen atoms from amine part, 1 nitrogen atom from 
pyridine group and 1 oxygen atom from water molecular. Therefore, the europium L4 complex 
starts to form at really low pH (about pH 2) and H2EuL4 species is the dominating species at 
pH 3((Fig. 80 left). pH 7.4 is the biological pH. Thus pH 3 and 7.4 were chosen for this study. 
Moreover, during the measurement, the UV-Vis absorption spectra of europium L4 complex 
show no difference with the ligand alone at pH 3, thus pH 5 was chosen to study same 
dominating species, H2EuL4. 
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Figure 80 : Species diagram of europium ion, [Eu] = 5E-5 M in 0.1M NaClO4 (left); [Eu] 
= [L4] = 1e-4 M in 0.1M NaClO4 (right). 
Due to the lack of formation constants of europium-L3 complex, same pH study like 
europium-L4 complex was done.  
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2.2 Study of europium-ligand complexes 
Because the interaction of europium-ligand complexes is quite clear, only the comparison 
of europium-ligand complex with ligand alone was done. The change over the UV absorption 
is mainly due to the aromatic part and amine branches. The fluorescence change is mainly due 
to the concentration and coordination of europium. Due to the problem with TRLFS apparatus 
in our lab, the fluorescence measurement was not performed, only the time resolved study was 
done with help of Prof. Niko HILDEBRANDT of group NanoBioPhotonique at C2N lab.   
a. Study of europium- L4 complex at pH 3 in 0.1M NaClO4 
For the study of europium-L4 complex at pH 3, the major species is the H2EuL4 species. 
The major species of ligand alone in the solution at this condition is monophosphonate, thus 
the four phosphonate groups and pyridine group could provide 4 oxygen atoms and 1 nitrogen 
atom for the Eu3+ coordination. For the amine part, the proton is still attached to the nitrogen at 
this pH, so there is a competition between europium ion with hydrogen. For europium alone in 
the solution, free europium ion alone is the dominate species. 
The shapes of absorption spectra of L4 and europium-L4 complex were different (Fig. 81). 
But there is no shift on the absorption band. Thus, the Eu3+ may be only complexed by the 
phosphanate groups of L4. The lifetime of complex is 0.33 ms which means there are about 2.7 
water molecules in the europium coordination.242 It confirms the interaction of Eu3+ with ligand 
only exists in the phosphonate groups. 
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Figure 81 : Study of europium-L4 complex, absorption measure; [Eu] = [L4] = 1E-4 M , 
pH 3, 0.1M NaClO4. 
b. Study of europium- L3 complex at pH 3 in 0.1M NaClO4 
For the study of europium-L3 complex at pH 3, the major species of ligand alone in the 
solution at this condition is monophosphonate, thus the two phosphonate groups and pyridine 
group could provide 2 oxygen atoms and 1 nitrogen atom for the Eu3+ coordination. For the 
amine part, since the proton is still attached to the nitrogen at this pH, there is a competition 
between the europium ion with hydrogen atom. For europium alone in the solution, free 
europium ion alone is the dominate species. 
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Figure 82 : Study of europium-L3 complex, absorption measure; [Eu] = [L3] = 1E-4 M , 
pH 3, 0.1M NaClO4. 
The shapes of absorption spectra of L3 and europium-L3 complex were different (Fig. 82). 
But there is no shift on the absorption band. Therefore, the Eu3+ may only complex with the 
phosphanate groups of L3. The lifetime of complex is 0.19 ms which means there are about 5.2 
water molecules in the europium coordination. It confirms the interaction of Eu3+ with ligand 
only exists in the phosphonate groups. 
c. Study of europium-L4 complex at pH 5 in 0.1M NaClO4 
For the study of europium-L4 complex at pH 5, the major species of complex is H2EuL4. 
The major species of ligand alone in the solution at this condition are monophosphonate and 
phosphonate group, thus the four phosphonate groups and pyridine group could provide 4 
oxygen atoms and 1 nitrogen atom for the Eu3+ coordination. For the amine part, as the proton 
is still attached to the nitrogen at this pH, there is a competition between the europium ion with 
hydrogen atom. For europium alone in the solution, europium ion alone is the dominate species. 
The shapes and absorption band of absorption spectra of L4 and europium-L4 complex were 
different (Fig. 83). Thus, the Eu3+ locates in the pocket part of L4. The lifetime of complex is 
0.37 ms which means there are about 2.3 water molecules in the europium coordination.242  
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Figure 83 : Study of europium-L4 complex, absorption measure; [Eu] = [L4] = 1E-4 M, 
pH 5, 0.1M NaClO4. 
d. Study of europium- L3 complex at pH 5 in 0.1M NaClO4 
Due to the precipitation of 10E-4M europium-L3 complex at pH 7.4 in 0.1M NaClO4, the 
test was done in 0.1M NaCl. The time resolve measurement was done with the solubilized part 
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of europium-L3 complex at pH 7.4 in 0.1M NaClO4. 
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Figure 84 : Study of europium-L3 complex, absorption measure; [Eu] = [L3] = 1E-4 M, 
pH 5, 0.1M NaClO4. 
For the study of europium-L3 complex at pH 5, the major species of ligand alone in the 
solution at this condition are monophosphonate and phosphonate group, thus the two 
phosphonate groups and pyridine group could provide 2 oxygen atoms and 1 nitrogen atom for 
the Eu3+ coordination. For the amine part, since the proton is still attached to the nitrogen at this 
pH, there is a competition between the europium ion with hydrogen atom. For europium alone 
in the solution, europium ion alone is the dominate species. 
The shapes of absorption spectra of L3 and europium-L3 complex have slightly differences 
(Fig. 84). But there is no shift on the absorption band. Thus, the Eu3+ may be only complexed 
with the phosphanate groups of L3. The lifetime of complex is 0.29 ms which means there are 
about 3.1 water molecules in the europium coordination. It confirms the europium ion is located 
in the pocket of ligand. 
e. Study of europium-L4 complex at pH 7.4 in 0.1M NaClO4 
For the study of europium-L4 complex at pH 5, the major species of complex are H2EuL4 
and HEuL4.The major species of ligand alone in the solution at this condition is the phosphonate 
groups, thus the four phosphonate groups and pyridine group could provide 4 oxygen atoms 
and 1 nitrogen atom for the Eu3+ coordination. For the amine part, as the proton is still attached 
to the nitrogen atom at this pH, there is a competition between the Eu3+ ion with hydrogen. For 
europium alone in the solution, europium ion alone and europium hydroxide are present.  
The shapes and absorption band of absorption spectra of L4 and europium-L4 complex were 
different (Fig. 85). Therefore the Eu3+ is located in the pocket part of L3. Moreover, the spectra 
of europium-L4 at pH 5 and 7.4 are different. The lifetime of complex is 0.39 ms which means 
there are about 2.1 water molecules in the europium coordination. It confirms the strong 
stability constant of EuL4 species due to encapsulating of Eu3+ ion by the L4 (table 26). 
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Figure 85 : Study of europium-L4 complex, absorption measure; [Eu] = [L4] = 1E-4 M, 
pH 7.4, 0.1M NaClO4. 
f. Study of europium-L3 complex at pH 7.4 in 0.1M NaClO4 
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Figure 86 : Study of europium-L3 complex, absorption measure; [Eu] = [L3] = 1E-4 M , 
pH 7.4, 0.1M NaClO4. 
Due to the precipitation of 10E-4M europium-L3 complex at pH 7.4 in 0.1M NaClO4, the 
test was done in 0.1M NaCl. The time resolved measurement was done with the solubilized part 
of europium-L3 complex at pH 7.4 in 0.1M NaClO4. 
For the study of europium–L3 complex at pH 7.4, the major species of ligand alone in the 
solution at this condition is the phosphonate group, thus the four phosphonate groups and 
pyridine group could provide 2 oxygen atoms and 1 nitrogen atom for the Eu3+ coordination. 
For the amine part, as the proton is still attached to the nitrogen atom at this pH, there is a 
competition between the europium with hydrogen. For europium alone in the solution, 
europium ion alone and europium hydroxide are present. 
The shapes and absorption band of absorption spectra of L3 and europium-L3 complex 
changed significantly (Fig. 86). Thus the Eu3+ is located in the pocket part of L3. Moreover, the 
spectra of europium-L4 at pH 5 and 7.4 are different. The lifetime of complex is 0.289 ms which 
means there are about 3.1 water molecules in the europium coordination. It confirms the 
relatively low stability constant of EuL3 species due to the presence of 3 water moleculers in 
the coordination of Eu3+ ion . 
2.3 Conclusion  
For the Eu-ligand complex, based on the thermodynamic constants which are reported in 
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the publication, UV-vis absorption and TRLFS study were done. Because of the small changing 
on the absorption spectra of europium-L3 complex with about 6 water molecules in the 
coordination and of europium-L4 complex with about 3 water molecules in the coordination at 
pH 3, it seems the Eu3+ ion is only complex with the phosphonate groups of the ligand. But at 
higher pH, pH 5 and 7.4, the Eu3+ ion is located in the pocket part of two ligands. Thus the 
environments of Eu3+ ion are not the same for the same species H2EuL4 at pH 3 and 5.  
 At lower pH, the hydrogen concentration is relatively high compared to the europium 
concentration. The Eu3+ ion cannot move to the pocket part due the proton which forms 
hydrogen bond. Therefore, the interaction of Eu3+ ion with the ligand occurs only through the 
phosphonate groups. This could explain why there is only a small change on the absorption of 
the ligand but not the shape. Then at higher pH, the hydrogen concentration is lower, the Eu3+ 
ion is encapsulated by the ligand, then the hydrogen band on the nitrogen atoms of amine parts 
is no longer exist which affect the shape of ligand absorption, then both the shape and absorption 
changed.  
3 IR characterization of two ligands with 
europium in aqueous solution 
The IR spectra of ligands have been fully described in chapter 3. 
3.1 IR spectra of europium -ligand complexation  
Only two samples, europium-L3 complex at pH 3 and europium-L4 complex at pH 7.4 were 
investigated. Due to the low solubility of europium-L3 complex, it is not possible to prepare a 
sample with a pH value over 3.2 at 2mM for the IR measurement. Thus pH 3 was chosen for 
IR study. Europium-L4 complex at pH 7.4 was chosen to understand the interaction at biological 
pH. Each sample in this study was prepared with the same molar equivalence of europium and 
ligand based on the UV-Vis absorption spectroscopy and fluorescence studies. All the spectra 
were normalized with carbon stretching vibrations eg at 1580 cm
-1. 
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Figure 87 : FT-IR spectra of europium-L4 at pH 7.4 in H2O. Spectra of europium–L4 in 
red and L4 in black. Difference spectrum europium-L4 minus L4 (blue). 
Symmetry of dianionic phosphonate group was confirmed with the phosphonate group 
vibration modes (Fig. 87 black). The distinctive spectral (Fig. 87 blue) features at 1053 cm−1, 
975 cm−1, 958 cm−1 and 913 (negative) cm−1 represent the phosphçnate modes,νas(P − O), 
νs(P − O), νs(P − O) and νas(P − OH). Positive bands at ν̌= 1183 cm
−1 (negative), 1138 cm−1 
and 992 cm−1 are related with pyridine group vibration change. For L4, the phosphonate groups 
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and pyridine group are possibly present in the Eu3+ coordination at pH 7.4. 
The symmetry of monoanionic phosphonate group in two samples was confirmed with the 
phosphonate groups vibration modes (Fig. 88 black), νas(P − O),νs(P − O) and νas(P − OH). 
The distinctive spectral features (Fig. 88 blue) at 1204 cm−1 (negative), 1175 cm−1(negative), 
1152 cm−1, 1036cm−1(negative), 1013cm−1,  998cm−1, and 900 cm−1(negative) represent the 
deprotonation of the phosphobate groups and pyridine group vibration change. Positive bands 
at ν= 1204 cm−1, 1152 cm−1, 998 cm−1 are related with pyridine group vibration change. Positive 
bands at ν̌ = 1175 cm−1, 1036 cm−1, 1013 cm−1 are assigned to  νas(P − O),  νs(P −
O) and νs(P − O). The negative band at ν̌= 900 cm
−1 is due to the displacement for hydrogen 
atoms by europium ion. Thus both pyridine group and phosphonate groups are changed in the 
coordination of Eu3+ which suggests Eu3+ strongly binds the phosphonate group and interferes 
with the coupling of the vibration modes of other function groups.  
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Figure 88 : FT-IR spectra of europium−L3 at pH 3 in H2O. Spectra of europium -L3 in 
red and L3 in black. Difference spectrum europium−L3 minus L3 (blue). 
4 Structural study of europium-ligand 
complexes 
4.1 Possible structure of europium-ligand complexes 
Previous experiments (TRLFS, UV-visible, FT-IR) have shown that europium ion is out of 
the pocket of L3 at pH 3. Meanwhile for pH 7.4, europium will directly complex with L4 and 
located in the pocket of ligand. Thus the coordination of europium is not the same for two pHs, 
3 and 7.4. 
4.2 Possible structure optimized by DFT  
Similar DFT calculation was done for europium-ligand complexes like the one for uranyl-
ligand complexes in chapter 3.  
For pH 3, the most energetically stable environment for europium with L3 ligand is 
composed of two oxygen atoms from monodentate phosphonate (Oph). With the help of UV-
Vis absorption study and TRLFS study and FTIR studies, a model was built for Eu-L3 complex 
with 7 H2O at pH 3 (Fig. 89 right): 2 oxygen atoms from monodentate phosphonate (Oph) and 
seven water molecules in its coordination sphere.  
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L3/Eu3+ with 7 H2O pH=3 
 
 
 
L4/Eu3+ with 1 H2O pH=7.4 
Figure 89 : Theoretical models optimized by DFT and electronic density of L3/Eu3+ with 
6 H2O at pH=3 (right) and L4/Eu3+ with 1 H2O at pH=7.4 (left) (Oxygen: red, carbon: 
blue, nitrogen: light green, uranium: yellow) 
For pH 7.4, the most energetically stable environment for europium with L4 ligand is 
composed of four oxygen atoms from monodentate phosphonate (Oph), two nitrogen atoms from 
amine (Namine) and one nitrogen atom from pyridine (Npyr). With the help of UV-Vis absorption 
, TRLFS and FTIR studies, a model was built for Eu-L4 complex with 1 H2O at pH 7.4 (Fig. 89 
left): 4 oxygen atoms from monodentate phosphonate (Oph), 1 oxygen atom from water 
molecule, 2 nitrogen atoms from amine (Namine) and 1 nitrogen atom from pyridine (Npyr). 
According to DFT calculations, the ligand L3 shows an asymmetric coordination of the 
europium ion due to the presence of seven water molecules in the first coordination sphere. The 
models suggest the ligand provides two oxygen atoms of the phosphonate groups for the 
coordination. The bond lengths of Eu-L3 complex with 7 H2O at pH 3 are list in table 27. 
 
 distance(Å) 
Eu-Op 2.28 & 2.29 
Eu-H2O 2.45-2.75 
Eu-P 3.55 & 3.60 
Table 27 : Distances calculated by DFT for the Eu-L3 complex at pH 3   
 
distance(Å) 
Eu-Npyr 2.66 
Eu-Namine 2.76 and 2.87 
Eu-OP 2.27-2.36 
Eu-H2O 2.91 
Table 28 : Distances calculated by DFT for the Eu-L4 complex at pH 7.4   
According to DFT calculations, the ligand L4 shows an asymmetric coordination of the 
metal ion due to the presence of a water molecule in the first coordination sphere. The models 
suggest the ligand provides three nitrogen atoms and four oxygen atoms of the phosphonate 
groups for the coordination. Two of the four methylene phosphonate groups are placed slightly 
above and below the plane of pyridine, while the other two remaining phosphonate groups point 
up and down and fold back to the Eu3+ ion. The bond lengths of Eu-L4 complex with 1 H2O at 
pH 7.4 are list in table 28. The calculation result is coherent with the calculation of Gd-L4 
complex at pH 7.13 
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4.3 EXAFS data analysis of the europium-ligand complex 
A comprehensive structural study by EXAFS was done to determine the composition of 
the coordination sphere of europium ion. Preliminary experiments of UV-Vis absorption, 
TRLFS and FT-IR studies showed that the complexes between europium and ligands are mainly 
the f Eu-L3 species at pH 3 and Eu-L4 species at pH 7.4. 
4.3.1 Eu-L3 complex study at pH 3 
During the measurement for the Eu-L3 complex at pH 3(Fig. 89 right), the precipitation has 
been formed. The possible reason for this phenomenon is the local pH increase because of the 
X-ray. Thus another Eu-L3 complex at pH 2.6 was prepared to prevent this problem. The 
absorption spectrum of Eu-L3 complex at pH 2.6 also has a little difference on absorption with 
the ligand alone at pH 2.6 which is similar with Eu-L3 complex at pH 3. The lifetime of 
europium at pH 2.6 is 0.15 ms which refers 6.5 water molecules in the coordination. Thus the 
stable adopted model at pH 2.6 should be similar with the most stable adopted model at pH 3 
(Table 27). Because it is hard to distinguish the different oxygen atom with different distance 
for EXAFS data analysis, the EXAFS fitting of europium is different from the one of uranium 
in this study, a directly fitting start from the EXAFS data on different shell was done. During 
the adjustment procedure, two shells were taken into account, the first shell is composed by 
oxygen atoms; the second shell is composed by phosphorus atom. The average distances of Eu-
O and Eu-P single scattering pathway were used.  
A Hanning adjustment window in k3 (2; 12.9) was used and the adjustment of spectra was 
in R (1; 5). Adjustment parameters such as amplitude (S0²) and ΔE0 are given for each 
experiment. The adjustment factor R (r) and the reduced quality factor (χ²i ln) are both provided 
as an indicator of the quality of the fit. 
path Reff(Å) Ndeg sigma^2(× 10−3 Å2) RFIT(Å) 
Eu-OFirst shell 2.50 9 7.89 2.42 
Eu-P 3.55 2 6.04 3.70 
Table 29 : Description of the paths used to fit the EXAFS data of the Eu-L3 complex at 
pH 3. S0² = 1; ΔE0 = 4.69 eV. R = 0.01; χ²i ln = 23.6 
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Figure 90 : Eu LIII edge k3–weighted EXAFS spectra (left) and the corresponding 
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Fourier transforms (right) of the L3-Eu complex at pH 3. The experimental spectra are 
given in line and the fits are given in dash line. 
The first shell coordination sphere of europium was fitted with nine oxygens to determine 
a mean value at 2.42 Å in agreement with literature.243–245 As for monodentate phosphonate 
phosphors (3.70 Å), distance was fitted in agreement with our calculated DFT model.  
4.3.2 Eu-L4 complex at pH 7.4 
The most stable adopted model at pH 7.4 (Fig. 89 left) includes four oxygen atoms (Op), 
one oxygen atom (Owater) and three nitrogen atoms (Npyr & 2Namine) in the first coordination 
(Table 28). The Op atom represents the oxygen atom of the monodente phosphonate group; 
Owater represents the oxygen atom of the water. Npyr atom represents the nitrogen atom of 
pyridine group; Namine represents the nitrogen atom from amine units. An additional layer 
representing the phosphors atoms associated with the above-mentioned phosphonate oxygen 
atoms has also been taken into account. 
2 3 4 5 6 7 8 9 10 11 12 13
F
T
 m
a
g
n
it
u
d
e
 i
n
  

(k
)k
L
4
_Eu/pH7.4
E
X
A
F
S
 a
m
p
lit
u
d
e
 i
n
 
(k
)k
0 2 4 6
r ÷  (Å)
L
4
_Eu/pH7.4
k(Å
-1
)
 
Figure 91 : Eu LIII edge k3–weighted EXAFS spectra (left) and the corresponding 
Fourier transforms (right) of the L4-Eu complex at pH 7.4. The experimental spectra are 
given in line. 
Also it is hard to distinguish the different oxygen atoms and nitrogen atoms with different 
distance for EXAFS data analysis, a directly fitting start from the EXAFS data on different shell 
was done. During the adjustment procedure, two shells were taken into account, the first shell 
is composed by oxygen atoms and nitrogen atoms; the second shell is composed by phosphorus 
atom. The average distances of Eu-O&N and Eu-P single scattering pathway were used.  
Unfortunately the fitting of Eu-L4 complex at pH 7.4 doesn’t works. The first shell of 
europium ion could be fit with 9 atoms. Due to the strong interaction at the second shell of 
europium ion, not enough atoms at the second shell could satisfy the coordination.   
5 Conclusion  
This chapter presented the work on the structural and thermodynamic study of europium-
ligand complex. Unfortunately due to the low solubility of Eu-L3 complex in 0.1M NaClO4 
solution the formation constant measurement failed with spectroscopy and potentiometry. 
From the structural study by UV-vis absorption study with TRLFS measurements, it 
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demonstrates the coordination of europium ion at pH 3 and 5 is not the same, out of the pocket 
of ligand for pH 3 while in the picket of ligand for pH 5. At pH 3, the interaction of europium 
ion with both ligands only exists in the phosphonate groups. At pH 5 and 7.4, the europium ion 
is located in the pocket part of both ligands. Since the phosphonate groups and other parts of 
ligand couldn’t provide sufficient donors for the coordination, extra water molecules from 
solution are compensate the coordination of europium. The possible complexation modes of 
Eu-L3 complex at pH 3 and Eu-L4 complex at pH 7.4 were further confirmed by FT-IR to settle 
down the experiment condition for EXAFS. Finally the DFT calculations followed with EXAFS 
measurements provide the accurate characterization of the coordination sphere of europium ion 
in the complexation site of L3 at pH 3.  
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General conclusion  
This thesis work is focus on the study of decorporation of actinides (U(VI) and 
Am/Cm(III)) based on a series of polyaminophosphonated chelating agent to target deliver 
these agents to the organs which retain actinides, e.g. liver, kidneys, bones. In this project, two 
new bis-phosphonated ligands, L2 & L3, and a tetra-phosphonated ligand, L4, were synthesized 
easily and tested for the complexation affinities (Fig. 92). These ligands were used as the MRI 
contrasts or SPECT agents. By using pyridine group as the backbone, the nitrogen atom of 
pyridine group could be treating as an intermediate donor. A preliminary test on technetium 
complex with bis- and tetra-phosphonated ligands was done to reveal the bio-distribution to 
target organs, bone and kidneys, and fast excretion in hours. The bis-phosphonated ligands, L2 
& L3, could provide 2 oxygen atoms and 3 nitrogen atoms for the coordination of actinide ions, 
while the tetra-phosphonated ligand, L4, could provide 4 oxygen atoms and 3 nitrogen atoms. 
Thus the two types of ligands could satisfy the coordination of actinyl ion like UO2
2+, the tetra-
phosphonated pyridine ligand is more preferred to complex with actinide ion like Am/Cm(III).  
L2
L4
L3
 
Figure 92 : Chemical structures of bis-phosphonated ligand L2 & L3 and tetra-
phosphonated ligand L4 
Uranyl study:  
The insufficient uranium chelation therapy for decorporation prompted us to investigate 
the complex of uranyl and polyaminophosphonated chelating agents in pseudo-physiological 
medium.  
The studies with UV-Vis absorption spectrum, TRLFS and FT-IR identify the different 
structures of uranyl ligand complexes at at pH 3 & 7.4. The complexation site of uranyl ion in 
the bis- and tetra-phosphonated ligands consists two monodentate phosphonate groups, two 
amine parts and the pyridine group.  
The EAXFS spectrum obtained was adjusted with the help of DFT calculation. For pH 3, 
the environments of uranyl ion are consist by two oxygen atoms from monodentate phosphonate 
groups, one nitrogen atom from pyridine group and two nitrogen atoms from the amine parts 
for both ligand, L3 and L4. For pH 7.4, the environments of uranyl ion are consist by two oxygen 
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atoms from monodentate phosphonate groups, one hydroxide, one nitrogen atom from pyridine 
group and two nitrogen atoms from the amine parts for both ligand, L3 and L4. The only 
difference on the coordination of uranyl ion at two pHs is the presence of hydroxide at pH 7.4.  
Ligand complexation constants (Kconcd) are 17.08 for L2, 15.2 for L3 at pH 7.4 and in 13.3 
to 15.3 for L4 by displacement titration method developed by Dr. Frederic TARAN. The 
complexation constant of L2 is similar with 17 for 5-LICAMS and 16.87 for 3,4,3-LI(1,2-
HOPO) which are the most effective uranyl chelating agents. By combining the UV-Vis 
absorption spectrum and TRLFS, the strong stability of uranyl-L3 complex was confirmed with 
competition metal, Na+, Ca2+ and Mg2+, at pH 7.4 and with completion protein, Calmodulin, at 
pH 5.5.  
So the bis-phosphonated ligands have strong complexation affinities and good stability 
with uranyl ion at biological condition due to the well design of chelating agents.  
Europium as analogue of Am/Cm(III) study:  
Because of the high mass activity of Am/Cm(III), Eu(III) was used as chemical analogue 
to perform the studies. Due to the low solubility of Eu-L3 complex in 0.1M NaClO4, 
thermodynamic constant study failed.  
Similar combining the UV-Vis absorption spectrum and TRLFS study was done for Eu-L3 
complex and Eu-L4 complex at pH 3, 5 and 7.4. Due to the hydrogen bone on the amine parts, 
the Eu(III) ion is complexed with phosphonate groups of ligand at low pH, while at high pH 
the Eu(III) ion is located in the pocket part of ligand due the decrease of hydrogen concentration.  
The EAXFS spectrum obtained was adjusted by a linear contribution of water molecules 
and the function goups of ligand. For Eu-L3 complex at pH 3, the contribution of ligand is only 
from the phosphonate groups. 7 water molecules is present is europium first shell. For Eu-L4 
complex at pH 7.4, the fitting cannot be done which might due to the degradation of Eu-L4 
complex under the X-ray.  
Perspectives  
This project is the first step in the development of polyaminophosphonated pyridine 
chelating agents for decorporation of actinides. There are still many studies to investigate and 
characterize.  
• Formation constants of uranyl ion with L2, L3 and L4: the formation constant study 
could be done with potentiometric titration in 0.1M NaCl with Ar protection and without light; 
• Formation constants of other actinides with L2 and L3 in 0.1M NaClO4: the formation 
constants could be done with potentiometric titration in 0.1M NaClO4 with other actinides. The 
results could give an idea about the complexation affinity of europium with L2 and L3 due to 
the similarity of lanthanides; 
• Toxicity of polyaminophosphonated pyridine chelating agents;  
• The chelation therapy by polyaminophosphonated pyridine chelating agents to sequester 
actinides to prevent acute effect and long-term effect;   
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Figure 93: Chemical structures of bis-phosphonated pyridine ligand 
• The synthesize of a new bis-phosphonated pyridine ligand (Fig. 93) for uranium 
chelating agents by replace nitrogen of amine parts by oxygen: the presence of hydroxide of 
uranyl coordination at pH 7.4 may depend on the 3 nitrogen atoms which can be define as 
intermediate donor or soft donor. By using oxygen, 4 hard donors could be in the uranyl 
coordination, t he stability of uranyl with new ligand might be higher.  
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Appendix I: materials 
 Experiment conditions  
Solvents and starting materials were purchased from Aldrich, Acros and Alfa Aesar and 
used without further purification unless specified. IR UV-VIS TRLFS  
1H, 13C, 31P NMR spectra were recorded on Avance 300, Avance 400 and Avance 500 III 
HD spectrometers operating at 300, 400 and 500 MHz respectively. Chemical shifts are 
reported in ppm, with residual protonated solvents as internal reference.115 The multiplicity are 
given as followed: s = singulet, d = doublet, t = triplet, q = quadruplet, qt = quintuplet, m = 
multiplet 
Elemental analyses and mass spectrometry analyses were carried out by the Service 
Commun d’Analyses of the University of Strasbourg or by the Laboratoire de Spectrométrie de 
Masse BioOrganique (LSMBO, IPHC) or by the Plateforme Analytique of the Laboratoire de 
Reconnaissance et Procédés de Séparation Moléculaire (RePSeM, IPHC). Elemental analysis 
and monoisotopic masses were calculated with the chemcalc software.246 Purifications were 
made on a SPOT II Interchim Flash Purification Liquid Chromatography. Distilled water was 
purified by ultra-pure MilliQ water.  
UV-visible spectrophotometric analyzes were performed on an Agilent Technologies Cary 
60 UV-vis apparatus equipped with a deuterium lamp and a tungsten lamp. The measurements 
were carried out in scanning mode from 200 to 800 nm (scanning speed of 3.3 nm / s). 
Time-resolved laser-induced fluorescence spectroscopy (TRLFS) experiments were 
carried out by using a continuum R Nd:YAG laser (frequency=10 Hz, pulse duration%7ns) 
coupled with a Panther OPO as the excitation source. Detection was perfumed by aSpectra-Pro-
300 monochromator (Acton Research Corporation) coupled with a CCD camera (Princeton 
Instruments). The excitation wavelength was chosen to be l=430 nm, and the laser power was 
about 2mJ. The emission spectra were recorded by using the WINSPEC/32 software (Princeton 
Instruments). The fluorescence spectra had a resolution better than 0.2 nm. The error in the 
fluorescence intensity was less than 5%.All fluorescence intensity measurements were carried 
out on non-aerated freshly prepared solutions in aquartz cell at acontrolled temperature of (20 
± 1) °C. Every measurement was repeated at least three times. The fluorescence spectra 
integration (λ=450–600 nm) and the fluorescence decay curves were calculated with the Origin 
2016 software program (OriginLab corporation). 
The infrared analyzes were carried out in attenuated total reflection mode ATR using a 
reflection diamond 1 coupled to a Bruker tensor spectrometer 27 equipped with a MCT detector 
cooled with liquid nitrogen. The measurements were carried out in scanning mode from 4000 
to 600 cm-1 (scanning speed of 10 kHz). 
 Preparation of stock solutions 
All aqueous solutions are prepared from ultra-pure MilliQ water (18 MΩ.cm-1). 
• Stock solution of uranium(VI)  
A commercial solution of uranium (1000 ppm, Inorganic Venture) was used for the 
preparation of samples analyzed by TRLFS and EXAFS. 
A solution of uranium chloride (0.05M) was used for ATR-IR and EXAFS. 
• Stock solution of europium(III)  
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The stock solution of EuCl3 for potentiometry was prepared by dissolving 0.7233 mg of 
EuCl3∙ H2O in 20 mL H2O. Final concentration is 4.7×10
-2 M. 
The stock solution of EuCl3 0.05M for EXAFS and ATR-IR was prepared by dissolving 
3.6641 mg of EuCl3∙ 6H2O in 20 mL H2O.  
A commercial solution of europium (1000 ppm, Inorganic Venture) was used for the 
preparation of samples analyzed by TRLFS. 
• Stock solution of L2 
The stock solution of L2 for potentiometry was prepared by dissolving 22.83 mg of 
synthesized ligand in 50 mL of 0.1M NaClO4 solution. Final concentration is 8.63×10-4 M. 
The 5 mM L2 stock solution of was prepared by dissolving 26.451 mg of L2 in 20 mL H2O 
• Stock solution of L3 
The stock solution of L3 for potentiometry was prepared by dissolving 25.30 mg of 
synthesized ligand in 50 mL of 0.1M NaClO4 solution. Final concentration is 8.17×10-4 M.  
The 5 mM L3 stock solution was prepared by dissolving 30.973 mg of L3 in 10 mL H2O 
• Stock solution of L4 
The stock solution of L4 for potentiometry was prepared by dissolving 25.30 mg of 
synthesized ligand in 50 mL of 0.1M NaClO4 solution. Final concentration is 8.17×10-4 M.  
The 5 mM L4 stock solution was prepared by dissolving 31.4485 mg of L4 in 10 mL H2O 
• Calmoduline 
Commercial calmodulin (Sigma Aldrich) was used for the preparation solutions analyzed 
by ITC. This protein is dissolved in a solution of HEPES at physiological pH at the desired 
concentration before use.  
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Appendix II : Experimental methods 
1 Potentiometry 
1.1 Preparation of solutions  
All solutions were prepared with deionized water. The latter has been prepared from osmosis 
water which has been filtered and purified by means of anionic and cationic ion exchange columns 
(Fisher Bioblock Scientific type R3-83002 and M3-83006) and activated carbon columns (Fisher 
Bioblock Scientific type ORC-83005). The water was then boiled, and then degassed by a stream of 
argon that passes beforehand through a cartridge (Sigma, Oxiclear) to remove any trace of oxygen. 
The solutions were prepared by weighing the samples using an analytical balance (Mettler Toledo 
AG-245). The ionic strength was set at 0.1 M using sodium perchlorate (Merck, p.a., NaClO4) and 
all measurements were made under standard temperature conditions (25.0 °C).  
1.2 Potentiometric titrations 
Potentiometric titrations of ligand L2 (8.63×10-4 M) and L3 (8.17×10-4 M) were made at using a 
Metrohm Basic Titrino 794 automatic titrator (Metrohm 2.794.0010) equipped with a combined glass 
microelectrode (Metrohm 6.0234.100, Long Life) and a 1 mL interchangeable unit (Metrohm 
6.3026.110). The absolute error on the volume of the cylinder is 3μL compared to the nominal volume 
of 1 mL. Potentiometric titrations were carried out using the MET-PH method (Monotone, Equivalent 
Point) available in the Tiamo light 1.2 software (Metrohm AG Ltd, Herisau, Switzerland) with the 
following characteristics: increment 3 μL, maximum flow of the burette 2 mL / min, maximum signal 
drift 1.5 mV / min and minimum equilibrium time 500 s. To calibrate the electrode, titrate a solution 
of perchloric acid (1.3-1.89× 10-2 M, Fluka, 70%, HClO4) with sodium hydroxide solution (1.1 -
1.28×10-1 M, BdH, AnalaR, NaOH) was carried out in a thermostated titration cell at 25.0 (2) °C 
(Lauda E200) under a constant argon flow, previously saturated with water vapor. 
The titration of the perchloric acid solutions has been previously determined by titration 
colorimetric with a solution of sodium tetraborate (Fluka, puris p.a> 99.5%, B4Na2O7.10H2O) in the 
presence of methyl red (RAL reagents). The sodium hydroxide solutions (BdH, AnalaR, NaOH) were 
titrated with potassium hydrogenophthalate (Fluka, puriss, p.a., C8H5KO4) in the presence of 
phenolphthalein. The Europium stock solution concentration was determined by complexometric 
titration with Titriplex III (Merck) in the presence of xylene orang. The GLEE247 program then made 
it possible to obtain the electrode calibration parameters (standard electrode potential E0/mV and 
slope of the electrode mV.pH-1) and to check the carbonate levels of the sodium hydroxide solutions 
used (always <5%). Potentiometric titrations (~ 300 points collected over a pH range between 2.5 and 
11.5) of the free ligands L2, L3 (Vtot = 10 mL, inert argon atmosphere, T = 25 °C. ) were treated by 
the program Hyperquad 2000.248,249 This program is based on methods of Non-Linear Least Squares 
Adjustment.250 For ligands L2, L3 at least three potentiometric titrations were processed, either 
separately or commonly, without any significant variation in the determined values. The distribution 
curves of the protonated species and metal complexes were calculated using the Hyss2009 program. 
The potentiometric titration of the Eu- L3 complex is carried out under the same experimental 
conditions (pH 2.5 to 11) as the free ligand, but this time in the presence of about one equivalent of 
Eu (III) ([L3] tot = [Eu] tot = 1.02×10-4 M, pH = (1) 2.49, (2) 11). Due to the precipitation of Eu- L3 
complex at acidic condition, it is not possible to measure the formation constants by UV-visible 
spectrophotometry according to pH.  
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2 UV-visible spectrophotometry 
UV/Vis spectroscopy is routinely used in analytical chemistry for the quantitative determination 
of different analytes, such as transition metal ions, highly conjugated organic compounds, and 
biological macromolecules. Spectroscopic analysis is commonly carried out in solutions but solids 
and gases may also be studied. 
Organic compounds, especially those with a high degree of conjugation, also absorb light in the 
UV or visible regions of the electromagnetic spectrum. The solvents for these determinations are 
often water for water-soluble compounds, or ethanol for organic-soluble compounds. (Organic 
solvents may have significant UV absorption; not all solvents are suitable for use in UV spectroscopy. 
Ethanol absorbs very weakly at most wavelengths.) Solvent polarity and pH can affect the absorption 
spectrum of an organic compound. Tyrosine, for example, increases in absorption maxima and molar 
extinction coefficient when pH increases from 6 to 13 or when solvent polarity decreases. 
2.1 Titration for free ligand L3 species 
The spectrophotometric titration according to the pH was performed in order to characterize the 
protonated species of the free ligand L3 and europium complex. A volume of 40 mL of a solution of 
free ligand L3 (1.02×10-4 M) was added to a titration vessel (Metrohm, 6.1414.150) maintained at 
25.0 (2) °C using a thermostat (Lauda E200) under a constant stream of argon, previously saturated 
with water vapor. After fixing the initial value of the pH at ~ 2.5 by addition of perchloric acid, the 
titration (pH 2.5 to 11) was carried out by adding known volumes of sodium hydroxide (0.1 M, NaOH, 
BdH, AnalaR) using a Metrohm Basic Titrino 794. After each base addition, an absorption spectrum 
(200 nm - 800 nm) was recorded automatically using a Cary 60 (Varian) spectrophotometer which 
equipped with a pulsed arc Xenon lamp. An optical fiber system (Hellma, 041.002-UV) connected to 
a Suprasil quartz immersion probe with a 10 mm optical path (Hellma, 661.500-QX) allowed in situ 
measurements. The processing of the data is with HypSpec.180,181 
2.2 Displacement titration of uranyl-ligand complex  
UV-visible spectrophotometric analyzes were performed on an Agilent Technologies Cary 60 
UV-vis apparatus equipped with a deuterium lamp and a tungsten lamp. The measurements were 
carried out in scanning mode from 200 to 800 nm (scanning speed of 3.3 nm / s). 
2.2.1 The solutions  
0.0125 M buffers were prepared by dissolving the acid form of buffer 12.5 mmol (MES for pH 
= 5.5, HEPES for pH = 7.4 and CHESS for pH = 9.0) and 112.5 mmol of n-Bu4Cl in 1L of Millipore 
water. The pH was adjusted to the pH meter by addition of nBu4N
+OH-- 30H2O.  
100μM SCP Solution: 6.25 mL of 4 mM SCP stock solution were mixed in 243.75 mL of 
appropriate buffer.  
SCP-UO2
2+ solution at 100 μM: 6.25 mL of stock solution of SCP at 4 mM were mixed in 242.55 
mL of water and 1.2 mL of uranyl stock solution (20mM) were added. Both stock solutions were 
stored for 1h before use. The ligand solutions were prepared by diluting the stock solutions of 2 mM 
ligands with water to obtain a final concentration of 400 μM. 
2.2.2 Procedure for the fast screening 
In each 1 mL centrifuge tube, 100 μl of SCP-UO2 solution (40μM) in HEPES buffer have been 
added, 16 μl of each ligand solution (5 mM) were added. The tubes were stored without light at room 
temperature for 36 hours for equilibration. The samples were read by Cary 60 UV-vis apparatus. 
Measurements were made at 690 nm for pH = 7.4.  
2.2.3 Procedure for the titration 
In each 1 mL centrifuge tube, 100 μl of SCP-UO2 solution (40μM) in HEPES buffer have been 
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added, different volume of each ligand solution (5 mM) were added to reach 0 to 10 eq of ligand 
concentration. Samples of SCP solution, SCP-UO2 solution and ligand solution at the same 
concentration are also prepared as reference.  The tubes were stored without light at room temperature 
for 36 hours for equilibration. The samples were read by Cary 60 UV-vis apparatus. Measurements 
were made at 690 nm for pH = 7.4 or 640 nm. 
Using the Hyss speciation program, we calculated the complexation conditional constants 
assuming that the complex formed L (tested) -uranyl has the stoichiometry 1: 1 in our experimental 
conditions. 
3 Time-resolved laser fluorescence spectroscopy 
(TRLFS) 
TRLFS is a widely used technique for the analysis of lanthanides and fluorescent actinides. It has 
several advantages such as speed of analysis, sensitivity (very low detection limit for uranium and 
europium, of the order of one μM) and selectivity (each fluorescent element is characterized by its 
absorption spectrum, its fluorescence spectrum and the life time of one of its emitting levels). 
3.1 Principle  
Luminescence is the emission of a radiation in response to absorption of energy induced by 
excitation. Many types of luminescence exist and are distinguished by the nature of excitation and 
radiative emission. Fluorescence is a form of luminescence defined by "the emission of 
electromagnetic radiation under the exposure of a radiation of the same type having either the same 
energy (resonance) or a higher energy". In the case of An or Ln, the characteristic times of the 
emissions are of the order of one microsecond or greater. Phosphorescence is a longer process than 
fluorescence that occurs after energy transfer to a higher spin state (triplet state). 
Fluorescence and phosphorescence are radiative relaxation processes which take place during the 
transition of the electrons from the lowest vibrational level of the excited electronic state in which 
they are to the different vibrational levels of the ground state (Fig. 94). The electronic states giving 
rise to these processes are called sending levels.  
Fluorescence corresponds to transitions between states of the same spin, its time scale is between 
10-12 and 10-6 s. Phosphorescence is slower (typically from millisecond to second) because it involves 
a spin change. In the case of the An and Ln, the radiation emission is accompanied by a spin change 
as is the case for phosphorescence, however, the life time is lower than the life time characteristic of 
phosphorescence. The term luminescence seems more appropriate for the f elements; nevertheless, it 
is the term fluorescence which is commonly used. 
 
Figure 94 : Perrin–Jablonski diagram251 
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3.2 Luminescence property of europium 
The emission bands corresponding to the f-f transitions of Eu (III) are narrow and of relatively 
low intensity. The ground state of Eu (III) is 7F0. The free ion is spherical symmetry, when in solution. 
It undergoes a lowering of the symmetry under the influence of the ligand field (crystalline field) 
which induces a degeneration lift of the spectroscopic levels (Figure 95). 
 
Figure 95 : Energy diagram and degeneracy lift for an Ln3+ ion 
 
Figure 96 : Partial energy diagram of Eu3+ (4f6) showing the relative magnitude of the 
interelectronic repulsion (terms), spin–orbit coupling (levels) and crystal-field effects 
(sublevels). The downward arrows indicate the excited states 5D0 and 5D1 from which 
luminescence occurs.252 
4f orbitals of lanthanides are generally insensitive to disturbance generated by a ligand field; 
however, some transitions (hypersensitive) show great variation in intensity depending on the 
environment of europium. The energy levels of the Eu3+ ion in solution as well as the wavelengths of 
transitions between these same levels are shown in Figure 96 & 97. 
The transition 5D0→7F2 (616 nm) is one of those hypersensitive transitions to the environment 
just like the 5D0→7F4 (698 nm) transition but to a degree less. The transition 5D0→7F0 (579 nm) is 
prohibited by the selectivity rules. Therefore it has an extremely low intensity. 
In this study, the europium ion was excited at 390nm. 
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Figure 97 : Energy levels of the aqueous Eu ion (III) and associated transitions 
3.3 Luminescence properties of uranium 
Like europium, uranium has fluorescence properties. His energetic transitions are shown in Fig 
4.4. The lifetime of uranium in solution (typically 2μs) is highly variable and depends both on 
temperature (a difference of 5 degrees can vary the life time of 0.5μs) but also the ionic strength and 
the nature of the background salt. Being subjected to hydrolysis (very low pH, several life times can 
be measured even if uranyl is alone in solution, the life times of hydrolyzed species of uranyl vary 
widely as well. 
 
Figure 98 : Fluorescence emission of uranyl 
The particular aspect of the fluorescence spectrum of uranyl is explained by the fact that each 
level of energy (including the ground state) is subdivided into several vibrational levels. The spectrum 
obtained during the fluorescence emission that accompanies the return to the ground state reflects the 
vibrational structure of the ground state of uranium that can be observed in figure 98. 
In this study, the uranyl ion was excited at 430nm. 
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3.4 Instrumentation 
TRLFS experiments were conducted using a laser excitation source Nd:YAG (7ns pulse at a 
frequency of 10 Hz with energy of 2 mJ) of the company Continuum coupled to an Optical Parametric 
Oscillator (OPO, Panther, Continuum). Detection is performed using a Spectra-Pro-300 
monochromator (Acton Research Corporation) coupled to a CCD camera (Princeton Instruments). 
The beam passes through a quartz cuvette containing the solution to be analyzed before reaching the 
detector. A lens and mirror system focuses the fluorescence beam onto the input slot of the 
spectrophotometer that selects the wavelength range to be observed. The CCD camera makes it 
possible to adjust the various measurement parameters for the resolution in time: the delay, the gate 
width, the integration time and the number of spectra. Spectra are recorded using WINSPEC software 
(Princeton Instruments).  
The excitation wavelength chosen for the measurement of uranium is 430nm and 395 nm for the 
measurement of europium samples.  
The error on the intensity of the fluorescence is less than 5% and the resolution greater than 0.2 
nm. 
3.5 Samples 
All fluorescent intensity measurements were conducted on samples non-aerated and freshly 
prepared at an ambient temperature of 25 ± 2 ° C. The pH of the solutions was adjusted using a 
microelectrode (semimicro, Mettler Toledo, France) and a pH meter (seven multi, Mettler Toledo, 
France). Samples containing uranyl were prepared at a concentration of 5 x 10-5M ligand and a uranyl 
concentration from 0 to 5 x 10-5M at fixed pH. The pH and ligand concentration are constant for the 
duration of the experiment and metal concentration is the only variable. MES buffer (5 mM) was only 
used for the preparation of uranyl-CaM solutions at pH 5.5. The pH is adjusted using NaOH and 
HClO4 (Sigma). The europium solutions are prepared for a concentration in 5 x 10
-5 M ligand and a 
europium concentration from 0 to 5 x 10-5 M. As with the uranyl experiment, the pH and ligand 
concentration are constant for the duration of the experiment and metal concentration is the only 
variable. The pH is adjusted using NaOH and HClO4 (Sigma). 
4 ATR-IR Spectroscopy 
Infrared spectroscopy is a means of diagnosis allowing determine the nature of the chemical 
bonds present in a molecule. Indeed, experience shows that certain vibration frequencies, called 
"group frequencies" are characteristic of the presence of a chemical group in the molecule studied.  
4.1 Principle  
Infrared spectroscopy uses the ability of molecules to stretch or deform specific frequencies that 
correspond to discrete energy levels (vibratory or rotational modes (Fig. 99)). The electromagnetic 
field induced by the infrared radiation can interact with a dipole moment of a molecular entity present 
in the material. When the field frequency coincides with the vibration frequency of a specific mode 
of the molecule, the interaction created causes the vibration of certain bonds and the absorption of 
the energy of the corresponding excitatory wave. The frequency with which the radiation is absorbed 
depends on the nature of the bonds, the mass of atoms involved and the environment close to the 
group considered. 
For a molecule to have an infrared spectrum, it must have a specific characteristic: a dipolar 
electric moment must change during the analysis. A heteronuclear diatomic molecule is therefore 
active with respect to infrared spectroscopy because its dipole moment of such a molecule changes 
when the bond extends or contracts. This is not the case for a homonuclear diatomic molecule because 
its dipole moment remains unchanged. 
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Figure 99 : Energy levels for a molecule. 
For more complex molecules, there are two modes of vibration: stretching or elongations 
(symmetrical, antisymmetric) and deformations (rotation, shear, torsion ...). Stretches are present in 
the region of the spectrum ranging from 4000 to 1000 cm-1 and are generally of high intensity. The 
deformation vibrations are of lower intensity and are located in the 1000-600 cm-1 region of the 
spectrum and constitute the fingerprint of the molecule. The infrared spectrum of a sample is 
established by passing a beam of infrared light through this sample. Examination of the transmitted 
light indicates the amount of energy absorbed at each wave number. 
4.2 General  
The infrared analyzes were performed in attenuated total reflection mode (ATR) using a 
reflection diamond coupled to a Bruker tensor spectrometer 27 which equipped with a liquid nitrogen 
cooled MCT detector. The analysis was carried out in scanning mode from 4000 to 600 cm-1 (scanning 
speed of 10 kHz). 
4.3 IR measurements of the uranyl-L3 complex 
The equal equivalence uranyl-L3 solutions (~2 mM) was prepared by increasing pH to 10 with 
sodium hydroxide (1 M) to solubilize the precipitation which present at acidic condition after mix the 
uranyl stock solution and L3 stock solution, then hydrochloride acid (0.1 M) and sodium hydroxide 
(0.1 M) were used to reach pH 3 and 7.4. 
The infrared spectra of uranyl-L3 solutions (~2 mM) and L3 solution (5 mM) at two pH were 
recorded on a reflection ATR diamond between 4000 and 600 cm-1 while a wet film was formed 
(resolution 2 cm-1, 64 sweeps per spectrum, scanning speed 10 kHz). 
4.4 IR measurements of the uranyl-L4 complex 
The equal equivalence uranyl-L4 solutions (~2 mM) was prepared by increasing pH to 10 with 
sodium hydroxide (1 M) to solubilize the precipitation which present at acidic condition after mix the 
uranyl stock solution and L4 stock solution, then hydrochloride acid (0.1 M) and sodium hydroxide 
(0.1 M) were used to reach pH 3 and 7.4. 
The infrared spectra of uranyl-L4 solutions (~2 mM) and L4 solution (5 mM) at two pH were 
recorded on a reflection ATR diamond between 4000 and 600 cm-1 while a wet film was formed 
(resolution 2 cm-1, 64 sweeps per spectrum, scanning speed 10 kHz). 
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4.5 IR measurements of the Eu-ligand complex 
The equal equivalence Eu-L3 solutions (~2 mM) was prepared by mixing the europium stock 
solution and L3 stock solution, then hydrochloride acid (0.1 M) and sodium hydroxide (0.1 M) were 
used to reach pH 3. 
The equal equivalence Eu-L4 solutions (~2 mM) was prepared by mixing the europium stock 
solution and L3 stock solution, then hydrochloride acid (0.1 M) and sodium hydroxide (0.1 M) were 
used to reach pH 7.4. 
The infrared spectra of the Eu-ligand complex solutions (~2 mM) at two pH were recorded on a 
reflection ATR diamond between 4000 and 600 cm-1 while a wet film was formed (resolution 2 cm-
1, 64 sweeps per spectrum, scanning speed 10 kHz). 
5 Functional Theory of Density (DFT) 
The foundations of density functional theory (DFT) have been laid in 1927 by Thomas and Fermi 
who calculated the energy of an atom by representing its kinetic energy as a function of the electron 
density. In this model, the n electrons dependent on 3n space coordinates are replaced by their density 
𝜌(𝑟) which depends only on three variables. The fundamental state of this system is described by the 
wave function ψo(𝑟1⃑⃑⃑⃑⃑, 𝑟1⃑⃑⃑⃑⃑,⋅⋅⋅ 𝑟𝑛⃑⃑⃑⃑⃑) which corresponds to a unique electronic density 𝜌0(?⃑⃑?). This wave 
function, and the energy E0 associated with it, are determined by the minimizing the total energy of 
the system. The external potential ?̂?ext(?⃑⃑?) created by the N nuclei of the system is then completely 
determined and thus fixes the Hamiltonian. Therefore, the number of electron n and the potential 
?̂?ext(?⃑⃑?), define all properties of the ground state. The energy of the ground state can be defined as a 
functional of 𝜌0(?⃑⃑?), which then makes it possible to determine all the properties of the ground state 
of the studied molecule. 
Theoretical calculations performed during this thesis (Calculations done by Jérôme Roques) aim 
to minimize the total energy of the "metal ion-ligand" model created in order to determine which 
models are the most energy stable and therefore most likely to form in solution. All structures have 
been optimized using the DFT approach implemented in Gaussian 09. The calculations were 
performed using the hybrid functional B3LYP. The MWB60 Stuttgart (MWP60) have been used to 
describe the uranium and neptunium atoms, MWB2 for oxygen, nitrogen and carbon, and the 6-31G 
database for the atom. hydrogen. In order to take into account the effects of the solvent, solvation was 
taken into account using a dielectric continuum model for the permittivity (ε0 = 80). The Polarizable 
Continuum Model (CPCM) has also been implemented in Gaussian 09. 
6 EXAFS Spectroscopy 
The EXAFS measurements presented in this work were carried out at the synchrotron of 
“Optimized Light Source of Intermediate Energy to LURE* (SOLEIL) in Saclay on the MARS line; 
As the samples are diluted (around the mM), the EXAFS signal comes from a fluorescence 
measurement. The MARS line is equipped with a high-purity 13-element germanium detector, a 
water-cooled Si (111) monochromator and two Pt-coated mirrors for harmonic filtering. EXAFS 
measurements were made at threshold LIII of uranium and europium. The data processing was done 
using the ATHENA software, and the Fourier transforms were applied via the Hanning windows 
using the ARTHEMIS software. 
6.1 The uranyl-L3 complex sample for EXAFS measurements 
The uranyl/L3 1/1.2 solutions was prepared by increasing pH to 10 with sodium hydroxide (1 M) 
to solubilize the precipitation which present at acidic condition after mix the uranyl stock solution 
and L3 stock solution, then hydrochloride acid (0.1 M) and sodium hydroxide (0.1 M) were used to 
reach pH 3 and 7.4. 
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6.2 The uranyl-L4 complex sample for EXAFS measurements 
The uranyl/L4 1/1.2 solutions (~2 mM) was prepared by increasing pH to 10 with sodium 
hydroxide (1 M) to solubilize the precipitation which present at acidic condition after mix the uranyl 
stock solution and L4 stock solution, then hydrochloride acid (0.1 M) and sodium hydroxide (0.1 M) 
were used to reach pH 3 and 7.4. 
6.3 The Eu-ligand complex sample for EXAFS measurements 
The equal equivalence Eu-L3 solutions (~2 mM) was prepared by mixing the europium stock 
solution and L3 stock solution, then hydrochloride acid (0.1 M) and sodium hydroxide (0.1 M) were 
used to reach pH 3. 
The equal equivalence Eu-L3 solutions (~2 mM) was prepared by mixing the europium stock 
solution and L3 stock solution, then hydrochloride acid (0.1 M) and sodium hydroxide (0.1 M) were 
used to reach pH 2.6. 
The equal equivalence Eu-L4 solutions (~2 mM) was prepared by mixing the europium stock 
solution and L3 stock solution, then hydrochloride acid (0.1 M) and sodium hydroxide (0.1 M) were 
used to reach pH 7.4. 
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Appendix III: Thermodynamic data 
 
The formation constants which used in this study for species calculation and stability calculation 
are in the table 30. 
formula log of formation constant formula log of formation constant 
(UO2)(OH) -5,2 HSCP 13,3 
(UO2)(OH)2 -10,3 H2SCP 23,4 
(UO2)(OH)3 -19,2 H3SCP 31,13 
(UO2)(OH)4 -33 H4SCP 37,68 
(UO2)2OH -2,7 HL2 9,5 
(UO2)2(OH)2 -5,6 H2L2 18,65 
(UO2)3(OH)4 -11,9 H3L2 24,82 
(UO2)3(OH)5 -15,6 H4L2 29,45 
(UO2)3(OH)7 -31 HL3 9,28 
(UO2)4(OH)7 -21,9 H2L3 18,19 
UO2Ca3CaM 18.81 H3L3 24,55 
UO2Ca3CaMOH 13.91 H4L3 29 
CaCaM 4,89 HL4 11,21 
Ca2CaM 9,32 H2L4 21,5 
Ca3CaM 12,81 H3L4 29,54 
Ca4CaM 16,31 H4L4 36,03 
EuL4 25,7 H5L4 41,56 
HEuL4 35,1 H6L4 45,76 
H2EuL4 42,6   
Table 30 : Formation constant which used in this study 
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 Résumé 
1 Introduction générale 
Lors de l’utilisation militaire et industrielle de l'uranium enrichi au milieu du XXe siècle, les 
propriétés de l'uranium, du plutonium et de la plupart des produits de fission n'ont pas été bien 
étudiées. Un grand nombre de matières radioactives produites au cours de cette période peuvent être 
considérées comme équivalentes à des tonnes de radium. Ainsi, avec le développement de l'industrie 
nucléaire, notamment les accidents industriels (Mayak, Tchernobyl, Fukushima), la manipulation et 
l'accumulation des actinides conduisent à considérer la dispersion, le devenir et les effets sanitaires 
de ces matières radioactives. 
Pour ce projet, nous nous concentrons sur les ligands de chélation de synthèse pour l'uranium et 
l'américium/curium en utilisant l'europium comme analogue chimique.   
La décorporation est la méthode dédiée à l'élimination des éléments radioactifs et toxiques qui 
ont été incorporés dans les organes cibles du corps humain. Les principaux traitements utilisés dans 
les thérapies de décorporation ont été énumérés dans le tableau 1 concernant la contamination par les 
actinides. Cependant, en réalité, cette stratégie se heurte à de nombreux obstacles : souvent difficiles 
à transférer à l'organe cible, difficiles à retirer des éléments radioactifs et toxiques déposés dans 
l'organe cible, liés à la complexité d'un organisme vivant. En pratique, un très bon ligand in vitro peut 
être totalement inefficace, et parfois même nocif, dans les évaluations in vivo. 
Type d'incorporation  Traitement 
Inhalation 
Lavage pulmonaire 
Chélation sanguine (iv, ip, im) 
Ingestion 
Pansement gastrique 
Purge de précipitation 
Blessé 
Lavage Excision chirurgicale, 
Pansement Chélation sanguine (iv, ip, im) 
Tableau 1：Principaux traitements utilisés dans les traitements de décorporation selon le type 
d'incorporation. iv, intraveineux ; ip, intrapéritonéal ; im, intramusculaire. 
 
Ainsi, pour mieux comprendre et étudier les méthodes efficaces d'élimination des actinides 
déposés dans le corps humain, trois aspects fondamentaux liés à cette question doivent être étudiés : 
les propriétés chimiques et physiques des actinides (uranium et américium/curium dans cette étude) ; 
la toxicologie des actinides (uranium et américium/curium dans cette étude) ; les contre-mesures après 
contamination (chélation thérapeutique dans cette étude).  
Les éléments actinides sont les 15 éléments chimiques de numéros atomiques 89 à 103 qui sont 
des éléments métalliques naturels ou artificiels. Le premier de ces éléments actinides est l'actinium et 
le dernier  le lawrencium. La production de ces radionucléides provient principalement des 
accélérateurs, de la nucléosynthèse, de la mise au point d'armes nucléaires, de la désintégration des 
isotopes et des centrales nucléaires civiles. Les propriétés chimiques des éléments actinides sont 
régies par leurs sous-couches électroniques les plus externes. Les actinides sont les éléments de 
transition qui remplissent la sous-couche 5f. Il existe donc des propriétés uniques pour l'actinide :  
- Tous les isotopes d'actinides sont radioactifs ; 
- Les rayons des actinides et des cations actinides sont les plus grands ;  
- Plusieurs des éléments actinides ont un grand nombre d'états d'oxydation. 
Du point de vue biologique, les actinides sont en fait les éléments chimiques qui n'ont aucun effet 
essentiel ou bénéfique sur la vie. En raison de leur radioactivité (radiotoxique) et de leur 
comportement chimique (chimio-toxique), les actinides sont considérés comme toxiques. Cependant, 
à des niveaux environnementaux normaux, cette toxicité pourrait être gérée par le corps humain lui-
même, par excrétion et/ou rétention du métal sous une forme biochimiquement inactive. Mais les 
essais d'armes nucléaires et l'exploitation industrielle des actinides avec des actinides, principalement 
 
142 
 
l'uranium et le plutonium, soulèvent des questions sociétales et environnementales en raison du risque 
de pollution et de contamination humaine. Par conséquent, la nécessité de comprendre les 
comportements des actinides chez l'homme est essentielle pour élucider leurs mécanismes de toxicité. 
Dans ce cas, la demande d'agents thérapeutiques chélateurs de l'actinide est également urgente.  
Selon ces modes de contamination, la voie biologique des actinides sera différente. Il existe 
quatre voies d'entrée principales et quatre voies d'excrétion des actinides dans l'organisme. 
Principales voies d'entrée : inhalation, ingestion, blessure et peau. 
Principales voies d'excrétion : expiration, excrétion d'excréments, excrétion d'urine et 
transpiration. 
Après une contamination externe ou interne, les actinides solubilisés pourraient être distribués 
aux organes cibles par la circulation sanguine. L'uranium, qui est sous forme de [UO2]
2+ et 
l'américium/curium, qui sont sous forme d'Am3+ et de Cm3+, sont transférés de préférence aux tissus 
du squelette, du foie et des reins et sont retenus à ces organes cibles. En raison de la chimio-toxicité 
et de la radiotoxicité de ces éléments, l'effet aigu sur la santé pourrait causer la mort et l'effet à long 
terme pourrait entraîner cancer, anémie et nécrose. 
Afin de limiter les dommages séquentiels aux organes en favorisant l'excrétion des actinides, des 
agents chélatants ont été utilisés à cette fin. L'acide diéthylènetriaminepentaacétique (DTPA) présente 
une affinité particulière pour les actinides(IV), et il est actuellement utilisé en clinique en cas de 
contamination. Les polyphosphonates (HEDP) sont également utilisés dans les cliniques pour la 
décorporation de l'uranium(VI). Le 3,4,3-Li(1,2-HOPO), dérivé du sidérophore, a montré de fortes 
affinités pour les actinides (III), (IV), (V) et (VI). Avec le développement des agents chélatants, 
plusieurs propriétés de ceux-ci mettent en évidence une forte affinité et sélectivité envers les actinides, 
une faible toxicité, un taux d'excrétion élevé.  
Les agents de décorporation sont toxiques en raison de la nature du ligand et de la grande quantité 
injectée pour le traitement par chélation dans un milieu biologique. Les éléments essentiels tels que 
le fer et le calcium sont également chélatés tout comme les actinides compte tenu de la concentration 
des éléments essentiels. Par conséquent, la conception de ces édifices moléculaires est nécessaire et 
concerne plusieurs aspects importants: 1) distribuer les agents chélatants aux organes cibles ; 2) 
excréter le complexe de l'élément toxique cible avec les agents chélatants par l'urine ou la bile ; 3) 
haute sélectivité et affinité de liaison avec l'élément toxique cible sur l'autre ion métallique pour 
diminuer la quantité totale des agents chélatants qui ont été injectés. Les ligands 
polyaminophosphonates de cette étude ont été initialement conçus pour l'imagerie par résonance 
magnétique (IRM) et la tomographie par émission monophotonique (TEMP).  D'après l'étude SPECT 
sur le complexe de ligands 99mTc, une grande quantité de 99mTc avec quatre groupes de ligands 
phosphonés pourrait être rapidement excrétée et une partie du complexe s'accumule dans les tissus 
osseux après 4 h. Alors que pour le 99mTc  avec deux groupes de ligands phosphonés, grâce au 
caractère plus lipophile, on trouvait une excrétion rapide et une rétention beaucoup moins importante 
dans les articulations. Les lanthanides pourraient former une liaison étroite avec quatre ligands de 
groupes phosphonates ayant des constantes de haute stabilité similaires à celles du DOTP, l'analogue 
phosphoné du DOTA. La coordination des lanthanides par le ligand des quatre groupes phosphonates 
est composée de 1’atome d'azote du groupe pyridine, 2 atomes d'azote des groupes amine, 4 atomes 
d'oxygène des groupes phosphonates et 1 atome d'oxygène des molécules d'eau. De plus, deux des 
groupes méthylène-phosphonate se trouvent près de ce plan du fragment pyridyle et forment une 
coordination au plan équatorial, les deux autres groupes méthylène-phosphonate sont placés au-
dessus et au-dessous du plan moyen du fragment pyridyle. En raison de la similitude du complexe de 
ligands actinides avec le complexe de ligands 99mTc et le complexe de ligands lanthanides, nous avons 
supposé que la bio-distribution et l'excrétion possible de quatre groupes phosphonates ligands et deux 
groupes phosphonates ligands auraient des comportements similaires avec le complexe du 99mTc avec 
les ligands. Grâce à cette structure moléculaire, une sélectivité et une affinité élevées avec les 
actinides pourraient être atteintes. Par conséquent, l'application potentielle au traitement par chélation 
devrait être prometteuse.  
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Ce projet de thèse est une étude préliminaire sur les ligands polyaminophosphonates, une série 
de ligands conçus pour les agents de contraste IRM et SPECT, pour chélater les actinides qui se 
déposent dans les organes cibles afin d'augmenter leur excrétion.  
Ce travail de doctorat s'est concentré sur la synthèse de ligands polyaminophosphonates et sur 
l'étude de la structure et de l'affinité de la forme complexe avec l'uranium(VI) et l'europium(III) 
comme analogue de l'américium/curium(III). La sphère de coordination de ces cations a été observée 
par spectroscopie UV-visible, TRLFS, FT-IR et EXAFS (Extended X-Ray Absorption Fine 
Structure). L'étude d'affinité a été réalisée par spectroscopie UV-visible et dans le cas des complexes 
europium, une mesure potentiométrique a été également réalisée. Enfin, la spectroscopie UV-visible 
et le TRLFS ont été utilisées pour tester d’une part la stabilité du complexe de ligand uranyle avec 
certains ions métalliques dans des conditions biologiques et d’autre part pour révéler l'interaction 
entre le système ternaire, ion uranyle/ligand/calmoduline. 
Ce projet s'est déroulé comme suit :  
- Synthétiser des ligands polyaminophosphonates capables de complexer l'uranium (VI) et 
l’europium (III) dans un milieu biologique. 
- Caractériser les structures du complexe du ligand uranyle formé par les ligands 
polyaminophosphonates synthétisés. Estimer les affinités de ces complexes de ligands uranyle par 
rapport au 5-LICAMS et au 3,4,3-LI(1,2-HOPO), qui ont une bonne application dans le traitement 
par chélation. L'étude des mécanismes de compétition avec le complexe et le ligand d'uranyle 
calmoduline et avec le complexe et le ligand d'uranyle ligand et l'ion métallique de compétition  
- Caractériser les structures de l'europium (comme analogue de américium/curium) complexe 
ligand formé par des ligands polyaminophosphonates synthétisés. 
2 Synthèse de ligands polyaminophosphonates 
Le ligand pour le contraste de l'IRM qui a fait l'objet d'études approfondies est un candidat 
prometteur. Ces ligands, de masse moléculaire comprise entre 300 et 600, pourraient fournir une 
coordination 7-8 pour le lanthanide et avoir une affinité de complexation vraiment forte. De plus, 
l'excrétion du complexe de ligands métalliques est assez rapide, de quelques heures à quelques jours. 
La toxicité est relativement faible.  
Parmi tous les ligands de contraste de l'IRM, les ligands polyaminophosphonates ont été choisis 
pour cette étude. La synthèse des ligands polyaminophosphonates a été développée par le groupe de 
Loïc Charbonniaire de l'IPHC. L'idée principale est d'utiliser des groupes phosphonés ayant un 
caractère de base dure et une charge négative élevée pour fonctionnaliser les positions 2 et 6 de la 
pyridine. De cette façon, la stabilité du complexe uranyle-ligand pourrait être augmentée. 
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Figure 1 : Structure chimique des ligands L1, L2, L3 et L4. 
 
Pour obtenir les ligands polyaminophosphonates L1-L3 (Figure 1), il faut une synthèse préalable 
de la plateforme pyridinique 1 qui porte les bras phosphonates (Figure 2). Les précurseurs des bras 
phosphonés sont les composés 3 et 5 (Figure 2). 
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Figure 2 : Structure chimique des précurseurs. 
 
La synthèse du ligand bis-phosphoné L1, L2 et L3 (Schéma 1) a été adaptée à partir de 
préparations connues de ligand pyridine phosphoné. L2 et L3 ont été obtenus par bromation de la 2,6-
dihydroxyméthylpyridine 1 disponible dans le commerce avec PBr3 à 0 °C, donnant 2,6-
dibromométhylpyridine (95%). Le diéthyl ((benzylamino)méthyl)phosphonate 3 a été obtenu à partir 
de benzylamine en deux étapes (schéma 1). On a ajouté du formaldéhyde à une solution agitée de 
benzylamine pour obtenir de la 1,3,5-Tribenzylhexahydrotriazine 2 (91%). Le composé 3 désiré (42%) 
a été synthétisé par réaction avec du diéthylphosphite. La réaction N-alkylation de 1 avec 3 a donné 
naissance au composé bisphosphoné 4 (79%) qui a donné le ligand L1 (9%), L2 (13%) et L3 (52%) 
après hydrolyse des groupes phosphonates par 6M HCl. 
 1  7
 L 1  L 2  L
 3
9% 13% 52%
K
2
CO
3
,MeCN
79%
reflux
 
Schéma 1 : Voie synthétisée des ligands bisphosphonate. 
 
3 Étude structurale et thermodynamique de l'uranyle avec des ligands 
polyaminophosphonates 
Après la caractérisation du ligand, l'étude d'interaction de l'uranyle et des ligands a été réalisée à 
pH 3 et 7,4. 
L'étude du complexe uranyle- L3 se déroule en 3 étapes à pH 3, l'uranyle étant principalement 
complexé par ion chlorure dans la première étape (0-0,2eq). Pour la deuxième étape (0,2-0,6eq), 
l'espèce principale est le complexe uranyle avec des groupes phosphonates de deux L3. L'espèce 
dominante est le complexe d'uranyle avec L3 dans la partie interne du ligand pour la troisième étape 
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(0,6-1 éq.).  
L'étude du complexe uranyle- L4 se déroule en deux étapes à pH 3 : il s'agit principalement d'un 
complexe uranyle avec des groupes phosphonates de L4 dans la première étape (0-0,2eq). Pour la 
deuxième étape (0,2-1 éq), l'espèce dominante est le complexe uranyle avec L4 dans la partie poche.  
Les ligands organiques monophosphonates protonés limitent l'affinité de complexation de 
l'uranyle à faible concentration. L'effet stérique de deux groupes benzyle de L3 pourrait limiter la 
liberté de coordination avec l’uranyle. 
Pour le complexe uranyle-ligand 1:1, les environnements de l'ion uranyle sont les mêmes pour 
les deux ligands, L3 et L4. La coordination se compose de deux atomes d'oxygène provenant de 
groupes phosphonates monodentés, d'un atome d'azote provenant du groupe pyridine et de deux 
atomes d'azote provenant des parties amine. 
A pH 7,4, les deux voies de dégradation sont minimisées par la mesure par le complexe uranyl-
ligand non-fluorescent. Pour les deux ligands, l'ion uranyle est directement complexé avec le ligand. 
Il n'y a qu'une seule espèce dans toute l'étude. Les ligands organiques phosphonates déprotonés sont 
plus faciles à complexation avec l'ion uranyle. L'environnement de coordination du complexe 
uranyle-ligand peut être le même selon la propriété de non-fluorescence.   
Pour le complexe uranyle-ligand 1:1, les environnements de l'ion uranyle sont les mêmes pour 
les deux ligands, L3 et L4. La coordination se compose de deux atomes d'oxygène provenant de 
groupes phosphonates monodentés, un hydroxyde, un atome d'azote provenant du groupe pyridine et 
deux atomes d'azote provenant des parties amine. En raison de la présence d'hydroxyde dans la 
coordination à pH 7,4, l'ion uranyle se déplace en avant du groupe pyridine.  La stoechiométrie des 
complexes uranyle-ligand à pH 7,4 est de 1:1 à 0-1 éq uranyle. 
Les constantes de complexation des ligands (Kconcd) sont 17,08 pour L2 et 15,2 pour L3 à pH 
7,4. Une comparaison a été effectuée avec le 5-LICAMS et le 3,4,3-LI(1,2-HOPO), qui sont des 
ligands bien connus et qui présentent des capacités d'élimination de l'uranyle in vivo. Les constantes 
de complexité sont 17 pour le 5-LICAMS et 16,87 pour le 3,4,3-LI(1,2-HOPO). Ainsi, les ligands 
polyaminophosphonates, synthétisés dans cette étude, ont des constantes de complexation similaires 
aux deux ligands cités. Le complexe uranyle- L3 présente une bonne stabilité face au calcium et au 
magnésium. Le test d'affinité par chélation avec les protéines a montré que l'ion uranyle a été soustrait 
de la calmoduline par 1eq L3 en 15 minutes, ce qui permet d'envisager des applications potentielles 
de décorporation d'uranium. 
Les ligands bis-phosphonés ont donc de fortes affinités de complexation et une bonne stabilité 
avec l'ion uranyle dans des conditions biologiques grâce à la bonne conception des agents chélatants. 
 
4 Étude thermodynamique de l’europium avec des ligands 
polyaminophosphonates 
En raison de l'activité massique élevée de l'Am/Cm(III), Eu(III) a été utilisé comme analogue 
chimique pour effectuer les études. En raison de la faible solubilité du complexe Eu- L3 dans 0,1M 
NaClO4, l'étude de la constante thermodynamique a échoué.  
Une combinaison similaire du spectre d'absorption UV-Vis et de l'étude TRLFS a été réalisée 
pour le complexe Eu- L3 et le complexe Eu- L4 à pH 3, 5 et 7,4. En raison de l'hydrogène sur les 
parties amines, l'ion Eu(III) est complexé avec des groupes phosphonate de ligand à faible pH, tandis 
qu'à pH élevé, l'ion Eu(III) est situé dans la partie interne du ligand en raison de la diminution de la 
concentration en hydrogène.  
Le spectre EAXFS obtenu a été ajusté en utilisation la contribution de molécules d'eau et de 
groupes fonctionnels de ligands. Pour le complexe Eu- L3 à pH 3, la contribution du ligand provient 
uniquement des groupes phosphonates. Pour le complexe Eu-L4 à pH 7,4, il n'a pas été possible de 
procéder à l'ajustement, ce qui pourrait être dû à la dégradation du complexe Eu-L4 sous le faisceau.  
5 Perspectives 
Ce projet est la première étape dans le développement d'agents chélatants polyaminophosphonés 
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à base de pyridine pour la décorporation des actinides. Il reste encore beaucoup d'études à étudier et 
à caractériser.  
- Constantes de formation de l'ion uranyle avec L2, L3 et L4: l'étude de la constante de formation 
pourrait être réalisée par titrage potentiométrique dans 0,1M NaCl avec protection Ar et sans lumière; 
- Constantes de formation d'autres actinides avec L2 et L3 dans 0,1M NaClO4 : les constantes de 
formation pourraient être réalisées par titrage potentiométrique dans 0,1M NaClO4 avec d'autres 
actinides. Les résultats pourraient donner une idée de l'affinité de complexation de l'europium avec 
L2 et L3 en raison de la similitude des lanthanides ; 
- Toxicité des agents chélatants polyaminophosphonés à base de pyridine ;  
- Le traitement par chélation au moyen d'agents chélatants à base de pyridine 
polyaminophosphonée pour séquestrer les actinides afin de prévenir les effets aigus et les effets à 
long terme ;   
 
Figure 3 : Structures du ligand pyridine bis-phosphoné 
- La synthèse d'un nouveau ligand pyridine bis-phosphoné (Figure 3) pour les agents chélatants 
de l'uranium par remplacement de l'azote des parties amines par l'oxygène : la présence d'hydroxyde 
de coordination uranyle à pH 7,4 peut dépendre des 3 atomes d'azote qui peuvent être définis comme 
donneur intermédiaire ou donneur mou. En utilisant de l'oxygène, 4 donneurs durs pourraient être 
dans la coordination uranyle. La stabilité de l'uranyle avec le nouveau ligand pourrait ainsi être plus 
élevée. 
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Résumé: En cas d’accidents nucléaires 
(Tchernobyl, Fukushima) ou d’exopsition à 
de l'uranium appauvri dans des zones de 
conflit, la décontamination est nécessaire 
pour réduire au mieux les conséquences de 
l’ingestion de radionucléides. Après une 
contamination externe ou interne, les 
actinides solubilisées sont distribués dans les  
organes cibles (squelette, foie, tissus, reins, 
etc.) via la circulation sanguine. Compte tenu 
de cette dispersion, la chélation de ces 
radionucléides par des ligands biologiques 
est une méthode efficace de décorporation 
pour favoriser l'excrétion de ces métaux 
déposés et ainsi réduire les risques pour la 
santé. 
En raison du faible taux de distribution 
dans les organes cibles (os, foie, reins) de 
l'acide diéthylènetriaminepentaacétique 
(DTPA), des agents de chélation ont été 
synthétisés et testés in vitro ou in vivo. Dans 
ce projet, plusieurs ligands 
polyaminophosphonates, (conçus à l'origine 
pour être des agents de contraste), ont été 
synthétisés selon leurs propriétés de bio-
distribution, de leurs groupes fonctionnels, 
de leur potentiel  site de  coordination  et  de 
leur lipophilie. Des études structurales et 
thermodynamiques ont ensuite été effectuées 
sur les complexes entre l'uranium (VI) et 
l’europium (III) (comme analogue de 
l’américium (III) et curium (III)) et les 
ligands polyaminophosphonates. La sphère 
de coordination de ces cations a été observée 
par spectroscopie UV-visible, TRLFS, FT-IR 
et la spectroscopie d’absorption X (EXAFS). 
L'étude de l’affinité a été réalisée par 
spectroscopie UV-visible. Enfin, les 
spectroscopies UV-visible et TRLFS ont été 
utilisées d’une part pour tester la stabilité du 
complexe ligand/uranyle en présence d’un 
ion métallique et d’autre part pour étudier le 
système ternaire : ion 
uranyle/ligand/calmoduline. 
Ces résultats ont permis de mieux 
comprendre les mécanismes de chélation et 
d’évaluer l'affinité chimique de ces ligands 
polyaminophosphonates pour l'uranium (VI) 
et l’europium (III). Cela devrait ainsi aider à 
la conception de nouveaux agents de 
chélation de plus en plus efficaces du point 
de vue de la décorporation. 
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Abstract : For exposed person who 
suffers from contamination of nuclear 
accidents (Chernobyl, Fukushima) or 
depleted uranium in war zones, 
decontamination is required to reduce the 
sequence damage of radionuclide intake. 
After an external or internal contamination, 
the solubilized actinides could be distributed 
to the target organs (skeletal, liver, kidneys 
tissues, etc.) via the bloodstream. Actinides 
are radio-toxic and chemo-toxic elements. 
Considering the dispersion, fate and health 
effect of the actinides, chelation therapy is an 
effective decorporation method to promote 
the excretion of deposited actinides to reduce 
the health risk.  
Due to the defect on weak distribution 
rate to the target organs (bone, liver, kidneys) 
of diethylenetriaminepentaacetic acid 
(DTPA) which currently used in clinics, 
plenty chelation agents were synthesized and 
tested in vitro or in vivo. In this project, 
several polyaminophosphonates ligands, a 
series ligand originally designed for MRI 
contrast and  SPECT  agents,  were   
synthesized according to the properties of 
ligand bio-distribution, functional groups, 
coordination site and lipophilic. Then the 
structural and thermodynamic studies were 
done with the complexes between metal ion 
such as uranium(VI) and europium(III) (as 
americium/curium(III) analogue), and 
polyaminophosphonates ligands. The sphere 
of coordination of these cations was 
observed by UV-visible spectroscopy, 
TRLFS, FT-IR and Extended X-Ray 
Absorption Fine Structure (EXAFS). The 
affinity study was done with UV-visible 
spectroscopy. Finally, the UV-visible 
spectroscopy and TRLFS were used to test 
the stability of uranyl ligand complex with 
competition metal ion in biological 
conditions and to reveal the interaction 
between the ternary system, uranyl 
ion/ligand/calmodulin. These results allow 
to better understand the chemical affinity and 
possible chelation mechanism of the 
polyaminophosphonates ligands for the 
above actinides and therefore to promote the 
design of new chelation agents. 
 
 
 
